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Plants have evolved over millions of years and have therefore become masters at making the 
molecules they require to survive. Many of these molecules (known as natural products) are 
valuable to us humans, as they can be used for various applications, such as in our 
agrochemicals and medicines. As plants often produce only small quantities of natural 
products, it is difficult to obtain enough material for our every-day use. It is therefore important 
to be able to access natural products by making them in the laboratory. 
The methods used in the laboratory to make these molecules are often wasteful and come with 
a high economic and environmental cost. Our research group therefore tries to mimic the 
methods used by plants to inspire the chemical approach taken in the laboratory to make these 
important materials. This allows us to develop new strategies to make the process more cost-
effective and efficient. 
The first part of this thesis describes our efforts to synthesise two related natural products, 
called angiopterlactone A and angiopterlactone B. They were discovered in a fern species 
found in Asia, which has been used in ancient Chinese medicine to treat various ailments such 
as snake bites and rheumatic pains. Firstly, we analysed how the fern is likely to make these 
compounds. We then used this analysis to develop a short and efficient strategy with which 
we could access angiopterlactone B from a cheap and readily available starting material.  
We also tried to make the related natural product angiopterlactone A, but after several attempts 
we had no success. As work in the laboratory is time intensive and expensive, it is possible to 
instead apply computational studies to predict structures of materials and reaction outcomes. 
The second part of this thesis describes the use of computational studies to understand why we 
did not manage to make angiopterlactone A. The results of these studies were then used to 







This thesis details our experimental and computational investigations into the (bio)synthesis 
of two related and structurally complex natural products: angiopterlactone A and 
angiopterlactone B.  
Chapter 1 introduces these natural products and outlines our biosynthetic speculations. It 
further describes our successful total synthesis of angiopterlactone B in four steps, starting 
from commercially available 2-acetylfuran. Particularly noteworthy is the final dimerisation, 
in which three new bonds, two new rings and three new stereogenic centres are formed in a 
single step. The structure and absolute configuration of our synthetic material was confirmed 
by X-ray crystallography and led us to revise the structure of the natural material. 
Chapter 2 outlines our computational nuclear magnetic resonance (NMR) studies of 
angiopterlactone A. These were utilised to investigate the relative configuration of 
angiopterlactone A, which we suspected was assigned incorrectly by the isolation chemists. A 
number of different methods were applied to predict the chemical shift and coupling constant 
data for some of our in-house synthesised compounds, as well as for angiopterlactone A. 
Utilising a combination of biosynthetic speculations, our synthetic experience, as well as our 
computational studies, we propose a revised structure for angiopterlactone A. 
Chapter 3 details our computational mechanistic investigations into the (bio)synthesis of 
angiopterlactone B, as well as its diastereoisomer dia-angiopterlactone B. These studies led us 
to propose that the key dimerisation step proceeds via a domino oxa-Michael/Michael/ring 
contraction sequence. Various homo- and cross-couplings of lactones were investigated to 
shed light on the predisposed reactivity and selectivity at play in the biogenesis of these natural 
products. We discovered that angiopterlactone A is unlikely to be accessible via this 
(bio)synthetic route.  
Chapter 4 summarises the work presented and provides further speculations on the 
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1.1.1 Angiopterlactones A and B: Isolation and Structural Elucidation 
 
Our natural product targets (−)-angiopterlactone A (1) and (+)-angiopterlactone B (2) (Figure 
1) are two compact and complex bis-lactone metabolites.2 Each contain an array of oxygen 
functionalities, as well as multiple contiguous stereogenic centres. The structural complexity 
of these metabolites, in combination with the biological activities reported for the extracts of 
Angiopteris plants,3 make these compounds of significant interest to synthetic chemists. Both 
angiopterlactones (1, 2) were isolated by Zou and co-workers in 2009 from the rhizomes of 
Angiopteris caudatiformis, a fern species native to Asia.2 The rhizome of this fern is used in 
China to treat a variety of ailments, including but not limited to enteritis and tuberculosis.2 It 
is interesting to note that from ten kilograms of Angiopteris caudatiformis 230 mg of (−)-
angiopterlactone A (1) were isolated, whereas only 20 mg of (+)-angiopterlactone B (2) were 
extracted.2  
          
Figure 1: Structures of (−)-angiopterlactone A (1) and (+)-angiopterlactone B (2) (proposed by Zou and 
co-workers)2  
The atom connectivity within the angiopterlactones (1, 2) was established by Zou and co-
workers, utilising 1D and 2D NMR spectroscopy.2 The relative configuration of (−)-
angiopterlactone A (1) was determined through NOESY experiments. A NOESY correlation 
between H3' and H5 led the authors to assign a cis relationship between these protons. 
However, given the rotatable nature of the ether linkage, this assignment could be flawed. 
They further utilised NOESY correlations to propose cis relationships between H2' and H3', 
as well as between H5 and H6. The absolute configuration of (−)-angiopterlactone A (1) was 
then determined by establishing the absolute stereochemistry of positions C6, C6' and C3'. 
Positions C6 and C3' were assigned as S and R respectively by employing the CD excitation 
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chirality method. The modified Mosher’s method was utilised to determine the 
stereochemistry of position C6' to be S.2  
The relative configuration of (+)-angiopterlactone B (2) was initially based on comparison to 
the stereochemistry observed in (−)-angiopterlactone A (1) and was then confirmed by X-ray 
crystallographic studies (Figure 1). The absolute configuration of (+)-angiopterlactone B (2) 
was then established through use of the CD excitation chirality method for positions C4 and 
C3' (both R) and modified Mosher’s method for position C6' (S).2 For a more detailed 
discussion regarding the assignment of stereochemistry, see Section 1.2.3. 
 
 
1.1.2 Biosynthetic Speculation 
 
Compounds co-isolated alongside natural products can often provide useful information and 
shed light upon their potential biosynthetic origins. Although the absolute configuration for 
each of the angiopterlactones (1, 2) was clearly presented and discussed in the isolation paper, 
no stereochemistry (neither relative nor absolute) was provided for their co-isolated 
compounds (Figure 2).2 
 
 
Figure 2: Representation of the angiopterlactones (1, 2) and co-isolated compounds (as shown in the 
isolation paper)2 
This makes it challenging to draw any firm conclusions as to plausible biosynthetic origins of 
the angiopterlactones (1, 2), particularly as various stereoisomers of these three compounds 
have previously been reported in the literature (e.g., compound 3 and its three stereoisomers 
have all been reported).4,5,6,7,8 Despite the ambiguity surrounding the precise stereochemistry 
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of the co-isolated compounds, their general structures still provide useful clues regarding 
possible biosynthetic pathways to the angiopterlactones (1, 2). 
 
Scheme 1: Our proposed biosynthesis for angiopterlactones A (1) and B (2) 
The isolation chemists speculated that (+)-angiopterlactone B (2) may be derived from (−)-
angiopterlactone A (1) via an intramolecular Michael addition (Scheme 1).2 With no further 
speculation provided, we proposed that (−)-angiopterlactone A (1) may be formed via an 
intermolecular oxa-Michael addition between mono-lactones 3 and 4. We proposed this for 
two main reasons, the first one being that lactones 3 and 4 are isomers of one another. There 
is literature precedent for similar δ-lactones to undergo a ring contraction to the corresponding 
γ-lactone (i.e., δ-lactone 5 to γ-lactone 6: Scheme 2),6,9 thus making δ-lactone 3 a possible 
biosynthetic precursor to γ-lactone 4. Secondly, a closer inspection of δ-lactone 3, revealed 
that it could conceivably be the aglycone of compound 7, which bears resemblance to the 
known natural products osmundalin (8) and angiopteroside (9).3,10 Our biosynthetic proposal 
raises many significant questions regarding control over chemo-, regio- and stereoselectivity 
and the potential need for enzyme involvement. However, there is promising literature 





Scheme 2: Previously reported ring contractions of δ-lactone 5 to the corresponding γ-lactone 66 
 
 
1.1.3 Domino oxa-Michael/Michael Reaction Sequences 
 
In our proposed biosynthesis of the angiopterlactones (1, 2), (+)-angiopterlactone B (2) is 
formed via a domino oxa-Michael/Michael reaction sequence. It is important to note that oxa-
Michael additions (integral to our proposed domino sequence) can have significant 
disadvantages. These include: reversibility, poor nucleophilicity of the alcohols and a lack of 
stereoselectivity.11,12 In order to increase the reactivity of the system, two possible methods of 
activation have been reported: employing bases to enhance the nucleophilicity of the alcohol; 
and applying Lewis or Brønsted acids for activation of the conjugate acceptor.11 The issue of 
reversibility (prevalent particularly in intermolecular oxa-Michael additions) can be 
effectively negated by embedding these oxa-Michael additions into domino processes.12 
Making use of complex domino reaction sequences in target-oriented synthesis can result in a 
multitude of advantages. Not only is it possible to obtain significant molecular complexity in 
a single transformation, but domino reactions also typically provide good stereocontrol and 
can result in better overall yields compared to stepwise approaches.13  
Similar domino processes containing consecutive Michael additions have previously been 
reported in the literature.14,15,16,17,18,19 For example in 2002, Taylor and co-workers reported the 
use of stoichiometric amounts of lithium hydroxide to synthesise highly functionalised 
tetrahydrofuran derivatives from hydroxyenones (Scheme 3).14 A few months later, Carreño 
and Ribagorda reported the use of stoichiometric amounts of sodium hydride to form 




Scheme 3: Example domino oxa-Michael/Michael processes from the literature14,15 
A pertinent example of a domino oxa-Michael/Michael process is found in the total synthesis 
of (±)-incarviditone (10), which was accomplished by a former PhD student in the Lawrence 
group (Dr Patrick Brown).17 It provided a useful study for our angiopterlactone system as they 
share the common feature of a domino oxa-Michael/Michael tetrahydrofuran ring-forming 
reaction (Scheme 4). This reaction was carried out at 70 °C in dichloroethane in the presence 
of 0.1 equivalents of potassium carbonate. The domino sequence was initiated by the 
homochiral oxa-Michael addition of (±)-rengyolone (11). The reversibility of the oxa-Michael 
addition in the key dimerisation step was combatted by trapping the product in a subsequent 
Michael addition.17 This successful domino oxa-Michael/Michael process gave us sufficient 
encouragement to utilise this proposed domino sequence toward the biomimetic synthesis of 
angiopterlactones A and B (1, 2).  
 
Scheme 4: Synthesis of (±)-incarviditone (10) from (±)-rengyolone (11)17 
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1.1.4 Previous Synthetic Approach 
 
A previous synthetic approach to the angiopterlactones (1, 2) was attempted by Ellen Rykers 
as part of an undergraduate project in the Lawrence Group at the Australian National 
University in Canberra.20 At the time, γ-lactone 4 was deemed to be synthetically easier to 
target than δ-lactone 3 and it was proposed that angiopterlactones A and B (1, 2) may be 
formed via isomerisation/dimerisation of γ-lactone 4. 
 
Scheme 5: Synthesis of γ-lactone 4 (unpublished work; E. Rykers)20 
 
The enantioselective synthesis of γ-lactone 4 was achieved in two steps (Scheme 5). The first 
step was a Still–Gennari (modified Horner–Wadsworth–Emmons) reaction of crotonaldehyde 
12, to yield (Z,E)-dienoate 13 in 60% isolated yield. Dienoate 13 was then regio- and 
enantioselectively dihydroxylated using the Sharpless asymmetric dihydroxylation (SAD) 
reaction with subsequent spontaneous cyclisation resulting in lactone 4. However, the fittingly 
named “SAD” reaction resulted in very poor overall yields and the isolation of pure compound 
proved to be particularly challenging. Despite these difficulties, small quantities of pure γ-
lactone 4 were isolated, which were utilised to examine an array of isomerisation and 
dimerisation conditions. These included varying the solvent, temperature and additive (both 
acids and bases). None of the conditions tested resulted in successful isomerisation or 
dimerisation and instead the only observed outcomes were either no reaction, epimerisation of 
lactone 4 or dehydration of lactone 4 (see examples in Scheme 6).  
 
Scheme 6: Failed dimerisation attempts of lactone 4 (unpublished work; E. Rykers)20 
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1.1.5 Planned Synthetic Approach 
 
The lack of success in isomerising or dimerising γ-lactone 4 indicated that accessing δ-lactone 
3 was essential for further investigations into the biomimetic synthesis of (−)-angiopterlactone 
A (1) and (+)-angiopterlactone B (2). An extensive literature search for pre-existing syntheses 
of δ-lactone 3, revealed that a variety of such procedures exist. Of the available reported 
syntheses, there were two of particular interest, due to their step economy (Scheme 7). The 
first of the two options was reported by Zhang and co-workers in 2007.8 The authors utilise a 
chiral pool starting material in order to gain access to lactone 3 in four steps. The second option 
was presented by Guo, Tang and co-workers.21 They achieved an enantioselective synthesis of 
lactone 3 in a mere three steps and so this synthesis formed the basis of our synthetic plan. The 
synthesis reported by Guo, Tang and co-workers began with the commercially available and 
inexpensive 2-acetylfuran (14). Upon completing an enantioselective Noyori reduction, the 
resulting (S)-alcohol 15 was subjected to an Achmatowicz reaction to form lactol 16 as an 
inconsequential mixture of diastereoisomers. A diastereoconvergent isomerisation then gave 
access to the required (S,S)-lactone 3.  
 
Scheme 7: Two literature syntheses of lactone 38,21 
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1.2 Results and Discussion 
 
The synthesis of (−)-angiopterlactone A (1) and (+)-angiopterlactone B (2) was envisioned to 
proceed by isomerising and dimerising δ-lactone 3. Following a similar protocol to that 
reported by Guo, Tang and co-workers,21 our initial endeavours were focused towards 
synthesising δ-lactone 3 via a three step process from 2-acetylfuran (14) (Scheme 8). 
 
Scheme 8: Our planned synthetic route towards the angiopterlactones (1, 2) 
 
 
1.2.1 Synthesis of Lactone 3 
 
Synthesis of (S)-Alcohol 15 
The first step in the synthesis towards lactone 3 is the enantioselective reduction of a ketone 
to a secondary alcohol. Our natural product targets require access to enantiopure material, as 
Zou and co-workers report the isolation of angiopterlactone A (1) and angiopterlactone B (2) 
in enantio-enriched form.2 In the year 1980, Noyori and co-workers reported the use of cationic 
Rh-BINAP complexes in asymmetric hydrogenations of α-(acylamino) acrylic acid derivates 
to gain access to the analogous amino acid derivatives in high enantiomeric excess.22 Since 
then, extensive research has been completed in the field, leading Noyori and co-workers to the 
discovery of oligomeric halogen-containing Ru(II)-BINAP complexes.22 These complexes 
proved to be efficient catalysts for the asymmetric hydrogenation of functionalised ketones. 
The so-called “Noyori asymmetric hydrogenation” refers to the reduction of ketones and 
olefins, utilising hydrogen gas and Ru(II)-BINAP complexes. A baffling number of 
applications for the Noyori asymmetric hydrogenation have been reported in the literature. An 
example within natural product synthesis includes the stereocontrolled and convergent 
synthesis of the CD spiroketal unit of spongistatin 1 (17) (Scheme 9).23 This natural product 
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is a marine macrolide that displays exceptional anti-tumour activities against a variety of 
human cancer cell lines.22,24 On route to the spiroketal unit 17, Holson and Roush utilised the 
(R)-enantiomer of the BINAP ligand to access (R)-alcohol 18 in good yield and high 
enantiomeric ratio (e.r.) (Scheme 9).23 
 
Scheme 9: Noyori asymmetric hydrogenation in the synthesis towards the CD spiroketal unit of 
spongistatin 1 (17)23 
Since the development of Ru(II)-BINAP complexes, further research in the field led to the 
discovery of a highly enantioselective reduction with a new class of chiral ruthenium catalyst. 
These catalysts employ toluenesulfonyl-diphenylethylenediamine (TsDPEN) as a ligand and 
have since been applied in a wide-range of reactions, particularly for prochiral ketones and 
imines.25,26 Xiao and co-workers reported asymmetric transfer hydrogenations of ketones 
using formate in water and a rhodium catalyst with a TsDPEN ligand.26 Such reactions are 
particularly attractive due to the non-toxic and non-flammable properties of water. Carreira 
and co-workers report a procedure for the enantioselective reduction of 2-acetylfuran (14) (our 
proposed starting material) to alcohol ent-15 utilising such a Rh-TsDPEN complex (19).27 
Despite requiring access to alcohol 15, we utilised Carreira’s method to initially target alcohol 





Scheme 10: Enantioselective reduction of 14 to alcohol ent-15  
The procedure outlined by Carreira et al. involves the in situ formation of rhodium catalyst 
19. Subsequent addition of sodium formate and 2-acetylfuran (14), resulted in the formation 
of alcohol ent-15 in 99% yield. Upon implementation of this literature procedure, we 
successfully accessed alcohol ent-15 (Scheme 10), however we discovered several drawbacks 
to the reaction. Firstly, we could not reproduce the high yield reported by Carreira and co-
workers.27 Instead only a moderate crude mass recovery was achieved, ranging between 55-
75%. Furthermore, full conversion of starting material to product was never observed, despite 
reaction times exceeding the 23 hours suggested by the literature. As we could not reliably 
reproduce the literature results, we investigated alternative conditions for the enantioselective 
reduction of 2-acetylfuran (14). 
Alternative conditions for the enantioselective reduction of 2-acetylfuran (14) were developed 
by Paterson and Haslett.28 This involved the use of (S,S)-Noyori catalyst 20, formic acid and 
triethylamine, to afford alcohol 15 in 99% yield and in an e.r. of 99:1.28 We synthesised (S,S)-
Noyori catalyst 20 following a literature procedure reported by Noyori and co-workers, which 
afforded us with more than 700 mg of the catalyst in >95% yield (Scheme 11).29 Reduction of 
2-acetylfuran (14) to alcohol 15, utilising freshly prepared (S,S)-Noyori catalyst 20, was 
successfully accomplished with a crude mass recovery >95%. The 1H NMR spectrum showed 
very clean formation of product. During purification by column chromatography, a loss of 
approximately 50% of the mass was consistently observed. It was therefore decided to use the 
crude material in the next step of the synthesis without purification. The e.r. was determined 
by chiral HPLC by comparison to authentic samples of racemic alcohol 15. After repeating 
the experiment several times on various scales, it was eventually completed on a multi-gram 







Scheme 11: Synthesis of (S,S)-Noyori catalyst 20 and the enantioselective reduction of 2-acetylfuran 
(14) to alcohol 15 
 
Synthesis of Lactol 16 
With alcohol 15 in hand, we set out to investigate the subsequent conversion to lactol 16 
(Scheme 8, Page 22). The conversion of alcohol 15 to lactol 16 can be achieved utilising the 
Achmatowicz rearrangement. The Achmatowicz rearrangement is a reaction in which furfuryl 
alcohols undergo an oxidative ring enlargement.30 There are numerous conditions with which 
furfuryl alcohols can undergo an Achmatowicz rearrangement. One of the most common sets 
of conditions, which has shown great success in the total synthesis of complex natural 
products, utilises N-bromosuccinimide (NBS) in aqueous tetrahydrofuran (THF).30 An 
example of an NBS mediated Achmatowicz rearrangement can be found in the total synthesis 
of castasterone (21), a plant-growth-regulating steroid (Scheme 12).31 Upon subjecting 





Scheme 12: Achmatowicz rearrangement step in the total synthesis of castasterone (21)31 
Similar conditions were utilised by Guo, Tang and co-workers, whose general synthetic 
strategy we were following to gain access to lactone 3 from 2-acetylfuran (14) (Scheme 7, 
Page 21). It has been suggested in the literature that the Achmatowicz rearrangement proceeds 
via bromination and oxidation of the furfuryl alcohol, followed by ring opening and 
consequent ring enlargement (Scheme 13).30,32 Implementation of this NBS-mediated 
rearrangement led us to the successful conversion of alcohol 15 to an inconsequential 
diastereomeric mixture (2:1) of lactol 16 (Scheme 13). Presumably this 2:1 ratio is in favour 
of the cis isomer, as Guo, Tang and co-workers21 reported a 3:1 cis:trans ratio of lactol 16. 
However, as the authors did not provide NMR data it is hard to determine for certain whether 
our attained 2:1 ratio favours the cis- or the trans-diastereoisomer. Our synthesis of lactol 16 





Scheme 13: Our Achmatowicz rearrangement of alcohol 15 to lactol 16 
 
Synthesis of lactone 3 / Dynamic Kinetic Isomerisation 
With several grams of lactol 16 in hand, our attention turned towards the diastereoconvergent 
isomerisation of lactol 16 to (S,S)-lactone 3. Guo, Tang and co-workers recently developed an 
iridium-catalysed dynamic kinetic isomerisation reaction which allows such a 
transformation.21 This is a rare example of a stereoconvergent internal transfer hydrogenation 
and the authors proposed a mechanism for this reaction (Scheme 14). The dehydrogenation of 
A and B is presumed to afford the metal complexes C and D respectively. Hydrogenation is 
then thought to result in products E and F. In the absence of a Brønsted acid catalyst, Guo, 
Tang and co-workers observed a ratio of 3:1 of E:F. They propose this to be a result of the 
rate of equilibration between the hemiacetals being slower than the rate of the internal transfer 
hydrogenation. Upon addition of an acid additive, the rate of interconversion between A and 
B became significantly faster than the internal transfer hydrogenation, making the 





Scheme 14: Guo, Tang and co-workers’ proposed mechanism for the iridium-catalysed isomerisation21  
 
Guo, Tang and co-workers completed optimisation studies and tested the scope for the 
transformation of various lactol species to their corresponding lactones. This led them to 
optimised conditions which consisted of utilising an Ir(COD)Cl dimer and 2,6-
dichlorobenzoic acid in chloroform.21 We subjected our lactol 16 to these conditions, to 
successfully gain access to (S,S)-lactone 3 with a high e.r. of 98:2 (Scheme 15). Upon scale-
up experiments the reaction was carried out on gram-scale, affording 2.7 g of lactone 3. With 
several grams of the monomeric lactone 3 in hand, efforts turned toward screening 
dimerisation conditions to target the angiopterlactones (1, 2). 
  




1.2.2 Dimerisation Studies  
 
It was our aim to find suitable conditions for the dimerisation of lactone 3 and then optimise 
them in order to selectively access either (−)-angiopterlactone A (1) or (+)-angiopterlactone B 
(2).  
Initially, we set out to utilise analogous dimerisation conditions to those which had previously 
been applied within the Lawrence group, due to the similarity in the domino oxa-
Michael/Michael THF ring forming reaction (Scheme 4, Page 19).17 These involved dissolving 
the starting material in dichloroethane, adding potassium carbonate and leaving the reaction 
mixture to stir overnight at 70 °C. The results from this first dimerisation attempt were very 
promising, as they successfully yielded 35% of the natural product (−)-angiopterlactone B (2) 
(Scheme 16). By inspection of the crude 1H NMR data, we could also determine the presence 
of unreacted starting material 3, γ-lactone 4 and γ-lactone 6. The formation of γ-lactone 4 is 
presumably a result of our planned ring contraction from the starting material. The γ-lactone 
6 is likely a consequence of base-mediated epimerisation of γ-lactone 4.  
 
Scheme 16: Our initial dimerisation attempt of lactone 3 to yield angiopterlactone B (2) and side-
products 4 and 6 
With our initial dimerisation attempt giving us an immediate hit, we wanted to investigate how 
modifying the reaction conditions might affect the outcome. We began by running the reaction 
at various temperatures. It was observed that at 40 °C no reaction occurred within three hours, 
whereas at 70 °C formation of dimer 2 could be observed within 30 minutes of starting the 
reaction. For temperatures exceeding 70 °C, the solvent dichloroethane (boiling point of 83 
°C)33 was removed before heating. At 110 °C, conversion of some starting material to product 
2 was observed, however with significant amounts of decomposition. At 160 °C, an even 
higher rate of decomposition was noted. With these results in mind, all following dimerisation 




Our initial conditions of potassium carbonate, dichloroethane and stirring at 70 °C overnight, 
formed the basis of our investigations. Dimerisation conditions were screened by completing 
small scale reactions, utilising internal standards and 1H NMR spectroscopy to gain 
quantitative data. The results of these reactions are summarised in Tables 1-6.1 
 
Varying the additive 
The investigation began by probing whether or not an additive was necessary for the 
dimerisation reaction to occur. Upon heating lactone 3 in dichloroethane overnight, no 
consumption of starting material could be detected by 1H NMR spectroscopy and thus it was 
concluded that an additive was indeed required. The next step was to investigate replacing 













1 Li2CO3 88 <1 <1 0 
2 Na2CO3 84 <1 0 0 
3 NaHCO3 79 <1 0 0 
4 K2CO3 9 2 2 25 
5 Rb2CO3 6 <1 <1 19 
6 Cs2CO3 11 1 <1 18 
7 (NH4)2CO3 29 3 1 0 
8 MgCO3 86 <1 <1 0 
9 CaCO3 87 <1 0 0 
10 KOH 42 4 3 10 
11 Pyrrolidine 47 20 7 0 
12 PTSA 0 57 3 0 
Table 1: Additive screen – Reproduced from Org. Lett. 2017, 19 (9), 2199–22011  
It is interesting to note that all trialled additives resulted in the formation of some γ-lactone 4 
and epimerised γ-lactone 6 (Scheme 16). The only reactions which resulted in successful 
dimerisation to angiopterlactone B (2) were entries 4, 5, 6 and 10. Entry 4 (potassium 
carbonate) provided the best yield and thus we continued our investigations utilising this 
additive. It is also interesting to note that our reaction conditions utilising PTSA at 70 °C, 
allow the formation of the ring-contracted γ-lactone 4 in 57% yield, with full consumption of 
the starting material and only minor quantities of the epimerised γ-lactone 6 present. The 
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previously reported methods in the literature for such ring contractions are less efficient and 
practical, requiring several months to obtain full consumption of the starting material.6,9 
 
Varying the potassium carbonate equivalents 
With potassium carbonate shown to be the highest yielding additive, the next step was to 
investigate the optimal stoichiometry. We trialled 0.2, 0.5 and 1.0 equivalents and found that 
the largest yield was provided by 0.2 equivalents (Table 2). The scale of these reactions was 
too small to accurately weigh out 0.1 equivalents of potassium carbonate. A larger scale 
reaction (400 mg of starting material 3) allowed the use of 0.1 equivalents of potassium 
carbonate and resulted in 28% isolated yield of dimer 2 (entry 1, Table 2). Further screening 
of conditions was completed on the same scale as previous attempts and therefore 0.2 













1* 0.1 - - - 28 
2 0.2 9 2 2 25 
3 0.5 5 <1 <1 19 
4 1.0 3 0 0 16 
*larger scale reaction (400 mg of starting material 3); 1.1 M, 70 °C, 40 h; yield refers to isolated yield 
Table 2: Potassium carbonate equivalents screen 
Reproduced in part from Org. Lett. 2017, 19 (9), 2199–22011  
 
Varying the solvent 
After varying the potassium carbonate equivalents, our investigation turned towards the 
solvent. Upon trialling alternative solvents (Table 3), it was found that dimer 2 formed in all 
of them (entries 1-7). Unfortunately chloroform and dichloromethane could not be heated to 













1 dichloroethane 9 2 2 25 
2 water 23 3 1 8 
3 toluene** 10 <1 <1 5 
4 acetonitrile 47 5 5 11 
5 carbon tetrachloride 38 2 2 11 
6 cyclohexane 27 2 2 9 
7 2-methyl THF 21 1 1 12 
*Chloroform and dichloromethane were trialled, but these could not be heated to sufficient temperatures for the 
dimerisation to take place in an acceptable time frame.                                                                                                                                    
**Poor crude mass recovery of <40%. 
Table 3: Solvent screen – Reproduced from Org. Lett. 2017, 19 (9), 2199–22011 
Throughout the screening of conditions, the related natural product (−)-angiopterlactone A (1) 
(proposed intermediate to angiopterlactone B (2)) was not observed. Zou and co-workers, who 
isolated both angiopterlactones (1, 2), reported the NMR data for (−)-angiopterlactone A (1) 
in deuterated dimethylsulfoxide (d6-DMSO).2 It was therefore reasoned that running and 
monitoring the reaction directly in this solvent, could facilitate detection of (−)-
angiopterlactone A (1) and/or other intermediates and side-products. Further to the results 
listed in Table 3, the reaction was completed in d6-DMSO, with initial attempts revealing a 
successful dimerisation process. The 1H NMR spectrum of the crude dimerisation product did 
not reveal the presence of (−)-angiopterlactone A (1). Unfortunately the heterogeneous nature 
of the reaction mixture complicated the running of the dimerisation directly in an NMR tube 
in the spectrometer. Further screening of dimerisation conditions was completed utilising 
dichloroethane, as product extraction from DMSO in larger scale reactions led to major loss 
of material. 
 
Varying the concentration 
Following our investigations into various solvents, we wanted to test whether a solvent was 
necessary for the reaction to occur. To this end, we heated neat lactone 3 with potassium 
carbonate which resulted in no reaction, therefore suggesting that the starting material and 
potassium carbonate (partially soluble in dichloroethane) must first be homogenised. Thus we 
tested dissolving the starting material first and adding potassium carbonate, before removal of 
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the solvent from the reaction mixture and consequently heating to 70 °C. Although this led to 
some dimerisation, it was found that the lack of solvent hindered consumption of starting 
material. Thus we investigated the effect of concentration on the dimerisation reaction. The 
reaction was completed utilising dichloroethane, with concentrations ranging from 0.5 M to 













1 0.5 66 2 <1 5 
2 0.8 14 2 2 15 
3 1.5 9 2 2 25 
4 3.1 13 3 3 28 
5 6.8 49 3 2 16 
Table 4: Concentration screen – Reproduced from Org. Lett. 2017, 19 (9), 2199–22011 
 
Varying the reaction time 
The final investigation we conducted on δ-lactone 3 was how reaction time affects the 
outcome. We noted that formation of dimer 2 reached a plateau after eight hours, with longer 
reaction times (e.g. 42 hours, entry 7, Table 5) leading to nearly full consumption of the 













1 1 66 3 2 5 
2 2 56 4 2 12 
3 3 55 4 3 15 
4 4 44 4 3 18 
5 5 37 5 4 20 
6 8 15 3 2 26 
7 42 2 0 0 26 
Table 5: Variation of reaction time – Reproduced from Org. Lett. 2017, 19 (9), 2199–22011 
34 
 
Further tests  
Our investigations into various additives revealed that we could access γ-lactone 4 from δ-
lactone 3 by utilising PTSA. Scaling-up this reaction led to the isolation of 75 mg of γ-lactone 
4. This material was then used to test the dimerisation conditions on this lactone, as well as on 
mixtures of the γ- and δ-lactones (3, 4) (Table 6).  
 









1* 4 0 6 6 0 
2* 3 (0.5 eq) & 4 (0.5 eq) 22 8 7 4 
3*,** 3 (1 eq) & 4 (0.1 eq) 8 1 1 16 
4 3 9 2 2 25 
* Note: γ-lactone 4 was slightly wet 
** Note: 1.8 M instead of 1.5 M  
Table 6: Dimerisation reactions utilising γ-lactone 4 
 
Upon subjecting γ-lactone 4 to the dimerisation conditions previously utilised (entry 1), 
epimerisation to γ-lactone 6 was observed. There was no formation of dimer 2 or δ-lactone 3. 
This suggests that that the ring contraction from δ-lactone 3 to γ-lactone 4 is indeed irreversible 
(as previously observed by Ellen Rykers; further investigations are discussed in Chapter 3)20. 
Furthermore, we noted that the 1H NMR spectrum showed some evidence of decomposition, 
suggesting that γ-lactone 4 may not be stable to the dimerisation conditions. This could explain 
our previous observations that upon longer reaction times, we do not increase the yield of 
dimer 2, but simultaneously consume almost all of the starting material (3) (Table 5). 
An equal mixture of δ-lactone 3 and γ-lactone 4 (entry 2) resulted in a lower yield of dimer 2, 
than when only δ-lactone 3 was utilised (4% vs 25%). Thus we completed a further test in 
which we added 10mol% of γ-lactone 4 to δ-lactone 3 (entry 3), which increased the yield of 
dimer 2 to 16%. This points towards the γ-lactone 4 not being directly involved in the 
dimerisation or perhaps even hindering the production of dimer 2.  
With the finalised reaction conditions in hand (K2CO3, dichloroethane, 70 °C), we turned our 
attention to testing the reproducibility and robustness of the dimerisation. The reaction was 
progressively scaled up from 20 mg to 3.5 g, with the final large scale reaction allowing for 
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the isolation of 864 mg of the natural product angiopterlactone B (2) in a single step (Scheme 
17). We then subjected the purified angiopterlactone B (2) to the dimerisation conditions, in 
order to ascertain whether it is stable to these conditions. After several hours, angiopterlactone 
B (2) remained unreacted. 
 
Scheme 17: Final large scale dimerisation reaction of lactone 3 to angiopterlactone B (2) 
 
Intriguing observations  
Examination of the 1H NMR spectrum of the crude dimerisation product of enantio-enriched 
lactone 3 reveals a remarkably selective reaction (Figure 3). The four major species present 
include recovered starting material (3), angiopterlactone B (2) and the two γ-lactones 4 and 6. 
Given the presence of the three lactones 3, 4 and 6 there are nine possible permutations to 
combine two of the three lactones and each pairing could result in eight diastereoisomers. Thus 
there are 72 possible dimeric structures (9 x 8 = 72), which could form via a domino oxa-
Michael / Michael reaction. It is therefore surprising that we observe the formation of a single 
dimeric structure, namely that of angiopterlactone B (2). The selectivity of this dimerisation 
reaction is further explored in Chapter 3. 
 
Figure 3: Methyl region of the 1H NMR spectrum of the crude dimerisation product (500 MHz, CDCl3) 
Reproduced in part from Org. Lett. 2017, 19 (9), 2199–22011 
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1.2.3 Structural Revision of (+)-Angiopterlactone B 
 
With angiopterlactone B (2) in hand, we investigated the structure proposed by the isolation 
chemists. Zou and co-workers reported an optical rotation of +22 (c 0.04, EtOAc),2 whereas 
that measured for our synthetic material was −25 (c 0.04, EtOAc).1 The absolute configuration 
of our synthetic material, (−)-angiopterlactone B (2), can be inferred from that of the preceding 
intermediates (3 and 15). It was further confirmed by the Flack parameter of 0.02(3) (explained 
in detail below), obtained during our X-ray crystallographic studies.1,34 We can therefore 
unequivocally assign the absolute configuration of our synthetic material, (−)-angiopterlactone 
B (2). This led us to propose that the absolute configuration of the natural material, 
(+)-angiopterlactone B (2) needs to be revised (Figure 4).  
 
Figure 4: Originally proposed2 structure of (+)-angiopterlactone B (2) and our revised structure1  
By considering our previously proposed biosynthesis (Scheme 1, Page 17), the revision of the 
absolute configuration reveals the known natural product angiopteroside (9) as a likely 
biosynthetic precursor (Scheme 18). Angiopteroside (9) is a glycoside natural product that has 
been isolated from several Angiopteris plants and was found to display promising activity for 
the inhibition of HIV-1 Reverse Transcriptase.35,10,3  
 
Scheme 18: Angiopteroside (9) as a likely biosynthetic precursor to (+)-angiopterlactone B (2) 
Two months after the publication of our total synthesis of (−)-angiopterlactone B (2) in 
Organic Letters,1 Bhattacharya and co-workers published a related total synthesis in the same 
journal.36 Their synthesis features the same intermediate δ-lactone 3, which upon subjecting 
to TBAF in anhydrous THF, resulted in a 62% yield of (−)-angiopterlactone B (2). Their seven 
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step synthesis towards δ-lactone 3 relies on the chiral pool starting material 24 and differs 
largely from our three step synthesis (Scheme 19).  
 
Scheme 19: Comparison of Bhattacharya synthesis36 and our synthesis1 of (−)-angiopterlactone B (2) 
Similarly to ourselves, Bhattacharya and co-workers concluded that the isolation chemists’ 
proposed structure for (+)-angiopterlactone B (2), did not coincide with their reported data. 
However, rather than re-assigning the absolute configuration of the natural material, 
Bhattacharya and co-workers state that their data unequivocally proves that the isolation 
chemists made a typographical error when reporting the sign of the optical rotation.36 
Bhattacharya et al. therefore suggest that the natural material is (−)-angiopterlactone B (2). 
This made us curious and thus we wanted to investigate this claim further. The methods 
utilised by the isolation chemists (Zou et al.)2, ourselves1 and Bhattacharya and co-workers36 
to assign the relative and absolute configuration of (+)/(−)-angiopterlactone B (2) are 













(c 0.04, EtOAc) 
 


























Values within square brackets are the Flack parameter, with its standard uncertainty 
*Note that Bhattacharya and co-workers did not report Flack parameters. These were extracted by our in-house 
crystallographer Gary Nichols using the files available on the CCDC database (1525957/1525958) 
Table 7: Summary of the data recorded in each of the publications pertaining to the assignment of the 
relative and absolute configuration of (+)/(−)-angiopterlactone B (2)1,2,36 
The basis of Bhattacharya and co-workers’ claim that the natural material must be (−)-
angiopterlactone B (2) is their observations from the CD excitation chirality method for their 
synthetic (+)- and (−)-angiopterlactone B (2). The latter resulted in a negative Cotton effect, 
which coincides with what the isolation chemists reported for the natural material. However, 
as the isolation chemists only reported the sign of the Cotton effect and did not provide the 
CD spectrum, it is possible that they made a typographical error when reporting the sign of the 
Cotton effect rather than the sign for the optical rotation. Therefore, Bhattacharya and co-
workers cannot claim to have unequivocally assigned the natural material as (−)-
angiopterlactone B (2). In order to gain further insights, we investigated how the relative and 
absolute configuration of angiopterlactone B (2) was determined in each of the publications. 
Upon closer inspection of the available data, it can be said that all three publications agree 
upon the atom connectivity and relative stereochemistry within the molecule. However they 
differ in the assignment of the absolute configuration. We assigned the absolute 
stereochemistry based on the absolute configuration of our preceding synthetic intermediates, 
as well as our X-ray crystal structure. This crystal structure resulted in a Flack parameter (x) 
and standard uncertainty (u) of x(u) = 0.02(3). Flack and Bernardinelli have previously 
reported that for the absolute configuration of a compound to be reliably determined by X-ray 
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crystallography, it must first be established that the standard uncertainty is reasonably small.37 
They state that u should be < 0.04 and x should be close to zero and within a region of three 
standard uncertainties (i.e., |x|/u < 3).37 Furthermore, Flack parameters > 0.5 typically indicate 
that the model of the crystal structure needs to be inverted.34 The x and u values obtained from 
our X-ray crystal structure (x = 0.02, u = 0.03)) satisfy all of the aforementioned requirements, 
thus confirming the absolute configuration of our synthetic (−)-angiopterlactone B (2).  
Bhattacharya and co-workers claim to have utilised X-ray crystallography to assign the 
absolute configuration. However, they did not provide the Flack parameter and standard 
uncertainty for their crystal structures and thus our in-house crystallographer Gary Nichol 
extracted them utilising the files available on the CCDC database. For (−)-angiopterlactone B 
(2) the Flack parameter is 0.6(9) and for (+)-angiopterlactone B (2) it is 1.4(10). Neither of 
these satisfy the above-mentioned requirements and thus Bhattacharya and co-workers cannot 
ascertain the absolute stereochemistry based on their crystal structure. Nevertheless, they 
could have deduced the absolute configuration from that of their preceding intermediates and 
by comparing their optical rotation to that of our synthetic (−)-angiopterlactone B (2). 
The isolation chemists based their assignment of the absolute configuration on the CD 
excitation chirality method and the modified Mosher method. The modified Mosher method 
can be utilised to assign the configuration of secondary alcohol centres and a detailed 
description of how to complete a Mosher analysis was reported by Hoye, Jeffrey and Shao in 
2007.38 Upon reacting an alcohol separately with each of the enantiomers of α-methoxy-α-
trifluoromethylphenylacetyl chloride (MTPA-Cl), diastereomeric esters are produced 
(Scheme 20).38 Analysis of the differences in the 1H NMR chemical shifts of the (S)- and (R)-
Mosher esters (ΔδH (S-R)) can then allow the assignment of the absolute configuration of the 
carbinol centre.38 The isolation chemists utilised this method to determine the absolute 
stereochemistry of position C6' (Figure 5). Based on their analysis of ΔδH (S-R), they conclude 
that H7' has a negative value (−0.09) and H2' and H4' have positive values (+0.01 and +0.02 
respectively) and thus position C6' must be S.2  
 
Scheme 20: Modified Mosher method; Reacting a secondary carbinol with the (S)-/(R)-MTPA-Cl to 




Figure 5: Numbering within (−)-angiopterlactone B (2)  
The isolation chemists report the procedure to prepare the (S)- and (R)-Mosher ester of their 
(+)-angiopterlactone B (2) and also attached the relevant spectra in their supporting 
information, allowing us to review their analysis. Upon closer inspection of their procedure 
for the preparation of the MTPA esters of (+)-angiopterlactone B (2), we noted that the authors 
state that reacting (S)-MTPA chloride with the natural product, resulted in the (S)-MTPA ester. 
This cannot be the case as the (R)-MTPA chloride is required to synthesise the (S)-MTPA ester 
(Scheme 20). Without further information, we cannot determine whether the typographical 
error results from the stereochemical assignment of the MTPA chloride, or the MTPA ester. 
The following analysis assumes that the MTPA ester was correctly identified as S. A further 
ambiguity arose upon inspection of the data provided. The isolation chemists reported the 
chemical shifts of the Mosher esters in DMSO (this could be a typographical error), but 
attached spectra in CDCl3. By calculating the ΔδH (S-R) values based on their reported 
tabulated shifts and their assignments of these signals, we agreed that H7' has a negative value 
and H2' and H4' have positive values (see Table 8). However, the isolation chemists do not 
mention/provide any 2D NMR spectra for the assignment of these signals. Upon examination 
of the provided data (including coupling constants), we propose that the peak assignment 










1H environment S / ppm R / ppm ΔδH (S-R) ΔδH (S-R) x MHz 
6' 5.45 5.48 −0.03 −18 
3' 4.56 - - - 
5 4.43 4.46 −0.03 −18 
6 4.30 4.30 0.00 0 
2' 4.20 4.19 +0.01 +6 
3A 3.35 3.34 +0.01 +6 
4' 3.35 3.33 +0.02 +12 
4 3.31 3.29 +0.02 +12 
3B 2.51 2.50 +0.01 +6 
7 1.50 1.51 −0.01 −6 
7' 1.40 1.49 −0.09 −54 
Table 8: ΔδH (S-R) analysis based on the isolation chemists’ reported peaks and assignments2,38 
Upon completing the Mosher analysis based on the isolation chemists reported chemical shifts, 
we utilised the integrated spectra (CDCl3) that they attached in their supporting information to 
select peaks in distinct environments. We could then manually calculate the coupling constants 
for each of the proton environments. Unfortunately peaks in the area of 3-4 ppm were 
overlapping and therefore we did not include these in our analysis. The assignment of the 
peaks was based on our assignments of (−)-angiopterlactone B (2) in CDCl3 (see Experimental, 
Section 1.4.2.6). The ΔδH (S-R) values indicate that H7' has a negative value, H2' also has a 
negative value and H3' is 0 (Table 9). These values, as well as the aforementioned 
uncertainties, suggest that the modified Mosher method cannot be utilised to unambiguously 










1H environment S / ppm R / ppm ΔδH (S-R) ΔδH (S-R) * MHz 
6' 5.45 5.48 −0.03 −18 
3' 4.57 4.57 0.00 0 
2' 4.43 4.46 −0.03 −18 
6 4.31 4.30 +0.01 +6 
5 4.20 4.19 +0.01 +6 
3B 2.51 2.52 −0.01 −6 
7 1.50 1.51 −0.01 −6 
7' 1.40 1.49 −0.09 −54 
Table 9: ΔδH (S-R) analysis based on our extracted values from the spectra and our assignment38 
As a result of the ambiguities present within the isolation chemists’ modified Mosher method, 
we investigated the assignments they made utilising the CD excitation chirality method. The 
isolation chemists state that “the δ-lactone ring adopted a boat conformation, which was in 
agreement with the negative Cotton effect (Δε −0.6) at 221 nm, suggesting the 4R and 3'R 
absolute configurations.”2 The first ambiguity present in this statement, is that the C3' position 
is not within the δ-lactone ring, but instead in the γ-lactone ring. In order to investigate if their 
statement holds true for the C4 position, we studied the reference provided by the isolation 
chemists as well as some of the associated references. 
It has been previously discussed that based on X-ray crystallographic studies, the lactone group 
(i.e., –C-CO-O-C-) within a ring must be planar.39,40 Due to this constraint, lactone rings must 
be either in a boat or a half-chair conformation. Following these studies, Wolf made some 
empirical observations based on saturated δ-lactones.41 He suggested that the sign of the 
Cotton effect is affected by the conformation adopted by the lactone ring and consequently the 
location of the β-carbon in relation to the lactone plane (Structures III-VI, Figure 6). In 1968, 











Figure 6: Beecham’s representation of the possible conformations and associated Cotton effect signs 
for his γ-lactones I and II, and Wolf’s δ-lactones III-VI42 
    
  
X-ray 
(–)-angiopterlactone B (2) 
γ-lactone of 2 δ-lactone of 2 
Figure 6 equivalent 
arrangement: 
I  IV 
Figure 7: X-ray crystal structure of (–)-angiopterlactone B (2) and the arrangement of the γ- and δ-
lactones within it 
Based on these empirical observations, we utilised the X-ray crystal structure of our synthetic 
material (−)-angiopterlactone B (2) in order to investigate how the sign of the Cotton effect 
may be affected by both the γ- and δ-lactone within the molecule (Figure 7). In the solid state, 
the δ-lactone is arranged in the boat conformation IV and should therefore result in a negative 
Cotton effect (Figure 6). The γ-lactone on the other hand is arranged as in structure I, with the 
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β-carbon above the plane of the lactone group. Thus the γ-lactone should contribute to a 
positive Cotton effect. Therefore within (−)-angiopterlactone B (2) there are two lactone units 
each contributing to opposite signs of the Cotton effect. In summary, it can be said that it is 
unlikely that the isolation chemists can utilise the CD excitation chirality method to 
unambiguously assign the stereochemistry of position C4 in their natural sample of 
angiopterlactone B (2).  
 
1.2.4 Further Investigations into (−)-Angiopterlactone B 
 
Following our investigations into the structure of the natural material angiopterlactone B (2), 
our attention turned towards determining the enantiopurity of our synthetic material. In order 
to determine the enantiomeric ratio of our synthetic (−)-angiopterlactone B (2), we attempted 
to obtain chiral HPLC data. Unfortunately, (−)-angiopterlactone B (2) could not be detected 
by the UV detector on our HPLC machine.  
In some cases where compounds cannot be identified by UV detectors, they can be derivatised 
to install a suitable chromophore. As (−)-angiopterlactone B (2) contains an alcohol group, we 
decided to derivatise this compound by utilising benzoyl chloride.43 Upon reacting 
(−)-angiopterlactone B (2) with benzoyl chloride, adduct 25 was successfully attained in 69% 
yield (Scheme 21). 
 
Scheme 21: Synthesis of adduct 25 from (−)-angiopterlactone B (2) 
In order to interpret the chiral HPLC results and obtain an enantiomeric ratio, access to the 
other enantiomer or the racemic (rac) compound 25 was necessary. Due to the ongoing interest 
in selective dimerisation reactions of racemic molecules in the Lawrence group, we targeted 
the racemic adduct 25. This was not a trivial endeavour, as we required access to the racemic 
dimer 2, which meant that the dimerisation reaction had to be completed utilising racemic 
lactone 3. As we now had a mixture of (+)- and (–)-lactone 3, there was the potential for us to 
form not only homochiral dimers, but also heterochiral dimers. Therefore, unless there is an 
inherent selectivity towards such homochiral dimers, this venture to synthesise adduct rac-25 
could prove challenging.  
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We began the synthesis towards racemic angiopterlactone B (2) by completing an 
Achmatowicz reaction on commercially available furfuryl alcohol rac-15 (Scheme 22). 
Following this, diastereoconvergent isomerisation successfully yielded lactone rac-3.  
Subjecting lactone rac-3 to the dimerisation conditions we previously employed for the 
enantiopure material, led to the formation of racemic angiopterlactone B (2), but with a 
significantly lower yield than that observed for the enantio-enriched dimer. Racemic 
angiopterlactone B (2) was then derivatised with benzoyl chloride to give adduct rac-25 in 
70% yield. With racemic adduct 25 and enantio-enriched adduct 25 in hand, chiral HPLC 
experiments were completed. Various columns and conditions were tested, however due to 
poor peak separation and low intensities, none resulted in a suitable HPLC trace for the 
determination of the enantiomeric ratio.  
 
Scheme 22: Synthesis of adduct rac-25 from alcohol rac-15 
Despite the lack of success in determining the enantiomeric ratio of dimer 2 using HPLC, we 
were successful in synthesising more than two grams of racemic lactone 3. Provided that the 
dimerisation reaction proceeds in the same manner as the enantio-enriched lactone 3, the 
racemic material could be utilised to conduct further screening of conditions and thus preserve 
our enantio-enriched lactone 3. Our synthesis towards adduct rac-25 demonstrated that we 
successfully formed racemic angiopterlactone B (2). Upon closer inspection of the 1H NMR 
spectrum of the crude dimerisation product rac-2, we noted that the spectrum looked very 
similar to that of the crude dimerisation product obtained using enantiopure δ-lactone 3 (Figure 
8). However, it appears that the reaction proceeds less cleanly, explaining the lower yield we 
observed for this reaction than the one obtained with the enantio-enriched material (10% and 
25-35% respectively). Upon purification by column chromatography, we were unsuccessful 





Figure 8: 1H NMR spectra. From top to bottom: δ-lactone 3, (−)-angiopterlactone B (2), crude of 





As we were unable to isolate or identify any further dimers, we hoped that completing the 
reaction in d6-DMSO (solvent in which the isolation chemists recorded the spectra for (–)-
angiopterlactone A (1)) would allow for better identification of possible intermediates / side-
products. Utilising lactone rac-3, several small scale reactions in d6-DMSO were attempted. 
However, we were unable to identify any further dimers in the 1H NMR spectrum of the crude 
dimerisation product, although this could be a result of overlapping peaks. 
The inherent selectivity observed in the dimerisation reactions for both the enantio-enriched 
and racemic starting material 3, left us with several unanswered questions. Why is this reaction 
so selective and why hadn’t we observed the related natural product (−)-angiopterlactone A 
(1)? These questions formed the basis of our interest in investigating the proposed structure of 
(−)-angiopterlactone A (1), as well as probing the underlying reaction mechanism in the 
formation of (−)-angiopterlactone B (2). If we can conclude how the dimerisation proceeds, 
we may be able to explain the regio- and stereo-selectivity. These examinations involved 
utilising computational methods in which NMR prediction studies and mechanistic 
investigations were completed (outlined in Chapters 2 and 3 respectively). It was hoped that 
these more detailed studies would shed light on the predisposed reactivity and selectivity at 





The enantioselective synthesis of δ-lactone 3 was successfully accomplished in three steps and 
various dimerisation conditions towards angiopterlactone A (1) and angiopterlactone B (2) 
were tested. This led to the discovery that treatment of lactone 3 with potassium carbonate in 
dichloroethane at 70 °C resulted in the successful synthesis of (−)-angiopterlactone B (2) 
(Scheme 23). The four step synthesis of (−)-angiopterlactone B (2) is scalable, enantioselective 
and protecting group free. With (−)-angiopterlactone B (2) in hand, we proposed a structural 
revision of the natural material and in doing so revealed the known natural product 
angiopteroside (9) as a likely biosynthetic precursor. 
 
Scheme 23: Synthesis of (−)-angiopterlactone B (2) from 2-acetylfuran (14) 
During our screening of various additives, we discovered that we could achieve a selective 
and efficient ring contraction of lactone 3 by using PTSA and heating overnight (Scheme 24). 
Furthermore, throughout our dimerisation studies we noted that we never observed the related 
natural product (−)-angiopterlactone A (1). 
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1.4.1 General Experimental Conditions 
 
Experimental Procedures, Glassware and Reagents 
Unless otherwise stated, reactions were performed under anhydrous conditions, under a 
positive pressure of dry nitrogen and glassware was dried using a heat gun. All reagents and 
solvents were purchased from commercially available sources and utilised without further 
purification, unless stated otherwise. Experimental details are provided for the largest scale 
procedure completed. Where yields are reported as a range, this represents the isolated yields 
obtained from several reactions. 
 
Chromatography 
Reactions were monitored by thin-layer chromatography (TLC), using silica gel plates (Merck 
Kieselgel 60 F254). Visualisation was effected by quenching of UV fluorescence (λ254nm) and 
by staining with a standard solution of p-anisaldehyde, followed by heating. Merck silica gel 
60 (230-400 mesh) was utilised for flash chromatography. Analytical chiral HPLC was 
conducted using an Agilent 1100 series system using a G1313 autosampler, a multiwavelength 
detector and a binary pump. 
 
Optical Rotation 
Optical rotations were measured using a Perkin-Elmer 341 polarimeter or an Optical Activity 
POLAAR 20 polarimeter, at 589 nm (sodium D line) with a cell path length of 1 dm and 
concentrations (c) reported in g/100 mL. Specific rotations are denoted as [𝛼]𝐷
20. 
 
Nuclear Magnetic Resonance (NMR) 
1H NMR spectra were recorded at 500 MHz or 600 MHz, using a Bruker Ascend 500 or Bruker 
UltraShield 600 spectrometer. Spectra were referenced using residual solvent peaks (CDCl3 = 
7.26 ppm and CD3OD = 3.31 ppm). Coupling constants (J) are quoted to the nearest 0.1 Hz. 
Assignment of proton signals was assisted by 1H-1H COSY, HSQC, HMBC and NOESY 
experiments. 13C NMR spectra were recorded at 126 MHz or 151 MHz, using a Bruker Ascend 
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500 or Bruker UltraShield 600 spectrometer. 13C NMR spectra were referenced using solvent 
peaks (CDCl3 = 77.16 ppm and CD3OD = 49.00 ppm). 13C NMR peaks are generally reported 
to one decimal place. Assignment of carbon signals was assisted by HSQC and HMBC 
experiments. 
 
Infrared Spectra (IR) 
Infrared spectra were recorded using a Shimadzu IR Affinity-1 Fourier transform IR 
spectrophotometer as neat samples, using Pike MIRacle ATR accessory. Absorption maxima 
(νmax) are quoted in wavenumbers (cm–1). 
 
Mass Spectroscopy 
High resolution mass spectra were recorded on a Bruker micrOTOF instrument using 
Electrospray Ionisation (ESI+).  
 
Melting Point 











1.4.2 Specific Experimental Conditions 
 
1.4.2.1 Experimental Procedure for (R)-Alcohol ent-15  
 
Compound ent-15 was prepared utilising a modified literature procedure.27  
A solution of [Cp*RhCl2]2 (3.00 mg, 5.00 µmol, 0.05 mol%) and (R,R)-TsDPEN (4.00 mg, 
10.9 µmol, 0.12 mol%) in H2O (18 mL) was heated at 40 °C for 1 h and subsequently cooled 
to rt. HCOONa (3.10 g, 45.6 mmol) and 2-acetylfuran (14) (1.00 g, 9.08 mmol) were then 
added to this cooled catalyst solution. 
The mixture was heated back up to 40 °C and left to stir for 16 h, after which the reaction was 
cooled to rt. The product was extracted with Et2O (3 × 40 mL), dried over anhydrous Na2SO4, 
filtered and concentrated under reduced pressure to afford ent-15 as a brown oil (crude NMR 
spectrum showed presence of unreacted starting material 14 [approximate starting material : 
product ratio was 3:1; as determined by NMR spectrum]) (crude: 0.56 g, 5.00 mmol, 55% 
crude mass recovery, e.r. 98:2). 
 
HPLC (Chiral Pak IA, i-PrOH/hexane (1:99), 1 mL·min−1, λ 210 nm) 23.224 min. See the 
Appendix, Section 1.2.1 for chiral HPLC traces. Data comparison was conducted with (S)-
alcohol 15 as well as commercially available alcohol rac-15.   
 
The remaining spectral data was in accordance with literature values27 and matched the data 





1.4.2.2 Experimental Procedure for (S,S)-Noyori Catalyst 20 
  
The (S,S)-Noyori catalyst 20 was prepared according to known procedures.28,29,44 
(S,S)-TsDPEN (0.48 g, 1.31 mmol), [RuCl2(ƞ6-p-cymene)]2 (0.40 g, 0.70 mmol) and powdered 
anhydrous KOH (0.54 g, 9.62 mmol) were added to anhydrous CH2Cl2 (25 mL). The resulting 
orange mixture was stirred for 5 min at rt and then H2O (25 mL) was added in one portion. 
The biphasic mixture was stirred for 10 min, diluted with H2O (40 mL) and the layers 
separated. The aqueous layer was extracted with CH2Cl2 (2 × 40 mL).  The combined organic 
extracts were dried over CaH2, filtered and concentrated under reduced pressure, to afford 
catalyst 20 as a dark purple solid (0.78 g, 1.3 mmol, >95%). This material was used 


















1.4.2.3 Experimental Procedure for (S)-Alcohol 15 
 
Compound 15 was prepared according to a literature procedure.28 
The (S,S)-Noyori catalyst 20 (0.78 g, 1.30 mmol) (see Section 1.4.2.2) was added to a solution 
of 2-acetylfuran (14) (14.0 g, 0.13 mol) in HCOOH (54 mL) and Et3N (200 mL). The resulting 
golden orange solution was stirred at 40 °C for 23 h.  
The reaction mixture was cooled to rt, diluted with H2O (120 mL), the layers were separated 
and the aqueous layer was extracted with Et2O (5 × 200 mL). The combined organic layers 
were washed with saturated aq. NaHCO3 (80 mL), dried over anhydrous Na2SO4, filtered and 
concentrated under reduced pressure, to afford alcohol 15 as a dark brown oil (14.0 g, 0.13 
mmol, >95%, e.r. 98:2). This material was used without purification in the subsequent step 
(see Section 1.4.2.4). A small sample of crude material was purified by flash chromatography 
(silica gel, dichloromethane + 1% methanol) for analytical purposes. The obtained 
spectroscopic data matched literature values.27,28  
 
Rf 0.43 (ethyl acetate / hexane, 1:1); 
 
[𝜶]𝑫
𝟐𝟎  synthesised 15: −23.7 (c 1.27, EtOH), purchased (−)-15: −25.3 (c 1.27, EtOH); 
 
1H NMR (500 MHz, CDCl3) δ 7.37 (dd, J = 1.9, 0.9 Hz, 1H), 6.32 (dd, J = 3.2, 1.8 Hz, 1H), 
6.23 (app. dt, J = 3.3, 0.8 Hz, 1H), 4.93-4.84 (m, 1H), 1.99 (s, OH), 1.54 (d, J = 6.6 Hz, 3H) 
ppm;  
 
13C NMR (126 MHz, CDCl3) δ 157.7, 142.0, 110.3, 105.2, 63.8, 21.4 ppm; 
 
IR (thin film) 3364, 2980, 1505 cm–1;        
    
HPLC (Chiral Pak IA, IPA/hexane (1:99), 1 mL·min−1, λ 230 nm) tRmajor = 20.280 min, tRminor = 
21.596 min. See the Appendix, Section 1.2.1 for chiral HPLC traces.  
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1.4.2.4 Experimental Procedure for Lactol 16 
 
Compound 16 was prepared utilising a modified literature procedure.21,27,45 
N-bromosuccinimide (NBS) was recrystallised from H2O.46 To a stirred solution of the crude 
(S)-1-(2-furyl)ethanol 15 (8.00 g, 71.4 mmol) in THF (88 mL) and H2O (30 mL) at 0 °C, 
NaHCO3 (12.0 g, 140 mmol), NaOAc (5.90 g, 71.9 mmol) and NBS (13.0 g, 73.0 mmol) were 
sequentially added. After 15 min, the reaction was quenched at 0 °C with saturated aq. 
NaHCO3 (900 mL) and diluted with Et2O (800 mL). 
The layers were separated and the aqueous layer was extracted with Et2O (3 × 800 mL) and 
the combined organic layers were dried over anhydrous Na2SO4 and concentrated under 
reduced pressure. The crude material was purified using flash chromatography (silica gel, 
petroleum spirit 40-60 / ethyl acetate, 2:1 → 1:1), to afford lactol 16 as a pale yellow solid 
(4.00 g, 31.3 mmol, 44%, d.r. 2:1). The obtained spectroscopic data matched literature 
values.27 
 
Rf 0.40 (petroleum spirit 40-60 / ethyl acetate, 1:1); 
 
1H NMR (500 MHz, CDCl3) δ 6.93 (dd, J = 10.2, 1.5 Hz, 1H‡), 6.89 (dd, J = 10.2, 3.4 Hz, 
1H†), 6.15 (dd, J = 10.3, 1.6 Hz, 1H‡), 6.10 (dd, J = 10.2, 0.7 Hz, 1H†), 5.67 (app. dq, J = 7.4, 
1.5 Hz, 1H‡), 5.63 (ddd, J = 5.0, 3.4, 0.7 Hz, 1H†), 4.71 (q, J = 6.8 Hz, 1H†), 4.23 (qd, J = 6.7, 
1.3 Hz, 1H‡), 3.22 (dd, J = 7.4, 1.5 Hz, OH‡), 3.00 (dd, J = 5.1, 1.3 Hz, OH†), 1.46 (d, J = 6.7 
Hz, 3H‡), 1.39 (d, J = 6.8 Hz, 3H†) ppm;  
 
13C NMR (126 MHz, CDCl3) δ 196.8†, 196.4‡, 147.9‡, 144.3†, 128.7‡, 127.5†, 91.1‡, 87.9†, 
75.4‡, 70.6†, 16.5‡, 15.5† ppm; 
 
IR (thin film) 3343, 3049, 2995, 1682 cm–1.  
 
† Major diastereoisomer  
‡ Minor diastereoisomer  
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1.4.2.5 Experimental Procedure for (S,S)-Lactone 3 
 
Compound 3 was prepared utilising a modified literature procedure.21 
Lactol 16 (3.80 g, 29.7 mmol), [Ir(COD)Cl]2 (0.50 g, 0.74 mmol), 2,6-dichlorobenzoic acid 
(2.80 g, 14.7 mmol) and anhydrous CHCl3 (290 mL) were added to a flask. The reaction 
mixture was stirred at rt for 16 h and was then concentrated under reduced pressure and 
purified by flash chromatography (silica gel, petroleum spirit 40-60 / ethyl acetate, 1:2) to 
afford lactone 3 as a light brown oil which slowly solidified (2.70 g, 21.1 mmol, 70%, e.r. 
98:2). The obtained spectroscopic data matched literature values.47,48 
 
Rf 0.27 (petroleum spirit 40-60 / ethyl acetate, 1:2); 
 
[𝜶]𝑫
𝟐𝟎 +148 (c 0.51, H2O), lit. +143 (c 0.53, H2O)48;  
 
1H NMR (600 MHz, CDCl3) δ 7.01 (dd, J = 9.7, 5.7 Hz, 1H), 6.11 (d, J = 9.7 Hz, 1H), 4.54 
(qd, J = 6.7, 2.7 Hz, 1H), 4.03 (dd, J = 5.7, 2.7 Hz, 1H), 2.11 (br s, OH), 1.50 (d, J = 6.7 Hz, 
3H) ppm;  
 
13C NMR (151 MHz, CDCl3) δ 163.9, 144.6, 123.0, 77.2, 63.2, 15.9 ppm; 
 
IR (thin film) 3445, 3056, 2991, 2947, 1690 cm–1;  
 
M.p. 47-49 °C (lit. 48-53 °C)47;  
 
HPLC (ADH, IPA/hexane (20:80), 0.7 mL·min−1, λ 254 nm) tRminor = 8.637 min, tRmajor = 





1.4.2.6 Experimental Procedure for (−)-Angiopterlactone B (2) 17  
 
K2CO3 (378 mg, 2.73 mmol) was added to a solution of lactone 3 (3.50 g, 27.3 mmol) in 
anhydrous (CH2Cl)2 (22 mL). The reaction mixture was heated to 70 °C and was stirred for 
16 h. It was evident that some solvent was lost during this process. The amorphous mixture 
was triturated with CHCl3 to extract the product before being concentrated under reduced 
pressure. The crude material (3.34 g, see the Appendix, Section 1.1.7 for crude NMR spectra) 
was purified by flash chromatography (silica gel, dichloromethane + 8% methanol) to afford 
(−)-angiopterlactone B (2) as a white crystalline solid (864 mg, 3.38 mmol, 25%). The 
obtained spectroscopic data (excluding the optical rotation) matched literature values.2  
 
Rf 0.20 (dichloromethane + 6% methanol); 
 
[𝜶]𝑫
𝟐𝟎 −25 (c 0.04, EtOAc), lit. +22 (c 0.04, EtOAc)2;  
 
1H NMR (500 MHz, CDCl3) δ 4.58 (dd, J = 5.6, 3.6 Hz, H3'), 4.31 (qd, J = 6.6, 1.7 Hz, H6), 
4.24 – 4.18 (m, H2'+6'), 4.15 (dd, J = 8.7, 1.7 Hz, H5), 3.43 (dd, J = 10.6, 5.5 Hz, H4'), 3.33 (dd, 
J = 16.2, 1.7 Hz, H3A), 3.28 (ddd, J = 10.0, 8.8, 1.3 Hz, H4), 2.50 (dd, J = 16.4, 8.9 Hz, H3B), 
2.44 (br s, OH), 1.46 (d, J = 6.6 Hz, H7), 1.31 (d, J = 5.7 Hz, H7') ppm;  
 
13C NMR (126 MHz, CDCl3) δ 172.9 (C5'), 169.9 (C2), 85.0 (C2'), 79.1 (C3'), 79.0 (C5), 73.4 
(C6), 66.6 (C6'), 49.1 (C4'), 36.8 (C4), 28.1 (C3), 17.7 (C7'), 16.8 (C7) ppm; 
 
1H NMR (500 MHz, CD3OD) δ 4.57 (dd, J = 5.4, 3.8 Hz, H3’), 4.44 (qd, J = 6.6, 1.7 Hz, H6), 
4.22 (dd, J = 8.7, 3.8 Hz, H2’), 4.18 (dd, J = 8.7, 1.7 Hz, H5), 4.05 (dq, J = 8.7, 6.4 Hz, H6’), 
3.53 (dd, J = 10.6, 5.3 Hz, H4’), 3.37 – 3.32 (m, H4), 3.13 (dd, J = 16.4, 1.0 Hz, H3A), 2.67 (dd, 
J = 16.4, 9.0 Hz, H3B), 1.40 (d, J = 6.6 Hz, H7), 1.27 (d, J = 6.4 Hz, H7’) ppm;  
 
13C NMR (126 MHz, CD3OD) δ 176.3 (C5'), 174.1 (C2), 86.6 (C2'), 80.3 (C3'), 79.8 (C5), 75.2 




HRMS (ESI+) C12H16O6: 279.0798 [M+Na]+ (calcd 279.0839); 
 
IR (thin film) 3543, 2940, 1752, 1722, 1709 cm–1; 
 





Natural angiopterlactone B2 
 1H NMR spectra 
CDCl3, 600 MHz 
δ / ppm (J, Hz) 
Synthetic angiopterlactone B 
 1H NMR spectra 
CDCl3, 500 MHz 
δ / ppm (J, Hz) 
3A 3.33 (d, 16.2) 3.33 (dd, 16.2, 1.7) 
3B 2.50 (dd, 16.2, 9.0) 2.50 (dd, 16.4, 8.9) 
4 3.28 (ddd, 9.0, 8.4, 10.2*) 3.28 (app. ddd, 10.0, 8.8, 1.3) 
5 4.15 (br d, 8.4) 4.15 (dd, 8.7, 1.7) 
6 4.31 (br q, 6.6) 4.31 (qd, 6.6, 1.7) 
7 1.46 (d, 6.6) 1.46 (d, 6.6) 
2’ 4.21 (m, overlap) 4.24 – 4.18 (m, overlap) 
3’ 4.58 (dd, 5.4, 3.0) 4.58 (dd, 5.6, 3.6) 
4’ 3.43 (dd, 10.2, 5.4) 3.43 (dd, 10.6, 5.5) 
6’ 4.21 (m, overlap) 4.24 – 4.18 (m, overlap) 
7’ 1.31 (d, 6.0) 1.31 (d, 5.7) 
OH 2.45 (s) 2.44 (br s) 
 
Table 10: Comparison of reported 1H NMR data for natural angiopterlactone B (2)2 and 1H NMR data 
for our synthetic material. *Peak shape similar to that observed in the 1H NMR spectrum of synthetic 2, 
therefore 10.2 Hz coupling constant assumed to be a typographical error. 
 
13C 
Literature 13C NMR spectra 
CDCl3, 150 MHz 
δ / ppm 
Experimental 13C NMR spectra 
CDCl3, 126 MHz 
δ / ppm  
2 169.8 169.9 
3 27.9 28.1 
4 36.6 36.8 
5 78.8 79.0 
6 73.3 73.4 
7 16.6 16.8 
2’ 84.9 85.0 
3’ 78.9 79.1 
4’ 48.9 49.1 
5’ 172.9 172.9 
6’ 66.4 66.6 
7’ 17.2 (17.5)* 17.7 
 
Table 11: Comparison of reported 13C NMR data for natural angiopterlactone B (2)2 and 13C NMR data 
for our synthetic material. *The value in brackets was taken directly from the provided NMR spectrum 
in the SI of the isolation paper.2 
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1.4.2.7 General Procedure for the Dimerisation Screening Process  
 
Lactone 3 and additive were weighed out into a sample vial. The solvent was added and the 
vial was sealed and placed into an oil bath at the designated temperature, for the designated 
amount of time.  
The mixture was then triturated with CHCl3 and concentrated under reduced pressure. The 
yield for each component (3, 4, 6 and 2) was calculated using 1H NMR spectroscopy, utilising 
dimethyl sulfone in (CD3)2SO or durene in CDCl3 as internal standards.  
 









1 Li2CO3 88 <1 <1 0 
2 Na2CO3 84 <1 0 0 
3 NaHCO3 79 <1 0 0 
4 K2CO3 9 2 2 25 
5 Rb2CO3 6 <1 <1 19 
6 Cs2CO3 11 1 <1 18 
7 (NH4)2CO3 29 3 1 0 
8 MgCO3 86 <1 <1 0 
9 CaCO3 87 <1 0 0 
10 KOH 42 4 3 10 
11 Pyrrolidine 47 20 7 0 
12 PTSA 0 57 3 0 

















1 dichloroethane 9 2 2 25 
2 water 23 3 1 8 
3 toluene** 10 <1 <1 5 
4 acetonitrile 47 5 5 11 
5 carbon tetrachloride 38 2 2 11 
6 cyclohexane 27 2 2 9 
7 2-methyl THF 21 1 1 12 
*Chloroform and dichloromethane were trialled, but these could not be heated to sufficient temperatures for the 
dimerisation to take place in an acceptable time frame.                                                                                                                                    
**Poor crude mass recovery of <40%. 















1 0.5 66 2 <1 5 
2 0.8 14 2 2 15 
3 1.5 9 2 2 25 
4 3.1 13 3 3 28 
5 6.8 49 3 2 16 





















1* 0.1 - - - 28 
2 0.2 9 2 2 25 
3 0.5 5 <1 <1 19 
4 1.0 3 0 0 16 
*larger scale reaction (400 mg of starting material 3); 1.1 M, 70 °C, 40 h; yield refers to isolated yield 
















1 1 66 3 2 5 
2 2 56 4 2 12 
3 3 55 4 3 15 
4 4 44 4 3 18 
5 5 37 5 4 20 
6 8 15 3 2 26 
7 42 2 0 0 26 







1.4.2.8 Experimental Procedure for (S,S)-Lactone 4 
 
Lactone 3 (200 mg, 1.56 mmol) was dissolved in anhydrous (CH2Cl)2 (1 mL). PTSA (54 mg, 
0.31 mmol) was added and the reaction mixture was stirred at 70 °C for 16 h. The reaction 
mixture was left to cool to rt and was then concentrated under reduced pressure and purified 
by flash chromatography (silica gel, petroleum spirit 40-60 / ethyl acetate, 1:2) to afford 
lactone 4 as a white crystalline solid (76 mg, 0.60 mmol, 38%). The obtained spectroscopic 
data matched literature values.49,50 
 
Rf 0.24 (petroleum spirit 40-60 / ethyl acetate, 1:2); 
 
1H NMR (500 MHz, CDCl3) δ 7.44 (dd, J = 5.8, 1.6 Hz, 1H), 6.19 (dd, J = 5.8, 2.1 Hz, 1H), 
4.93 (app. dt, J = 5.4, 1.8 Hz, 1H), 3.93 (app. p, J = 6.2 Hz, 1H), 2.34 (br s, OH), 1.32 (d, J = 
6.5 Hz, 3H) ppm;  
 
13C NMR (126 MHz, CDCl3) δ 172.7, 153.3, 123.0, 87.1, 68.3, 18.8 ppm; 
 
1H NMR (600 MHz, CD3OD) δ 7.68 (dd, J = 5.8, 1.5 Hz, 1H), 6.23 (dd, J = 5.8, 2.1 Hz, 1H), 
5.06 (ddd, J = 4.4, 2.1, 1.6 Hz, 1H), 4.00 (qd, J = 6.5, 4.3 Hz, 1H), 1.29 (d, J = 6.5 Hz, 3H) 
ppm;  
 
13C NMR (151 MHz, CD3OD) δ 175.6, 156.7, 122.9, 88.9, 68.1, 19.1 ppm;  
 
IR (thin film) 3400, 3074, 2947, 1716, 1690 cm–1;  
 





1.4.2.9 Experimental Procedure for Adduct 25  
 
 
Compound 25 was prepared utilising a modified literature procedure.43 
 
(−)-Angiopterlactone B (2) (20 mg, 78 µmol) was dissolved in CH2Cl2 (2 mL) and the solution 
was cooled to 0 °C. Et3N (110 µL, 780 µmol), benzoyl chloride (27 µL, 230 µmol) and DMAP 
(few crystals) were added in sequence and the solution was consequently warmed to rt and left 
to stir for 0.5 h.  The reaction mixture was then concentrated under reduced pressure and the 
crude material was purified by flash chromatography (silica gel, dichloromethane + 4% 
methanol) to afford adduct 25 as a white crystalline solid (19 mg, 53 µmol, 67%). 
 
 
1H NMR (500 MHz, CDCl3) δ 8.06-8.00 (m, H10'), 7.58-7.52 (m, H12'), 7.45-7.39 (m, H11'), 
5.46 (dq, J = 8.6, 6.4 Hz, H6'), 4.63 (dd, J = 5.1, 3.7 Hz, H3'), 4.57 (dd, J = 8.6, 3.7 Hz, H2'), 
4.29 (qd, J = 6.6, 1.9 Hz, H6), 4.19 (dd, J = 8.9, 1.9 Hz, H5), 3.41 (dd, J = 10.4, 5.1 Hz, H4'), 
3.36-3.26 (m, H3A+4), 2.50 (dd, J = 16.7, 8.8 Hz, H3B), 1.50 (d, J = 6.3 Hz, H7'), 1.45 (d, J = 6.6 
Hz, H7) ppm;  
 
13C NMR (126 MHz, CDCl3) δ 173.0 (C5'), 169.8 (C2), 165.7 (C8'), 133.2 (C12'), 130.3 (C9'), 
129.9 (C10'), 128.4 (C11'), 81.6 (C2'), 79.0 (C3'), 78.8 (C5), 73.5 (C6), 70.1 (C6'), 48.7 (C4'), 36.8 
(C4), 28.0 (C3), 16.6 (C7), 16.2 (C7') ppm; 
 
HRMS (ESI+) C12H16O6: 383.1117 [M+Na]+ (calcd 360.1101); 
 
IR (thin film) 3001, 2909, 1778, 1736, 1715 cm–1; 
 




1.4.2.10 Experimental Procedure for Lactol rac-16 
 
Compound rac-16 was prepared utilising a modified literature procedure.21,27,45 
N-bromosuccinimide (NBS) was recrystallised from H2O.46 To a stirred solution of purchased 
1-(2-furyl)ethanol rac-15  (8.00 g, 71.4 mmol) in THF (88 mL) and H2O (30 mL) at 0 °C, 
NaHCO3 (12.0 g, 140 mmol), NaOAc (5.85 g, 71.3 mmol) and NBS (12.7 g, 71.4 mmol) were 
sequentially added. After 20 min, the reaction was quenched at 0 °C with saturated aq. 
NaHCO3 (900 mL) and diluted with Et2O (800 mL). 
The layers were separated and the aqueous layer was extracted with Et2O (3 × 800 mL) and 
the combined organic layers were dried over anhydrous Na2SO4 and concentrated under 
reduced pressure. The crude material was purified using flash chromatography (silica gel, 
petroleum spirit 40-60 / ethyl acetate, 2:1), to afford lactol rac-16 as a pale yellow solid (3.86 
g, 30.1 mmol, 42%, d.r. 2:1). The NMR data matched the data collected for compound 16 in 






1.4.2.11 Experimental Procedure for Lactone rac-3 
 
Compound rac-3 was prepared utilising a modified literature procedure.21 
Lactol rac-16 (3.82 g, 29.8 mmol), [Ir(COD)Cl]2 (0.50 g, 0.74 mmol), 2,6-dichlorobenzoic 
acid (2.84 g, 14.9 mmol) and anhydrous CHCl3 (290 mL) were added to a flask. The reaction 
mixture was stirred at rt for 16 h and was then concentrated under reduced pressure and 
purified by flash chromatography (silica gel, petroleum spirit 40-60 / ethyl acetate, 1:2) to 
afford lactone rac-3 as a light brown oil which slowly solidified (2.39 g, 18.7 mmol, 63%). 





1.4.2.12 Experimental Procedure for Angiopterlactone B (rac-2) 17  
 
K2CO3 (16 mg, 0.12 mmol) was added to a solution of lactone rac-3 (154 mg, 1.20 mmol) in 
anhydrous (CH2Cl)2 (1 mL). The reaction mixture was heated to 70 °C and was stirred for 16 
h. It was evident that some solvent was lost during this process. The amorphous mixture was 
triturated with CHCl3 to extract the product before being concentrated under reduced pressure. 
The crude material was purified by flash chromatography (silica gel, dichloromethane + 5% 
methanol) to afford racemic angiopterlactone B (2) as a white crystalline solid (14.8 mg, 






1.4.2.13 Experimental Procedure for Adduct rac-25   
 
 
Compound rac-25 was prepared utilising a modified literature procedure.43  
 
Racemic angiopterlactone B (2) (12.5 mg, 48.8 µmol) was dissolved in CH2Cl2 (1 mL) and the 
solution was cooled to 0 °C. Et3N (68.0 µL, 488 µmol), benzoyl chloride (17.0 µL, 146 µmol) 
and DMAP (few crystals) were added in sequence and the solution was consequently warmed 
to rt and left to stir for 0.5 h.  The reaction mixture was then concentrated under reduced 
pressure and the crude material was purified by flash chromatography (silica gel, 
dichloromethane + 4% methanol) to afford adduct rac-25 as a white crystalline solid (12 mg, 








Chapter 2: Computational NMR Prediction Studies 
 
Chapter 1 provided a detailed description of the successful total synthesis of (–)-
angiopterlactone B (2). Next we set out to understand why we had not observed the related 
natural product angiopterlactone A (1) (Figure 9). This compound was co-isolated with 
angiopterlactone B (2) in substantial amounts and was presumed to be its biosynthetic 
precursor.2 
 





2.1.1 Project Aims and Objectives 
 
Based on biosynthetic speculations, angiopterlactone A (1) should presumably have been 
observed as an intermediate to angiopterlactone B (2) (Scheme 25). After analysing the 1D 
and 2D NMR spectra provided in the appendix of the isolation paper2, we believe the general 
atom connectivity within the structure to be correct. However the question arose as to whether 
the isolation chemists can unequivocally assign the relative/absolute configuration within the 
molecule. The relative stereochemistry between H3'-H5 was assigned as cis based on their 
NOESY correlation. Considering these protons are located next to freely rotatable bonds, a 
NOESY correlation is not sufficient evidence that the relative assignment of these protons 
should be cis. Furthermore, the absolute configuration of position C6' was assigned utilising 
the modified Mosher’s method. As we previously discovered some typographical errors and 
discrepancies in their Mosher method (see Chapter 1, Section 1.2.3), we are not certain that 
position C6' can be unequivocally assigned as S. Thus, we speculated that (–)-angiopterlactone 
A (1), may actually be a diastereoisomer of the reported structure. To this end, a series of 
computational NMR prediction studies were completed to investigate the relative 




Scheme 25: Summary of our biosynthetic speculations from Chapter 1 
 
 
2.1.2 General Background Theory 
 
Quantum Mechanics and the Schrödinger Equation 
At the heart of quantum chemistry lies the Schrödinger equation, for which the time-
independent equation is given in shorthand form by:  
 𝑯𝜓 = 𝐸𝜓 Eq. 1 
where the action of the Hamiltonian operator (H) on a system described by the wavefunction 
(ψ), returns the total energy (E) of the system.51 This equation can only be solved exactly for 
single electron systems and thus for larger molecules, approximations must be introduced. One 
key step in this direction is the Born-Oppenheimer (BO) approximation, which separates 
nuclear and electronic motion as a result of their large differences in mass.51,52 This allows the 
electronic part to be solved utilising nuclear positions as parameters, resulting in a potential 
energy surface (PES) for which minima and saddle-points (transition states) may be 
located.51,53,54  
One of the main approaches to solving the Schrödinger equation within the BO approximation 
is the density functional theory (DFT). The foundation of this approach was introduced by 
Hohenberg and Kohn in 1964, who proved that the ground state energy of a system can be 
obtained from its electron density.55 However, difficulties were encountered when describing 
all energy components as a functional of electron density.56 In 1965, Kohn and Sham 
developed a practical solution to this problem.57 The basis of their approach involved splitting 
the kinetic energy functional into two parts: one which can be calculated exactly (electrons are 
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considered as non-interacting) and another which required approximations to be made to 
account for electron-electron interactions.58 The Hamiltonian operator can be divided into four 
terms: 
 𝑯 = 𝑯𝑲 + 𝑯𝑽 + 𝑯𝑱 + 𝑯𝑿𝑪 Eq. 2 
where K represents the kinetic component, V the electron nuclear interaction, J the Coloumb 
component and XC the exchange-correlation term (to account for electron-electron 
interactions). A number of approaches have been developed for the approximation of this 
exchange-correlation term and a hierarchy of these methods and example functionals are 























Figure 10: Hierarchy of exchange-correlation functionals; representative examples are provided in 
parentheses (adapted from Chem. Soc. Rev. 2016, 45, 6093-6107)59 
Chemical Accuracy 
+ Dependence on exact exchange 
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Basis Sets  
 
Basis sets are a combination of functions (basis functions) that describe molecular orbitals. In 
theory, any type of function (e.g., Slater or Gaussian) may be utilised, as long as i) it describes 
the physics of the system and ii) it is easy to calculate.56 Slater functions (based on hydrogen 
atomic orbitals), fulfil the first requirement, however their evaluation is computationally 
demanding.53 To overcome this problem, Gaussian functions were introduced, as they can be 
more readily solved.53 However, Gaussian functions provide less accurate descriptions of the 
system and thus a combination of Gaussian functions is typically used.56 A minimum 
description of the occupied orbitals is provided by Single Zeta (SZ) basis sets, which utilise a 
single function for every occupied orbital. Double Zeta (DZ) basis sets double the number of 
functions utilised for each occupied orbital and these can be further increased to Triple 
(Quadruple, etc.) Zeta basis sets.56 Pople developed split valence basis sets in which core and 
valence electrons are treated separately. For example the 3-21G basis set utilises 3 functions 
to describe the core atomic orbitals, 2 for the first valence orbital and 1 for the second valence 
orbital.  
A further improvement in the description of a system can be achieved by the addition of diffuse 
(with small exponents) and polarisation (with increased angular momentum) functions. 
Diffuse functions improve the description of electron densities (which may be far from the 
nucleus), while polarisation functions can improve the modelling of bonding and electron 
distribution.53,56 
 
Transition State Theory 
 
Transition state theory (TST) allows the connection between computed and experimental 
observables. Within the BO approximation, a chemical reaction can be described as the 
movement of nuclei from one minimum to the next, via a transition state (TS) (Figure 11).56 
The TS is the configuration of the molecule which divides the reactant from the product and 




Figure 11: Graphical representation of a generic reaction pathway 
The free energy of activation (ΔG‡) and the free energy of the reaction (ΔGr) can be obtained 
from energy profiles (Figure 11). The free energy of activation is the energy difference 
between a transition state of a reaction and its corresponding reactants and can be utilised to 
estimate the rate constant (k) for a chemical reaction. The rate constant can be described by 
the Eyring equation (Eq. 3), where h is Planck’s constant, kB is Boltzmann’s constant, R is the 












Another important aspect to consider when describing the environment of a system, is the 
inclusion of a solvent. Computations are often completed in the gas-phase, in which the 
surroundings of a molecule are treated as a vacuum.60 However, interactions between the 
solute and the solvent (e.g., via hydrogen bonding) can affect the compound’s geometry and 
thus treating a molecule in the gas-phase can incur inaccuracies and errors. Such errors can be 
minimised by utilising solvent models, which are generally divided into explicit and implicit 
methods. 
The explicit solvation model involves the inclusion of individual solvent molecules around the 
compound of interest and therefore requires extensive sampling of the conformational 
space.56,60 This is computationally demanding and makes the use of implicit solvent models an 
attractive alternative. These model the solvent according to its dielectric constant and therefore 
lack an explicit description of non-covalent interactions. Examples of implicit solvent models 
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include the polarisable continuum model (PCM) and the density based solvation model 
(SMD).60  
 
2.1.3 Computational Nuclear Magnetic Resonance Spectroscopy (NMR) 
 
NMR Spectroscopy for Structural Elucidation 
 
NMR spectroscopy is a powerful and versatile tool, which provides chemists with the ability 
to complete structural elucidations.61 Despite the developments in the field of NMR 
spectroscopy and the wide array of techniques available (ranging from 1D spectra to powerful 
2D techniques), incomplete or incorrect structural assignments of natural products still occur.62 
The assignment of stereochemistry can be complex, particularly if multiple diastereoisomers 
are possible. Such cases can necessitate the synthesis of multiple diastereoisomers and 
interpretation of the NMR data to make a conclusive structural assignment. This is a time-
consuming and challenging process and thus the ability to accurately simulate and predict 
NMR spectra could provide the experimental chemist with invaluable insights. Such 
computational techniques have become increasingly popular and thus efforts have gone into 
the development of reliable methods to allow steadfast computations of NMR properties, such 
as chemical shifts (δ) and coupling constants (J).  
 
Chemical Shifts 
The computational prediction of NMR chemical shift values relies on the ability to describe 
the electron density around a nucleus, as well as how this electron density responds to a 
magnetic field.61 The NMR shielding tensor (σ) is obtained from the second derivative of the 
total energy (E) with respect to the magnetic field (B) and the nuclear magnetic moment (μ) 






 Eq. 4 
When applying a magnetic field vector to electronic structure computations, a problem termed 
the gauge problem is encountered.61 In order to introduce a magnetic field into calculations, 
an arbitrary origin needs to be defined for the associated vector potential. This is impractical, 
as the computed shielding tensor would therefore depend upon the position of the vector. To 
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avoid this dependence, the most common approach is to utilise gauge-including atomic orbitals 
(GIAOs) in the NMR property computation.60,61  
In order to compare the computational to the experimental results, the shielding tensor needs 
to be converted into a chemical shift. There are two main approaches commonly utilised for 
this conversion: utilising a reference compound or applying the linear scaling method. The use 
of a reference compound (for example tetramethylsilane, SiMe4) involves the calculation of 
both the compound of interest and the reference compound, utilising the same computational 
method. The chemical shift (δi, in parts per million) can then be obtained by subtracting the 
shielding tensor of the compound of interest (σi), from the shielding tensor of the reference 
compound (σref) (Eq. 5).64 
 𝛿𝑖 = 𝜎𝑟𝑒𝑓 − 𝜎𝑖 
Eq. 5 
 
The second way to obtain NMR chemical shifts from shielding tensors, is to use the linear 
scaling method. This involves the use of several reference compounds, whose shielding tensors 
must be computed utilising the same computational method as for the compound of interest. 
The computed shielding tensors are then plotted against their corresponding experimental 
chemical shifts and a line of best fit is obtained. Utilising the slope and intercept from this line 
of best fit, the chemical shift of the compound of interest can be obtained from its shielding 
tensor following Eq. 6.60 This approach has the advantage that it can remove systematic errors 
and it has been reported that well-performing methods have slopes deviating no more than 








Coupling constants (J-values) can prove to be useful in the assignment of the relative 
configuration and conformation of molecules, due to their dependence on geometry. They are 
typically reported in units of Hertz and their magnitude is a result of a combination of factors, 
such as bond distances and dihedral angles.61 The magnitude of 3JH-H can be predicted utilising 
the Karplus equation (Eq. 7), where A, B and C are empirically derived constants dependent 
on the atoms and substituents in a system and ϕ is the dihedral angle between H-C-C-H.61,66  
 𝐽𝐻−𝐻 = 𝐴 + 𝐵𝑐𝑜𝑠𝜙 + 𝐶𝑐𝑜𝑠2𝜙 Eq. 7 
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Reports in the literature show that both homonuclear and heteronuclear total nuclear spin-spin 
coupling constants can be computed utilising DFT.67,68,69 The contributing factors are the spin-
dipole (SD), the Fermi contact (FC), diamagnetic spin-orbit (DSO) and paramagnetic spin-
orbit (PSO) terms:70  
where n is the number of chemical bonds between the two nuclei under study. The SD and FC 
terms are a result of the interaction between the nuclear magnetic field and the spin of the 
electrons, whereas the DSO and PSO terms represent the interactions between the nuclear 
magnetic moments and those created by the movement of electrons. These four terms vary in 
their contribution to the coupling constant depending on the nuclei and the extent of their 
separation.61,68 
    
General Workflow 
 
Computational NMR spectroscopy studies involve a number of steps (Figure 12). As some 
molecular fragments are flexible, these studies typically necessitate an initial conformational 
search to locate the lowest energy conformers of the compound of interest. Each conformer is 
then subjected to geometry optimisation and characterised as a real minimum (DFT 
optimisation). This is followed by NMR calculations, from which electronic energies and 
isotropic shielding constants are extracted. Once the computed isotropic shielding constants 
are in hand, their relative contributions are calculated utilising the Boltzmann analysis 
(conformer averaging). The Boltzmann weighted isotropic values must then be converted into 
chemical shifts (δ). Computed chemical shifts are then compared to experimental/ literature 
values, in order to perform an error evaluation. More detailed descriptions of each of these 
steps are in the sections to follow. 
 
Figure 12: General workflow for a computational NMR prediction study 
 
Conformational Sampling  
Organic molecules exist in different low energy conformers, which depend on their flexibility 












 nJ = nJFC + nJSD + nJPSO + nJDSO Eq. 8 
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temperature at which the NMR experiment is run and therefore experimental NMR spectra 
represent a Boltzmann-weighted average of all of the conformers. As NMR property 
calculations are completed on static structures with specific coordinates, a similar 
consideration must be implemented computationally.  
Conformational searches depend on the size and complexity of the molecule, as well as the 
presence of rotatable bonds. For small molecules with few rotatable bonds, one may opt to 
manually locate relevant conformers by making educated guesses as to the geometries, 
followed by running them through an optimisation process.60 Alternatively, an automated 
conformational search employing molecular mechanics can be employed. Several programs 
capable of such a search exist, including but not limited to Macromodel, Spartan and TINKER.  
 
DFT Optimisation and NMR Calculations 
A number of DFT functionals for the completion of geometry optimisations and NMR 
property calculations have been used in the literature, including mPW91PW91, ωB97XD, 
M06-2X and B3LYP.71 A common choice of basis set are Pople’s split valence basis sets. 
Jensen developed specific basis sets for the calculation of nuclear magnetic shielding constants 
(termed pcSseg-n), however concluded that these often perform worse than standard basis 
sets.72 Tantillo has created an online repository summarising linear regression parameters for 
various combinations of functionals and basis sets utilised for geometry optimisation and 
isotropic shielding constant calculation.73  
 
Boltzmann Weighting  
Upon extraction of the energies, a Boltzmann weighting is completed to determine the relative 
contribution of each conformer. The weighting of each conformer (ωi) can be described by Eq. 
9, where E is the energy extracted from the single point calculation, R is the gas constant and 
T is the temperature.61 These Boltzmann weighted isotropic values are then converted into a 















Analysis and Error Evaluation  
In order to compare different computational techniques and their ability to accurately predict 
NMR data, a set of parameters or statistical methods are required. Common parameters utilised 
in the literature include the mean absolute error (MAE), standard deviation, regression analysis 
(R2) and root-mean-square-error (RMSE).64,74,75,76 The mean absolute error can be described 
by Eq. 10, where N is the number of chemical shifts used in the comparison, δcalc is the 









Although these parameters can prove useful in comparing computational techniques, there are 
situations in which more sophisticated processes are required. For example in the case of 
diastereoisomers, their chemical shifts can be similar to one another thus preventing the ability 
to confidently assign the correct structure based on these parameters. 
Alternatively/additionally to utilising these parameters, a number of statistical methods have 
been developed, whose increased complexity provide more confidence in structural 
assignments.  
In 2009, Smith and Goodman introduced the CP3 parameter, which addressed the problem of 
assigning two sets of experimental data to two possible structures.74 CP3 is based on the 
comparison between differences in computed chemical shifts and differences in experimental 
chemical shifts. In conjunction with Bayes’ theorem, utilising this parameter then allows the 
assignment of the structure.74 One of the biggest limitations of CP3 is the constraint of needing 
two sets of experimental data and two or more candidate structures.77 This limitation led Smith 
and Goodman to the development of a new probability measure in 2010, which they termed 
DP4.77 
The major advantage of DP4 over CP3 is that it only requires one set of experimental data, to 
which two or more candidate structures can be compared.77 The DP4 analysis is based on 
calculated error probabilities for scaled computed chemical shifts for each hydrogen and 
carbon atom. It assumes that these errors follow a statistical Student’s t-distribution. Bayes’ 
thereom is then applied to transform the product of the individual error probabilities for each 
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This equation77 provides the probability (P) that candidate structure ‘i’ is the correct one out 
of the available possibilities (m). The cumulative Student’s t-distribution function (Tv with v 
degrees of freedom) is characterised by the experimental chemical shift of nucleus k (δexp,k), 
the scaled calculated chemical shift (using the linear analysis technique) of nucleus k in 
candidate structure j (δjscaled,k), the mean (μ) and the standard deviation (σ). The values of v, μ 
and σ were obtained from an analysis of a set of test molecules for which the authors had 
experimental data, where v = 11.38 (13C) or 14.18 (1H), μ = 0 and σ = 2.306 ppm (13C) or 0.185 
ppm (1H).77 
DP4 was further developed and expanded upon by Sarotti and co-workers in 2015 and was 
termed DP4+.78 In order to improve the accuracy of the DP4 predictions, they modified the 
procedure to include unscaled chemical shifts, as well as utilising higher levels of theory for 
the GIAO NMR calculations.78,79    
 
2.1.4 Example Case Studies from the Literature 
 
Computational NMR prediction studies have been utilised to facilitate numerous structural 
reassignments of natural products. Here we have chosen three representative examples, which 
showcase how the applications of such computational studies have developed over time.  
The first example (vannusal B) utilised NMR prediction studies post-synthesis. The structure 
(with the exception of absolute configuration) of the marine natural product vannusal B, was 
originally assigned in 1999 by Pietra and co-workers using a combination of mass 
spectroscopy and NMR spectroscopy techniques (Figure 13).80 In 2010, Nicolaou and co-
workers successfully synthesised the originally proposed structure of vannusal B, which led 
to the discovery that the spectroscopic data did not match that of the natural product.81 By 
completing the laborious synthesis of eight diastereoisomers, the authors successfully revised 




Figure 13: Originally assigned and revised structures of vannusal B80,82 
After the structural revision of the molecule, Bagno and co-workers published a computational 
study of the NMR properties for the eight synthesised diastereoisomers of vannusal B.83 
Calculated 13C chemical shifts and coupling constants (JH-H) revealed that out of the examined 
structures, the revised structure was the closest match to the experimental data. This 
demonstrates that the use of computational methods throughout the structural investigations 
of vannusal B, may have assisted in narrowing down the number of viable targets, on which 
synthetic efforts could then be focused.  
In our second example, computational studies were applied prior to synthesis in order to 
identify the most likely structure of the natural product nobilisitine A, which was consequently 
synthesised in the laboratory. This compound was first isolated in 1999 by Evidente and co-
workers and its structure was assigned by IR and NMR spectroscopy (Figure 14).84 Upon the 
synthesis of the enantiomer of the originally proposed structure, Banwell and co-workers noted 
that the 1H and 13C spectra did not match those reported for the natural product.85 This led 
Tantillo and Lodewyk into a computational NMR spectroscopy investigation in an effort to 
predict the true structure of nobilisitine A.86 Upon computing 1H and 13C chemical shifts for 
eight diastereoisomers and comparing them to experimental results of the originally proposed 
structures, they predicted a revised relative stereochemistry (Figure 14). They then utilised the 
DP4 method to gain confidence in their tentative assignment of the structure, which resulted 
in a 99.8% calculated probability.86 Based on these computational studies, Banwell and co-
workers set out to synthesise this newly proposed structure, during which they confirmed a 




Figure 14: Originally assigned and revised structure of nobilisitine A84,87 
The final example involved the natural products dichrocephone A and dichrocephone B. 
Tantillo, Christmann and co-workers combined the power of biosynthetic considerations with 
computational NMR spectroscopy studies and total synthesis, to successfully complete the 
total synthesis and structural revision of dichrocephone A (Figure 15).88 Upon synthesising the 
structure originally assigned as dichrocephone A, the authors realised that the 1H and 13C NMR 
spectra did not match those reported for the natural product.88,89 Inspection of heteronuclear 
multiple-bond coherence spectra led the authors to the conclusion that the correct structure for 
dichrocephone A would likely be a diastereoisomer of the proposed structure. Utilising 
biosynthetic speculations, in which they suggest that dichrocephone A is the precursor to 
dichrocephone B, they concluded that only two diastereoisomers were conducive to their 
proposed pathway (these correspond to the originally assigned and the revised structures of 
dichrocephone A in Figure 15). This significantly narrowed down the possibilities and thus 
the synthetic targets. In order to support their proposal and possibly eliminate a further 
diastereoisomer, the authors then completed computational studies. DP4 analysis resulted in a 
99.8% probability that the correct structure of dichrocephone A is the diastereoisomer depicted 
as the ‘revised structure’ in Figure 15. They successfully synthesised this diastereoisomer, 
which they confirmed to be the correct structure of dichrocephone A (Figure 15).  
 
Figure 15: Originally assigned and revised structures of dichrocephone A and the related natural 




2.1.5 Biosynthetic Considerations / Structures to Investigate 
 
The case studies from the literature provided examples for the use of computational NMR 
chemical shift predictions to facilitate structural reassignments of natural products. We began 
our investigations by examining the originally proposed structure of (–)-angiopterlactone A 
(1). Assuming that the relative stereochemistry is incorrect, there were 16 possible 
diastereoisomers which needed to be investigated (five stereogenic centres, therefore 25 = 32 
potential stereoisomers; 16 pairs of enantiomers). Synthesising these 16 compounds would be 
a time-consuming process and thus we needed to use an approach that would allow us to 
narrow down the number of possible structures.  
Our biosynthetic speculations proposed reacting γ-lactone 4 and δ-lactone 3 to form 
angiopterlactone A (1) (Scheme 25, Page 69).1 Based on the assumption that this proposal is 
correct, we searched the literature for viable building blocks that match our biosynthesis. The 
δ-lactones ent-3 and 5 have previously been isolated from natural sources and are presumably 
the aglycones of the known natural products angiopteroside (9) and osmundalin (8) (Figure 
16).35,90 Thus these compounds formed the basis of our available starting materials. We know 
from our synthetic experience that such δ-lactones can undergo ring-contractions to their 
corresponding γ-lactones, which is a process that has also previously been reported in the 
literature.6 Thus δ-lactones ent-3 and 5 could form γ-lactones ent-4 and 6 respectively (Figure 
16). 
 
Figure 16: Possible monomeric γ- and δ-lactones ent-3, ent-4, 5 and 6 
Based on the assumption that these four lactones are the only ones available in nature for an 
oxa-Michael addition to occur between a γ- and a δ-lactone, we now have a limited number of 
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possible combinations. Four structures arise from the combination of each δ-lactone (acting as 
the Michael donor) with either of the γ-lactones (acting as the Michael acceptor). As the oxa-
Michael addition can occur from either the Si or Re face (labelled in blue and red respectively, 
Figure 17), these combinations result in a total of eight possible structures of angiopterlactone 
A (1) (labelled Ⅰ-Ⅷ in Figure 17). These diastereoisomers became the basis for our 
computational investigations. 
 
Figure 17: Our suggested eight possible structures of angiopterlactone A (1) (originally proposed 
relative stereochemistry by isolation chemists is represented in I) (Si face oxa-Michael addition denoted 
by blue, Re by red) 
 
 
2.1.6 Literature Protocols and Method Choice 
 
Upon reducing the number of possible structures from 16 to 8, decisions had to be made with 
regards to our computational methods. These included choosing the functional, basis set size 
and whether to include solvent in the calculation. A large variety of computational NMR 
prediction studies have been reported in the literature. We chose four well-reported and 
detailed protocols (summarised in Table 17) for preliminary testing, which varied in the 
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computational methods used. Methods 1-3 (M1-M3) utilise the linear regression analysis (see 
Section 2.1.3) to remove any systematic errors. This requires scaling factors specific to the 
level of theory applied for both the geometry optimisation and shielding tensor calculations, 
which are summarised in the Appendix, Table 36, Page 204.  
Approach 
Geometry Optimisation 
Method                  Solvent 
                                    (model) 
NMR Calculation 
Method                  Solvent 





































Table 17: Summary of conditions used for each of the approaches 
Hoye and co-workers75 have combined the use of molecular mechanics and DFT to 
characterise small organic molecules (Table 17, approach M1). They utilised the M06-2X 
functional for geometry optimisation, followed by NMR calculations using the GIAO method 
at the B3LYP/6-311+G(2d,p) level of theory. Tantillo et al.60 generated a repository73 which 
provides access to empirical scaling factors for computed chemical shifts utilising various 
combinations of functionals. In our study we utilised the M06-2X functional for the geometry 
optimisation and the mPW1PW91 functional for NMR calculations (Table 17, approaches 
M2A and M2B). Utilising these methodologies to form the basis for our investigations, we 
also tested variations of these approaches to evaluate the effect of solvent and basis set size on 
the final results. Pierens65 reported the use of the B3LYP functional for geometry optimisation 
and the mPW1PW91 functional for the calculation of shielding tensors (Table 17, approach 
M3). The main advantage of this method is that Pierens utilised a variety of solvents, whereas 
methods M1 and M2 are restricted to using chloroform, so this methodology formed the basis 
of our third approach. The final approach we tested (method M4, Table 17) was recently 
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published by Butts, Myers, Aggarwal and co-workers.91 They utilised the mPW1PW91 
functional for both the geometry optimisation and NMR calculation. Their investigations were 
aimed towards utilising NMR prediction studies to aid in the identification of the true 
structures of the natural products baulamycins A and B. This approach is not dissimilar to our 
endeavours and thus we utilised their studies as a comparison to the previously listed methods.  
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2.2 Computational Methods 
 
All DFT calculations were performed using the Gaussian 0992 software. Details of the level of 
theory utilised for each method are summarised in Table 17, Page 83. All NMR calculations 
were completed utilising the GIAO method. The functionals used include B3LYP, 
mPW91PW91, M06-2X and ωB97XD. The B3LYP93,94 functional is Becke’s hybrid 3-
parameter functional. MPW1PW9195,96 is a hybrid functional utilising mPW exchange and 
PW91 correlation. M06-2X97 is a hybrid meta exchange correlation functional which has 54% 
HF exchange (twice the exchange from Truhlar’s Minnesota-06 (M06) functional). The 
ωB97XD98 functional is a range separated functional which was developed by Head-Gordon 
and includes empirical dispersion corrections. 
Solvent was modelled using an implicit description of chloroform / dimethylsulfoxide 
applying either the SMD or PCM continuum model. Solvent cavities were defined by the 
default SMD-Coulomb99 and UFF100 atomic radii respectively, except for method M1 in which 
they were defined by UA092 atomic radii for the geometry optimisation and Bondi101 for the 
NMR calculation.  
Energies (E) were evaluated at 298 Kelvin (K). Vibrational entropy contributions towards 
Gibbs Free energy values (G) were calculated utilising a free-rotor approximation for low 
frequency modes. These calculations were completed utilising GoodVibes.102 To switch 
between free-rotor approximations and harmonic approximations for vibrations, a smooth 
damping function centred around a frequency of 100 cm-1 was used.103 Throughout the 
discussion, varying energy terms are utilised. E is the potential energy taken from the higher 
level of theory single point calculation (see Table 17, page 83 for the level of theory used). H 
is the enthalpy including the thermal correction from the vibrational contributions H = E + 
(Hlow - Elow), where Hlow and Elow are the enthalpy and potential energy extracted from the 
geometry optimisation. The final term utilised is G, which refers to the Gibbs free energy that 
has been corrected to consider ro-vibrational frequencies. It can be described by G = E + (Glow 
- Elow), where Glow is the Gibbs Free energy after geometry optimisation.  
In order to complete our conformational sampling, we utilised the conformational scanning 
function (scan) installed in the TINKER104 modelling package. This function uses a basin 
hopping algorithm to efficiently sample the conformational space, where each basin represents 
a distinct region of this space. This is followed by local minimisation to identify the lowest 
energy conformer within each basin. The energy window of conformational minima was set 
to 10 kcal/mol.    
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2.3 Results and Discussion 
 
In Section 2.1.1 we proposed that the isolation chemists may have incorrectly assigned the 
relative configuration of the natural product (–)-angiopterlactone A (1). We investigated this 
proposal by completing computational NMR prediction studies. Methods M1-M4 (Table 17, 
Page 83) were employed to examine a number of variables and how they might affect our 
ability to distinguish between diastereoisomers. Methods M3 and M4 were then utilised to 
compute 1H and 13C chemical shifts and JH-H coupling constants to distinguish between the 
eight structures under investigation for (–)-angiopterlactone A (1) (compounds I-VIII, Figure 
17, Page 82). We then proposed a revised structure for (–)-angiopterlactone A (1) and utilised 
the DP4 analysis to further support this revision. 
Please note: for ready ease of access, a removable, laminated sheet, containing the structures 
of the investigated diastereoisomers of angiopterlactones A and B (1, 2), can be found at the 
back of this thesis. These figures have also been reproduced on the final page of this thesis.  
 
2.3.1 Preliminary Testing 
 
Conformational Search 
The first step of a computational NMR prediction study typically involves a conformational 
search in order to locate the lowest energy conformers of the compound of interest (see Section 
2.1.3). For small molecules with few rotatable bonds, relevant conformers can be located 
manually, however this process can be time consuming and subject to human error. It could 
therefore be advantageous, particularly for larger systems, to employ automated 
conformational searches. We tested both techniques on δ-lactone 3 and γ-lactone 4 (Table 18) 
and utilised method M3 (Table 17, Page 83) to compute 1H and 13C chemical shifts in both 
chloroform and dimethylsulfoxide (DMSO). A commonly used technique to compare 
computed and experimental chemical shifts and establish the ‘goodness of fit’ of a data set is 
the mean absolute error (MAE) (Eq. 10, Page 77).75 Thus for both the 1H NMR and 13C NMR 
data the computed chemical shifts were compared to their respective experimental values to 










Solvent Method 1H MAE 13C MAE 1H MAE  13C MAE 
CHCl3 
Manual  0.07 5.1 0.15 1.9 
Automated 0.10 1.0 0.13 1.6 
DMSO 
Manual  0.19 2.9 0.18 1.7 
Automated 0.07 1.0 0.19 1.5 
Table 18: 1H and 13C MAE values (ppm) for manual vs automated generated conformers of δ-lactone 3 
and γ-lactone 4 (method: M3, solvent: CHCl3 / DMSO, energy utilised for Boltzmann analysis: E)  
The results indicated that generally the use of the automated conformational search resulted in 
lower 1H and 13C MAE values compared to those obtained when using a manual technique 
(Table 18). Thus we utilised the conformational scanning function for all future calculations. 
 
Effect of Basis Set Size on Geometry Optimisation 
Next, we examined if the basis set size utilised for the geometry optimisation affects the NMR 
chemical shift predictions. This was analysed using methods M2A and M2B, as both 
approaches use identical conditions for the NMR calculation, but differ in their basis set size 
for the geometry optimisation (Table 17, Page 83). The 1H and 13C MAE values were 
calculated for the δ- and γ-lactones 3 and 4, as well as their respective diastereoisomers 5 and 













 Method δ-lactone 3 δ-lactone 5 γ-lactone 4 γ-lactone 6 
1H MAE / 
ppm 
M2A 0.15 0.22 0.19 0.21 
M2B 0.16 0.22 0.18 0.19 
13C MAE 
/ ppm 
M2A 1.5 3.3 1.4 1.8 
M2B 1.4 3.3 1.4 1.8 
Table 19: 1H and 13C MAE values for δ-lactone 3, γ-lactone 4 and their respective diastereoisomers 5 
and 6. MAE values are calculated by comparing the computed chemical shift of the compound (a or b), 
to the experimental shift of a (M2A / M2B, CHCl3, G)  
 
MAE values can be utilised in order to ascertain the predictive power between 
diastereoisomers. An example to illustrate how MAE values can be used to distinguish 
between diastereoisomers is made utilising data from δ-lactone 3 and its diastereoisomer 5. 
The 13C MAE value of 1.5 ppm for δ-lactone 3 (M2A, a, Table 19) is obtained by comparing 
the computed shift of lactone 3 (a) to the experimental chemical shift of lactone 3 (a). In 
theory, if the computed 13C chemical shift of lactone 5 (b) is compared to the experimental 
value of δ-lactone 3 (a), we should observe a much larger MAE value. Utilising our example 
of diastereoisomer 5 (b) and comparing the computed 13C chemical shifts to the experimental 
values of δ-lactone 3 (a), results in an MAE value of 3.3 ppm. This is much larger than the 
previously observed value of 1.5 ppm and therefore this method provides us with a 
distinguishing power between these two diastereoisomers. 
The comparison of the MAE values between methods M2A and M2B for lactones 3, 5, 4 and 
6 (Table 19), shows that the differences in MAE values are minimal. Furthermore, based on 
these MAE values, our ability to distinguish between diastereoisomers remains unaffected. 
This suggests that for the purposes of our investigations, the use of the computationally more 
expensive and larger basis set (i.e., method M2B) is not warranted. It has previously been 
reported in the literature that smaller basis sets in the geometry optimisation are sufficient.65,105  
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Solvent Effects on the Geometry Optimisation 
Following our conclusion that larger basis sets for the geometry optimisation did not 
significantly affect the MAE values or our ability to distinguish between diastereoisomers, we 
investigated solvent effects. This involved studying how the inclusion/exclusion of solvent in 
the geometry optimisation affects the subsequently calculated chemical shift values. To 
explore this we utilised γ-lactone 4 and δ-lactone 3 and methods M1 and M2A (Table 17, Page 
83). For each method the geometry optimisation was separately run in the gas and the solvent 
phase. As this involved modifying the literature procedure, the slope and intercept values 
reported for methods M1 and M2A (Table 36, Page 204) were no longer applicable and thus 
isotropic shielding values could not be converted to chemical shifts using the linear scaling 
method. Instead we utilised the tetramethylsilane (TMS) referencing method (see Section 
2.1.3) to obtain chemical shifts. This required an NMR calculation of TMS at the same level 
of theory as that of each of the methods M1 and M2A, as well as the modified procedures. The 
corresponding 1H and 13C chemical shift values can be found in the Appendix, Table 37, Page 
205. 
Method M2A was originally reported as utilising the gas phase in the geometry optimisation. 
Upon calculating 1H and 13C MAE values for γ-lactone 4 and δ-lactone 3, we found that 
regardless of whether the geometry optimisation was run in the solvent or gas phase, MAE 







1H MAE / 
ppm 
Gas 0.20 0.20 
Solvent 0.19 0.20 
13C MAE / 
ppm 
Gas 6.1 5.5 
Solvent 5.9 5.4 
Table 20: 1H and 13C MAE values for γ-lactone 4 and δ-lactone 3 (M2A, gas / CHCl3, G) 
An analogous approach was taken utilising method M1, which usually includes solvent in the 
geometry optimisation. The MAE values for γ-lactone 4 and δ-lactone 3, reflect that the 
differences in MAE values for calculations run in the gas or solvent phase were minimal (Table 
21). Thus the added computational cost of using solvent in the geometry optimisations is 









1H MAE / 
ppm 
Gas 0.26 0.28 
Solvent 0.25 0.27 
13C MAE / 
ppm 
Gas 3.0 2.9 
Solvent 2.8 2.9 
Table 21: 1H and 13C MAE values for γ-lactone 4 and δ-lactone 3 (M1, gas / CHCl3, G) 
 
 
Drawing Comparisons Between Methods - M1 vs. M2 vs. M3 
We previously investigated the effect of basis set size on the geometry optimisation and found 
that the smaller basis set gave us satisfactory results. Next we investigated whether including 
solvent in the geometry optimisation affects the results and found that for our purposes, 
calculations in the gas phase were sufficient. These factors were taken into consideration when 
choosing with which method(s) to proceed for the analysis of the angiopterlactones (1, 2).  
Based on our previous investigations we could eliminate method M1, as the geometry 
optimisation is run in the solvent phase. Furthermore we could also disregard method M2B, 
due to the larger basis set size used in the geometry optimisation. Next we compared the results 
of methods M2A and M3, both of which run the geometry optimisation in the gas phase and 
utilise a relatively small basis set of 6-31+G(d,p). Whereas method M2A restricts the user to 
computing NMR data in chloroform, method M3 has the distinct advantage that the authors 
completed investigations using a variety of solvents. As the isolation chemists reported the 
NMR data of (–)-angiopterlactone A (1) in DMSO, we required the ability to utilise this 
solvent in our computations. Therefore we needed to investigate if method M3 provides 
similarly accurate results to method M2A. 
Previously, we computed 1H and 13C MAE values for the γ-lactone 4 and δ-lactone 3 utilising 
method M2A (Table 17, Page 83). This approach was then used to complete computations for 
(+)-angiopterlactone B (2) (Table 22). Following this, method M3 was applied to obtain 1H 





















1H  0.19 0.15 0.17 
13C 1.4 1.5 1.0 
M3 
(CHCl3) 
1H  0.12 0.09 0.09 
13C 1.5 1.0 1.0 
M3 
(DMSO) 
1H  0.17 0.06 0.12 
13C 1.3 1.0 1.3 
Table 22: 1H and 13C MAE values for γ- and δ-lactones 4 and 3, as well as (+)-angiopterlactone B (2) 
(M2A / M3, CHCl3 / DMSO, G) 
The data in Table 22, shows that generally method M3 provides more accurate 1H and 13C 
chemical shift predictions (reflected by the smaller MAE values). Thus we moved forward 
with this methodology to compute the NMR chemical shifts of these compounds in the solvent 
DMSO (Table 22). The results suggest that the predictions in DMSO give us similar 1H and 
13C MAE values to those observed when utilising chloroform and thus we could now utilise 
this method to compute the chemical shifts of the diastereoisomers of the angiopterlactones 
(1, 2). 
 
Method M3 (DMSO) – Investigation into Energies 
Next we investigated whether the inclusion of thermal and entropic effects (E vs. H vs. G) 
would affect our ability to distinguish between diastereoisomers. Employing method M3 
(DMSO), the 1H and 13C chemical shifts and coupling constants (JH-H) were computed for γ-
lactone 4, δ-lactone 3, angiopterlactone B (2) and the seven relevant diastereoisomers (based 
on the diastereoisomers under investigation for (–)-angiopterlactone A (1), discussed in 
Section 2.1.5). 
The 1H, 13C and JH-H MAE values for γ-lactones 4 and 6 were calculated by comparing their 
respective computed NMR data, to the experimental data of lactone 4 (Table 23). This method 
is used for all compounds throughout the remainder of this chapter. The results reflect that 
inclusion of thermal and entropic corrections barely affect the MAE values. The same trend 
was observed for δ-lactones 3 and 5 (Table 23). When comparing the MAE values of 
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diastereoisomers 4 and 6, we noted that it was not possible to distinguish between them. For 
δ-lactone 3 and its diastereoisomer 5 on the other hand, the distinguishing power between the 
correct and the incorrect structure remains intact for all three energies. 
   
γ-lactone 4 (a) 
 
γ-lactone 6 (b) 
E H G E H G 
1H MAE / ppm 0.19 0.18 0.17 0.12 0.11 0.11 
13C MAE / ppm 1.5 1.4 1.3 1.4 1.4 1.5 
J MAE / Hz 0.7 0.7 0.7 0.6 0.6 0.7 
 
  
δ-lactone 3 (a) 
 
δ-lactone 5 (b) 
E H G E H G 
1H MAE / ppm 0.07 0.07 0.06 0.14 0.15 0.16 
13C MAE / ppm 1.0 1.0 1.0 3.1 3.2 3.2 
J MAE / Hz 0.4 0.4 0.4 2.0 2.2 2.2 
Table 23: 1H, 13C and JH-H MAE values for lactones 4 and 3, as well as their diastereoisomers 6 and 5. 
MAE values are calculated by comparing the computed chemical shift of the compound (a or b), to the 
experimental shift of a (M3, E / H / G, DMSO)  
 
To complete further investigations into the thermal/entropic/enthalpic effects on the predicted 
chemical shifts and coupling constant data, calculations were completed for (+)-
angiopterlactone B (2) (compound Ⅰ) and seven of its diastereoisomers (II-VIII) (Table 24). 
1H, 13C and JH-H MAE values were calculated by comparing the computed NMR data of a 




1H MAE / ppm I II III IV V VI VII VIII 
E 0.12 0.11 0.17 0.18 0.17 0.26 0.23 0.14 
H 0.12 0.12 0.17 0.18 0.17 0.26 0.23 0.14 
G 0.12 0.12 0.18 0.18 0.18 0.26 0.23 0.15 
13C MAE / ppm I II III IV V VI VII VIII 
E 1.4 1.5 2.2 2.3 3.1 2.7 3.1 3.5 
H 1.4 1.4 2.2 2.3 3.1 2.7 3.1 3.5 
G 1.3 1.4 2.2 2.2 3.1 2.7 3.1 3.4 
JH-H MAE / Hz I II III IV V VI VII VIII 
E 1.0 0.9 2.4 2.6 4.1 3.5 1.8 2.3 
H 1.0 0.8 2.4 2.6 4.1 3.6 1.8 2.3 
G 0.9 0.8 2.4 2.5 4.1 3.6 1.8 2.3 
Table 24: 1H, 13C and JH-H MAE values for (+)-angiopterlactone B (2) (compound I) and seven of its 
diastereoisomers (II-VIII) (blue: initial oxa-Michael addition from Si face; red: initial oxa-Michael addition 
from Re face). MAE values are calculated by comparing the computed chemical shift of the relevant 
compound (I-VIII) to the experimental shift of I (M3, E / H / G, DMSO) 
The results show that differences between 1H, 13C and JH-H MAE values across the three 
energies are relatively small and thus inclusion/exclusion of thermal and entropic contributions 
does not significantly affect the data. As the MAE values for G of γ-lactone 4, δ-lactone 3 and 
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(+)-angiopterlactone B (2) (compound I) were always less than or equal to those of E and H, 
we decided to utilise G for all future calculations.  
 
 
2.3.2 An Alternative Approach: Method M4 
 
During our investigations we became aware of the work of Butts, Myers, Aggarwal and co-
workers who published an alternative protocol (herein described as method M4).91 In this 
protocol, final geometry optimisations were carried out at the mPW1PW91/6-311G(d,p) 
[PCM (CH3OH)] level of theory, followed by the NMR calculation at the mPW1PW91/6-
311G(d,p) [PCM (CH3OH)] level of theory (Table 17, Page 83).91 The authors then used 
Boltzmann population analyses, as we have done previously, to weight the conformers 
generated for each structure. M4 differs from our previously employed methods in that instead 
of using the linear regression method to convert the isotropic shielding tensors into chemical 
shifts, they used the TMS referencing technique (see Section 2.1.3). Upon acquiring the 
calculated chemical shifts, systematic errors were then removed by calculating a scaled 
chemical shift according to the linear scaling method. This is a similar approach to that detailed 
by Goodman and Smith to complete their DP4 analysis (Section 2.1.3).77 Method M4 further 
details the use of Boltzmann averaged scalar coupling constants (JH-H and JH-C) to distinguish 
between diastereoisomers. Upon computing the 1H-1H and 1H-13C coupling constants, they 
were weighted according to the Boltzmann population. Butts, Myers, Aggarwal and co-
workers then applied a 6% linear scaling correction to the total calculated nuclear spin-spin 
coupling constant prior to calculating the Boltzmann populations.  
Butts, Myers, Aggarwal and co-workers used a variety of analytical techniques, which 
included the use of MAE values as well as the DP4 analysis. The authors noted that these alone 
were insufficient in providing structural discrimination between their proposed 
diastereoisomers. They then utilised the χ2 (reduced) analysis to better distinguish between 
structures. The χ2 values were calculated utilising Eq. 12, in which 𝛿𝑐𝑎𝑙
𝑖  is the calculated and 
Boltzmann averaged chemical shift for nucleus i, 𝛿𝑒𝑥𝑝
𝑖  is the experimental chemical shift and 
𝜎𝛿
2 is the square of the expected standard deviation. The authors based these expected standard 
deviations on some literature values for rigid molecules, as well as their own in-house 
experience. The values of these standard deviations are: 0.15 ppm for δH, 1.5 ppm for δC and 
1 Hz for JH-H (and JH-C).91 Eq. 12 is also utilised when calculating χ2 values for the coupling 












As a result of χ2 values being dependant on the number of deviations utilised to calculate them, 
the authors calculated χ2 (reduced) values for each diastereoisomer (Eq. 13). The number of 
deviations utilised to calculate the χ2 value is represented by n and the number of parameters 







The γ-lactones 4 and 6 and δ-lactones 3 and 5 
 
In order to apply method M4 to our own compounds we had to complete a computation of 
TMS utilising the authors’ described level of theory, but exchanging methanol with DMSO 
(See Appendix, Table 37, Page 205). We then computed isotropic shielding constants and 
consequently Boltzmann weighted and TMS scaled 1H and 13C chemical shifts for γ-lactone 4 
and its diastereoisomer 6. 
Butts, Myers, Aggarwal and co-workers noted in their study, that specific data points were 
excluded from linear scaling and further analysis. Upon contacting the authors they detailed 
that certain calculated NMR data was disregarded as it resulted in a poor fit to the 
corresponding experimental values (e.g., the authors noted that 13C chemical shift data for 
carbonyl positions frequently resulted in deviations of 5-10 ppm).  
 
Figure 18: Numbered γ- and δ-lactone for analytical purposes 
Upon studying the difference between the predicted chemical shifts of γ-lactone 4 and the 
corresponding experimental values, we noted that 1H chemical shifts mostly provided a good 
data fit. We therefore utilised all chemical shifts and scaled them using the linear regression 
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method. Most of the computed 13C chemical shifts on the other hand (except the methyl 
position, C7, Figure 18), resulted in large differences when compared to their experimental 
values (> 4 ppm). Thus we excluded the 13C chemical shifts for γ-lactones 4 and 6 from the 
analysis. We then turned to calculating the JH-H coupling constants for each of the γ-lactones 4 
and 6, which provided a good fit to the experimental data. Application of a 6% linear scaling 
to these coupling constants (as previously suggested in the literature)67,91 improved the 
predicted JH-H coupling constant values. Consequently we utilised the scaled 1H and JH-H data 
to calculate the MAE, standard deviation and χ2 (reduced) values. These values reflect a 
minimal distinguishing power between γ-lactone 4 and its diastereoisomer 6 (Figure 19). 
 
 
Figure 19: MAE, standard deviation and χ2 (reduced) values for the scaled 1H and JH-H data of γ-
lactone 4 and its diastereoisomer 6 (M4, DMSO) 
We completed the same calculations for δ-lactones 3 and 5. The computed 1H NMR chemical 
shift data provided a good fit to the experimental values, except for position C4 (Figure 18) 
which was thus excluded from further analysis. Once more we excluded the carbon chemical 
shifts from further analysis as most of the TMS scaled 13C chemical shifts largely deviated 
from the experimental data. The JH-H coupling constants provided a good fit to the data, which 
improved when the 6% linear scaling was applied. Upon calculating the MAE, standard 
deviation and χ2 (reduced) values, we noticed that the data provided us with a clear 
distinguishing power between the diastereoisomers (Figure 20). Particularly the χ2 (reduced) 
values of the 1H chemical shifts, as well as all statistical JH-H coupling constant values allowed 
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Figure 20: MAE, standard deviation and χ2 (reduced) values for the 1H and JH-H data of δ-lactone 3 and 
its diastereoisomer 5 (M4, DMSO) 
 
(+)-Angiopterlactone B (2) and seven of its diastereoisomers 
 
Next we investigated whether this method would allow us to distinguish between 
diastereoisomers in larger systems. Therefore we tested method M4 on (+)-angiopterlactone 
B (2) (compound Ⅰ) and seven of its diastereoisomers (Table 24, Page 93 or removable sheet, 
Figure B). Utilising the same procedure as for lactones 3 and 4, the chemical shift and coupling 
constant data for the eight compounds I-VIII were computed. Based on the computed values 
of (+)-angiopterlactone B (2) (compound I), the 1H and 13C chemical shifts and JH-H coupling 
constants shown in Figure 21 were excluded from the scaling and processing of the data. This 
was mainly due to their large deviations from the experimental value in all diastereoisomers. 
The CH2 protons as well as their associated coupling constants were excluded as 
conformational rotations caused these positions to swap frequently and thus could not be 
assigned a corresponding experimental value. For a direct comparison of how the inclusion of 
all data points and the exclusion of poorly fitting data points affects the overall 1H, 13C and 
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Figure 21: 1H, 13C and JH-H data which was ignored (labelled in red) for the linear scaling and further 
analysis of (+)-angiopterlactone B (2) and seven of its diastereoisomers 
The 1H, 13C and JH-H data was used to calculate the corresponding MAE, standard deviation 
and χ2 (reduced) values (Figure 22). The results indicate that based on these values, compounds 
III-VIII can be excluded. This leaves us with only two structures likely to correspond to (+)-
angiopterlactone B (2), diastereoisomers I or II. As the majority of the chemical shift and JH-H 
coupling constant data surrounding the carbinol centre were excluded, we were not able to 




Figure 22: MAE, standard deviation and χ2 (reduced) values for the 1H and JH-H data of (+)-
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We previously noted for δ-lactone 3 that excellent structural discrimination was provided by 
the JH-H values. This trend was also observed for compounds I-VIII of angiopterlactone B (2). 
As we ultimately aim to predict whether the structure initially proposed by the isolation 
chemists for (–)-angiopterlactone A (1) is correct, we were most interested in stereogenic 
centres C2', C3', C6', C5 and C6 (Figure 23). If we can establish the correct cis/trans 
relationship between protons H2'-H6', H2'-H3' and H5-H6, we should in theory be able to 
eliminate seven of the eight structures and therefore identify the correct diastereoisomer.  
 
Figure 23: Stereogenic centres we are most interested in identifying (labelled in black) 
As noted in Figure 21, the coupling constants between protons H2'-H6' varied largely and thus 
had to be eliminated, which meant we weren’t able to distinguish between compounds I and 
II. The large variation of these coupling constants, could be due to the flexibility of the side 
chain. A literature search suggested that corresponding coupling constants in related γ-lactones 
also vary greatly.106,107 Despite not being able to utilise the JH2'-H6' to distinguish between 
diastereoisomers I and II, utilising the JH-H coupling constant values of H2'-H3' and H5-H6 
should in theory allow us to eliminate six of the eight structures. Thus for each of the structures 
I-VIII, the deviations of each of these coupling constants from the experimental values were 
calculated (Table 25).  
entry JH-H deviation / Hz Ⅰ Ⅱ Ⅲ Ⅳ Ⅴ Ⅵ Ⅶ Ⅷ 
1 H2'-H3' 1.4 1.3 0.3 0.0 3.7 3.7 3.7 3.7 
2 H5-H6 0.3 0.2 6.6 6.5 6.9 7.0 0.4 0.5 
Table 25: Deviation of computed JH-H values for H2'-H3' and H5-H6 from their experimental values for 
compounds I-VIII of angiopterlactone B (2) 
Protons H2' and H3' have a cis relationship in structures I-IV, whereas structures V-VIII all 
have a trans relationship (Table 24, Page 93 or removable sheet, Figure B). Table 25 shows 
that the JH-H deviation of H2'-H3' from the experimental values is < 1.5 Hz for structures I-IV 
and > 3.5 Hz for structures V-VIII. Thus structures V-VIII can be eliminated and the H2'-H3' 
protons can be assigned as cis. Diastereoisomers I, II, VII and VIII all display a cis relationship 
between H5-H6. The deviation of the computed values from the experimental values clearly 
reflect that whilst these structures all have values ≤ 0.5 Hz, those with the trans protons (III-
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VI) all have values ≥ 6.5 Hz. Therefore structures III-VI can be eliminated and H5-H6 assigned 
as cis. Thus utilising only the two JH-H coupling constants H2'-H3' and H5-H6, we have 
eliminated structures III-VIII, leaving us with diastereoisomers I and II. Utilising the two 
coupling constants H2'-H3' and H5-H6, we calculated the MAE, standard deviation and χ2 
(reduced) values (Figure 24). These validated that based on these two JH-H coupling constants, 
structures III-VIII could be eliminated. Given this success in narrowing down the possible 
structures from eight to two, we moved forward with computing the data for the structures we 
deemed most likely for the natural product (–)-angiopterlactone A (1). 
 
Figure 24: MAE, standard deviation and χ2 (reduced) values for the JH-H data of H2'-H3' and H5-H6 of 
(+)-angiopterlactone B (2) (compound I) and seven of its diastereoisomers (M4, DMSO) 
 
(–)-Angiopterlactone A (1) 
Our investigations continued by studying the proposed structures (I-VIII) for (–)-
angiopterlactone A (1) (see Figure 17, Page 82 or removable sheet, Figure A). Compound Ⅰ 
represents the opposite enantiomer of the structure which was previously proposed by the 
isolation chemists.2 Based on our results and analysis for compounds γ-lactone 4, δ-lactone 3 
and (+)-angiopterlactone B (2), we excluded the positions summarised in Figure 25, as well as 
all 13C chemical shifts from further analysis. The remaining values were then utilised to scale 
the data as previously described and calculate the relevant MAE, standard deviation and χ2 
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diastereoisomer, preliminary results suggest that structures V-VIII could be excluded. We thus 
completed further examinations of the data. 
 
Figure 25: 1H and JH-H data which was ignored for the scaling and further analysis of the structures 
under investigation for (–)-angiopterlactone A (1) 
 
 
Figure 26: MAE, standard deviation and χ2 (reduced) values for the 1H and JH-H data of the eight 
diastereoisomers under consideration for (–)-angiopterlactone A (1) (M4, DMSO) 
Similarly to our analysis of (+)-angiopterlactone B (2) and its diastereoisomers, we analysed 
coupling constants H2'-H3' and H5-H6 to eliminate further structures. Thus we completed a 
separate analysis in which only these two coupling constants were considered for structures I-
VIII (Figure 27). The computed JH2'-H3' values for structures V-VIII (H2'-H3' trans), deviated 
> 3.6 Hz from the experimental values, which means we can eliminate these options and assign 
H2'-H3' as cis. With the exception of structure III, the JH-H deviation values for H5-H6 reflect 
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Figure 27: Deviation (in Hz) of computed JH-H values for H2'-H3' and H5-H6 from their experimental 
values for compounds I-VIII of (–)-angiopterlactone A (1) (M4, DMSO) 
Based on our observations that H2'-H3' are cis, we narrowed down the viable structures to 
compounds I-IV. These differ in the stereochemistry at the C6 and the C6' (hydroxyl) position. 
As the poor data fit of TMS scaled 13C chemical shifts to the experimental values limited us to 
1H chemical shifts and JH-H coupling constants, we proceeded by investigating these 
compounds with method M3, which previously provided a good data fit. 
 
2.3.3 Final Method Choice: Method M3 
 
Method M3 (DMSO) was utilised to compute the NMR data for γ-lactone 4, δ-lactone 3, the 
angiopterlactones (1, 2) as well as all relevant diastereoisomers. 
 
The γ-lactones 4 and 6 and δ-lactones 3 and 5 
 
For γ-lactones 4 and 6, we noted that the 1H chemical shifts provided a good fit to the 
experimental values. This was also the case for the 13C chemical shifts, with the exception of 
position C6 (Figure 18, Page 95) which was thus excluded from further analysis. None of the 
JH-H coupling constants deviated largely from the experimental data and therefore all values 
were included in the analysis. Upon testing the 6% linear scaling on the coupling constants 
(which we completed for all compounds when utilising method M4), we found that for the 
monomeric lactone units 3 and 4, as well as (+)-angiopterlactone B (2), the data fit was not 
significantly improved and thus a 6% linear scaling was not applied to any of the compounds. 
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lactones 4 and 6 (Figure 28). Similarly to method M4 we found a lack in distinguishing power 




Figure 28: MAE, standard deviation and χ2 (reduced) values for the 1H and 13C chemical shift data and 
JH-H coupling constant data for γ-lactone 4 and its diastereoisomer 6 (M3, DMSO) 
Following our analysis of the data for γ-lactones 4 and 6, we investigated δ-lactones 3 and 5. 
All of the 1H and 13C chemical shifts, as well as the coupling constants provided a good data 
fit and thus no positions were excluded from further analysis. Analysis of the MAE, standard 
deviation and χ2 (reduced) values showed that the data provided a clear distinction between the 
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Figure 29: MAE, standard deviation and χ2 (reduced) values for the 1H and 13C chemical shift data and 
JH-H coupling constant data for δ-lactone 3 and its diastereoisomer 5 (M3, DMSO) 
 
(+)-Angiopterlactone B (2) and seven of its diastereoisomers 
Following the computation of NMR properties of the γ- and δ-lactone units, we utilised method 
M3 (DMSO) to investigate the 1H and 13C chemical shifts and JH-H coupling constant values 
for (+)-angiopterlactone B (2) (compound Ⅰ) and seven of its diastereoisomers II-VIII (see 
Table 24, Page 93 or removable sheet, Figure B). Upon computing these values, several data 
points were excluded. For the 1H chemical shifts the CH2 protons were removed as 
conformational rotations caused these positions to swap frequently and thus could not be 
assigned a corresponding experimental value. Their associated JH-H coupling constants were 
also excluded, as well as JH2'-H6', which resulted in large variations due to the nature of the 
rotatable bonds. Except for carbons C4 and C4' (typically an error of 4-8 ppm), the 13C 
chemical shifts provided a good data fit, which meant that we now had more data to work with 
than with method M4. Upon calculating the 1H, 13C and JH-H MAE, standard deviation and χ2 
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III-VIII, leaving only structures I or II as viable options (Figure 30). This observation is 
consistent with what we previously observed when utilising method M4. For a direct 
comparison of how the inclusion of all data points and the exclusion of poorly fitting data 





Figure 30: MAE, standard deviation and χ2 (reduced) values for the 1H and 13C chemical shift data and 
JH-H coupling constant data for (+)-angiopterlactone B (2) and seven of its diastereoisomers (II-VIII)    
(M3, DMSO) 
 
(–)-Angiopterlactone A (1) 
Based on our success in narrowing down the number of structures for (+)-angiopterlactone B 
(2) from eight to two, we moved forward to compute the 1H, 13C chemical shifts and JH-H 
coupling constants for the proposed structures of (–)-angiopterlactone A (1) (see Figure 17, 
Page 82 or removable sheet, Figure A). By taking into consideration problematic positions 
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we once more excluded certain positions from further data analysis. For the 1H chemical shifts 
we excluded the CH2 protons and for the coupling constants we excluded H2'-H6', as well as 
all coupling constants associated with the CH2 group. No data was removed for the 13C 
chemical shifts. The 1H, 13C and JH-H MAE, standard deviation and χ2 (reduced) values for the 
eight diastereoisomers of angiopterlactone A (1) were then calculated (Figure 31).  
 
 
Figure 31: MAE, standard deviation and χ2 (reduced) values for the 1H and 13C chemical shift data and 
JH-H coupling constant data for eight possible structures (I-VIII) for (–)-angiopterlactone A (1)  
(M3, DMSO) 
Initial results allowed us to eliminate structures V-VIII. By comparing solely the χ2 (reduced) 
values (Figure 32), we could tentatively narrow down the possible structures to compounds I-
III. From these structures, compound II provided the best fit to the data. However, given how 
close the values for compounds I-III are, we cannot confidently identify a particular 
diastereoisomer and thus we revisited our previous approach of completing a separate analysis 
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Figure 32: χ2 (reduced) values for the 1H and 13C chemical shift data and JH-H coupling constant data 
for eight possible structures (I-VIII) for (–)-angiopterlactone A (1) (M3, DMSO) 
By considering only the JH-H coupling constants for H5-H6 and H2'-H3' and plotting the 
deviation (in Hz) from the experimental values for each of the diastereoisomers I-VIII, it 
became clear that the only structures which provide suitable results were structures I-III 
(Figure 33). This supports our previous tentative exclusions of structures IV-VIII. As the 
deviations for the H2'-H3' coupling constants from the experimental values follow the trends 
of the structures (low deviations for cis compounds I-IV; high deviations for trans compounds 
V-VIII), H2'-H3' could be assigned as cis. Our proposed viable structures are therefore 
diastereoisomers I-III. As the JH-H coupling constants for H5-H6 did not allow us to confidently 
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Figure 33: Deviation (in Hz) of computed JH-H values for H2'-H3' and H5-H6 from their experimental 
values for compounds I-VIII of angiopterlactone A (1) (M3, DMSO) 
We concluded that the most viable structures were I-III. Structures I and II have the cis 
relationship between protons H5-H6 in common, whereas structure III has a trans relationship. 
If we can more confidently assign these protons as being either cis or trans, we can further 
narrow down the viable structures from three to two/one. Therefore we turned our attention to 
some of our in-house synthesised compounds (Figure 34). Relevant coupling constants are 
summarised in Table 26. 
 
Figure 34: In-house synthesised compounds and the structure proposed by isolation chemists for (–)-
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JH5-H6 cis trans 
Lactones 3 & 5 2.9 Hz 8.9 Hz 
Angiopterlactones 2 & 2.VI 1.6 Hz 8.4 Hz 
δ,δ-tricyclic dimer 26 0.9 Hz  
(–)-angiopterlactone A (1)2 3.0 Hz 
Table 26: The JH5-H6 coupling constants for our in-house synthesised compounds and the literature 
value of (–)-angiopterlactone A (1)2 
The isolation chemists reported a coupling constant of 3.0 Hz for JH5-H6 in (–)-angiopterlactone 
A (1).2 The coupling constant JH5-H6 for our synthesised cis-δ-lactone 3 was 2.9 Hz whereas 
that for trans-δ-lactone 5 (recently synthesised by Dr Katherine Law, Lawrence group) was 
8.9 Hz. Furthermore, our synthetic material (–)-angiopterlactone B (2) had a cis-relationship 
between H5-H6 and the JH-H coupling constant was 1.6 Hz. Dr Katherine Law synthesised a 
diastereoisomer of (–)-angiopterlactone B (2) in which the H5-H6 protons are trans (herein 
named dia-angiopterlactone B (2.VI)) and the corresponding J5H-6H was 8.4 Hz. In addition, 
Dr Katherine Law synthesised δ,δ-tricyclic dimer 26, which has a cis relationship and a 
coupling constant of 0.9 Hz. These coupling constants would suggest that H5-H6 in (–)-
angiopterlactone A (1) are arranged in a cis-relationship, thus eliminating structure III. 
Therefore the remaining viable structures are diastereoisomers I and II.  
To gain further confidence in excluding structure III we tested an alternate approach. In the 
monomeric lactone units we previously observed excellent distinguishing power between the 
pair of diastereoisomers for δ-lactone 3 and 5. Thus for the purpose of the analysis of (–)-
angiopterlactone A (1), we split the molecule in half in order to better reflect the δ-lactone 3 
(Figure 35). The MAE, standard deviation and χ2 (reduced) values for the ‘δ-ring half’ of (–)-
angiopterlactone A (1) were then calculated (Figure 36).  
        








Figure 36: ‘δ-ring half’ MAE, standard deviation and χ2 (reduced) values for the 1H and 13C chemical 
shift data and JH-H coupling constant data for eight possible structures (I-VIII) for (–)-angiopterlactone A 
(1) (M3, DMSO)  
Out of the eight structures, the best data fit for all analysis techniques was provided by 
diastereoisomer II, suggesting that this may be the correct structure of (–)-angiopterlactone A 
(1). This would be a very interesting result as it suggests (based on the assumption that a δ-
lactone is the biosynthetic precursor to the angiopterlactones (1 and 2)) that the dimer consists 
of a cross dimerisation between the δ-lactone ent-3 and its diastereoisomer 5 (Scheme 26). 
(+)-Angiopterlactone B (2) on the other hand is formed via a homo-coupling of two units of 
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Scheme 26: Proposed coupling towards the angiopterlactones (1, 2)  
 
The DP4 Analysis 
In order to gain greater confidence in our tentative conclusion that diastereoisomer Ⅱ 
represents the correct structure for angiopterlactone A (1), we turned to the DP4 probability 
analysis developed by Smith and Goodman in 2010 (see Section 2.1.3).77 This analysis has 
been suggested to be more successful than probabilities based on the mean absolute errors at 
assigning structures correctly with high confidence.77  
To complete the DP4 analysis on our obtained data set (utilising method M3), it was necessary 
to compute TMS at the same level of theory (see Appendix, Table 37, Page 205). Utilising Eq. 
11 (Page 78) and TMS scaled 1H and 13C chemical shifts, we completed the DP4 analysis for 
each of our sets of diastereoisomers for γ-lactone 4, δ-lactone 3, angiopterlactone B (2) and 
angiopterlactone A (1). 
It is interesting to note that subsequent to completing the computational NMR prediction 
studies and the writing of this chapter, Sarotti and co-workers published a quantum-based 
NMR method for the assignment of absolute configuration of compounds.108 This included a 
case study of (–)- and (+)-angiopterlactone B (2) to assign their absolute stereochemistry. 
Utilising their DP4+ probability (modification of DP4), the authors attained >99.9% 
probability for the stereoisomer with the correct relative stereochemistry. We utilised the 
shielding tensors provided in their supporting information which corresponded to structures I-
VIII of angiopterlactone B (2), to calculate the DP4 probability. This involved computing TMS 
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at their described level of theory (mPW1PW91/6-31+G(d,p)[PCM(CH3OH)]//B3LYP/6-
31G(d)) (see Appendix, Table 37, Page 205). This resulted in an overall probability of 85% to 
assign the correct structure. We then utilised their provided excel spreadsheet and shielding 
tensors to complete the DP4+ analysis for the eight diastereoisomers corresponding to I-VIII 
(Table 24, Page 93 or removable sheet, Figure B). This yielded a 99% probability of correctly 
identifying structure I as the correct diastereoisomer, a significant improvement to the 85% 
attained applying DP4. However, during our computational NMR prediction studies and prior 
to their publication detailing the examination of (+)-angiopterlactone B (2), we had contacted 
the developers78 of the DP4+ method. Before applying this analysis, we were interested in 
gaining a better understanding of how the DP4+ probability is calculated (their provided excel 
spreadsheet is a ‘black box’ in which shielding tensor values are added and percentages appear, 
without being able to follow how this occurs). Unfortunately the authors did not provide us 
with any details and thus we utilised only the DP4 method for our data. 
 
Lactones 4 and 3 
We began by investigating DP4 analyses of γ-lactone 4, δ-lactone 3 as well as their respective 
diastereoisomers 6 and 5. The DP4 analysis includes three variations, one in which only the 
proton data is utilised to calculate error probabilities, one in which only the carbon data is used 
and finally one in which a combination of both the proton and the carbon data is used.  
Initially we utilised all available computed and experimental 1H and 13C chemical shifts 
(without excluding any positions) to complete the analyses (Type X, Entry 1, Table 27). We 
then separately completed a DP4 analysis utilising a similar technique to that in method M4, 
in which TMS referenced chemical shifts largely deviating from the experimental data were 
excluded prior to analysis (Type Y, Entry 2, Table 27). Finally we completed the DP4 analysis 
by ignoring the positions discussed in each of the above sub-sections for method M3 (Type Z, 
Entry 3, Table 27). It is interesting to note that whereas previously (utilising MAE, standard 
deviation and χ2 (reduced) values) we could not distinguish between γ-lactone 4 and its 
















1H only 70 30 97 3 
13C only 60 40 100 0 
Both 1H & 13C 78 22 100 0 
2 Y 
1H only 70 30 98 2 
13C only N/A N/A N/A N/A 
Both 1H & 13C N/A N/A N/A N/A 
3 Z 
1H only 70 30 97 3 
13C only 50 50 100 0 
Both 1H & 13C 70 30 100 0 
Table 27: DP4 analysis of γ-lactone 4 and δ-lactone 3, as well as their respective diastereoisomers 6 
and 5 (N/A = not applicable) 
When utilising all of the available 1H and 13C chemical shifts (Entry 1, Table 27) we observed 
that the analysis incorporating both proton and carbon data provided the best structural 
discrimination. By excluding chemical shifts largely deviating from the experimental shifts 
(Entry 2, Table 27) we were restricted to solely 1H chemical shift data. This resulted in a less 
accurate prediction of the correct diastereoisomer than for the best result of Entry 1. It is 
interesting to note that by excluding positions discussed in the above sub-sections, we 
observed less accurate prediction of the correct diastereoisomer for the γ-lactones 4 and 6, 
however equivalent predictive power for δ-lactones 3 and 5 as compared to Entry 1 (Entry 3, 
Table 27). We decided to take forward method types X and Z to complete a DP4 analysis of 
(+)-angiopterlactone B (2) (structure I) and seven of its diastereoisomers (II-VIII) (Table 28). 
 
(+)-Angiopterlactone B (Compound I) and seven diastereoisomers (II-VIII) 
Entry Type % probability I II III IV V VI VII VIII 
1 X 
1H only 57 41 0 0 0 0 0 1 
13C only 38 37 14 6 1 3 0 0 
Both 1H & 13C 59 41 0 0 0 0 0 0 
2 Z 
1H only 57 41 0 0 0 0 0 1 
13C only 48 43 4 2 1 2 1 0 
Both 1H & 13C 61 39 0 0 0 0 0 0 
Table 28: DP4 analysis of (+)-angiopterlactone B (2) (I) and seven of its diastereoisomers (II-VIII) 
The results in Table 28 show that by following method type Z, the distinguishing power 
between the diastereoisomers is better for the carbon only data than for method type X. This 
led to the overall percentages for both the 1H and 13C data to be slightly larger for the correct 
structure (compound I). Generally the data fit and DP4 analysis of (+)-angiopterlactone B (2) 
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and seven of its diastereoisomers reflected trends previously observed and allowed us to 
narrow down the possible structures from eight to two. We therefore completed the DP4 
analysis for the eight structures proposed for (–)-angiopterlactone A (1) (compounds I-VIII).  
 
(–)-Angiopterlactone A (Compounds I-VIII) 
As we did not exclude any of the chemical shifts which can be assigned for our previous 
analysis of angiopterlactone A (1) when following method M3, method type X and Z were 
equivalent and the results are summarised in Table 29 and Figure 37. 
 % probability I II III IV V VI VII VIII 
1H data only 3 53 15 3 4 6 14 1 
13C data only 19 73 7 1 0 0 0 0 
1H & 13C data 1 96 3 0 0 0 0 0 
Table 29: DP4 analysis of the eight possible structures (I-VIII) for (–)-angiopterlactone A (1) 
 
 
Figure 37: DP4 analysis of the eight possible structures (I-VIII) for (–)-angiopterlactone A (1) 
As the combination of proton and carbon data has always given us the most distinguishing 
power between diastereoisomers, it is reassuring that our DP4 analysis of the eight 
diastereoisomers I-VIII result in a 96% probability that structure II is the correct one. This 
agrees with all of our previously made observations. Based on this large probability, synthetic 
investigations are underway in the laboratory in an attempt to synthesise diastereoisomer Ⅱ. 
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In Section 2.1.1 we proposed that (–)-angiopterlactone A (1) may be a diastereoisomer of the 
structure initially suggested by the isolation chemists. By completing computational NMR 
prediction studies, utilising methods M1-M4 (Table 17, Page 83) and variations thereof, we 
concluded that the best method for our lactone systems was provided by method M3. Utilising 
method M3 and investigating various analytical techniques, we tentatively proposed a 
structure for (–)-angiopterlactone A (1.II) (Figure 38). This tentative conclusion was further 
confirmed upon completing Goodman and Smith’s DP4 analysis, which provided us with a 
96% probability that this was the correct structure. Therefore by utilising a combination of 
biosynthetic speculations, our synthetic experience with these compounds, as well as 
computational studies, we narrowed down the possible structures for (–)-angiopterlactone A 
(1) from 16 diastereoisomers, to just 1. Given the encouraging results, Dr Katherine Law 
(Lawrence Group) is currently completing synthetic investigations in which she is targeting 
our proposed structure for (–)-angiopterlactone A (1.II). 
 
Figure 38: Structure proposed by isolation chemists for (–)-angiopterlactone A (1) and our proposed 
structure (1.II) 
Following our investigations into the structure of (–)-angiopterlactone A (1), questions 
regarding the selectivity of the dimerisation reaction encountered in Chapter 1 still remained. 
Furthermore our proposed structure for (–)-angiopterlactone A (1.II) implicates a cross- rather 
than a homo-dimerisation (Scheme 26, Page 111). We therefore completed mechanistic 







Chapter 3: Computational Mechanistic Investigations 
 
Chapter 1 detailed the successful total synthesis of (–)-angiopterlactone B (2) (Figure 39). 
Computational nuclear magnetic resonance (NMR) studies were outlined in Chapter 2 and led 
to a proposed revised structure for (–)-angiopterlactone A (1) (Figure 39). Next we set out to 
investigate the reaction mechanism for the (bio)synthesis of (–)-angiopterlactone B (2), as well 
as for our proposed structure of (–)-angiopterlactone A (1.II). 
 
Figure 39: Our synthetic (–)-angiopterlactone B (2), the structure of (–)-angiopterlactone A proposed 
by the isolation chemists2 (1) and our revised structure (1.II) 
 
3.1 Project Background and Aims 
Following our success in synthesising (–)-angiopterlactone B (2), a number of unanswered 
questions remained, the first of which was why we had not observed the related and co-isolated 
natural product (–)-angiopterlactone A (1). Upon examining the NMR spectra and methods 
utilised by the isolation chemists to assign the relative and absolute configuration within the 
angiopterlactones (1, 2), we completed NMR prediction studies and suggested that (–)-
angiopterlactone A (1) may be a diastereoisomer of the originally proposed structure. Based 
on our biosynthetic speculations (Chapter 1, Section 1.1.2), this structure is unlikely to be 
accessible from a homo-dimerisation of δ-lactone ent-3 and instead requires a cross-






Scheme 27: Proposed starting materials necessary to synthesise the revised structure of (–)-
angiopterlactone A (1.II) 
A further question which remained unanswered following our synthetic investigations in 
Chapter 1, was the inherent selectivity we observed in the dimerisation reaction. The NMR 
spectrum of the crude dimerisation product showed a remarkably selective reaction. In an 
effort to shed light upon this selectivity and to investigate likely biosynthetic/synthetic 
pathways to our proposed structure for (–)-angiopterlactone A (1.II), we performed 
computational mechanistic studies.  
These mechanistic studies are outlined in this chapter and are divided into three main sections. 
The first section describes our investigations into the mechanism for the (bio)synthesis of (+)-
angiopterlactone B (2). The second one examines the mechanism for the synthesis of the 
related dimer, dia-angiopterlactone B (2.VI). The final section explores cross-dimerisations 
between δ-lactone ent-3 with δ-lactone 5, to probe whether these might provide access to 




3.2 Computational Methods 
 
All DFT calculations were performed using the Gaussian 0992 software, employing the 
ωB97XD98 DFT functional in combination with the 6-311++g(d,p) basis set. Solvent was 
modelled using an implicit description of dichloroethane applying the SMD continuum model. 
Solvent cavities were defined by the default SMD-Coulomb radii.99 Due to the flexibility of 
the systems studied, conformational sampling was completed utilising the conformational 
scanning function (scan) implemented in the TINKER104 modelling package. This function 
uses a basin hopping algorithm to efficiently sample the conformational space, where each 
basin represents a distinct region of this space. This is followed by local minimisation to 
identify the lowest energy conformer within each basin. The energy window of conformational 
minima was set to 10 kcal/mol. Hydrogen bond interactions were confirmed by using the 
natural bond orbital (NBO) analysis within the Gaussian software (NBO version 3)109. 
Molecular graphics were created utilising Pymol110.  
Gibbs free energies (G) are reported at the reaction temperature of 343 K using a quasi-RRHO 
treatment. These calculations were completed utilising GoodVibes.102 To switch between free-
rotor approximations and harmonic approximations for vibrations, a smooth damping function 
centred around a frequency of 100 cm-1 was used.103 Vibrational frequencies were utilised to 
confirm stationary points as transition states (TS, presence of one imaginary frequency) or 
minima (no imaginary frequencies). The connection of TS species with corresponding ground 
state species was confirmed by utilising intrinsic reaction coordinate (IRC) calculations.111 
In each of the energy profiles, the energies of the intermediate (INT) and transition state (TS) 
species have been reported relative to the starting material. RC1/2 are the first and second step 
of the ring contraction, oM is the oxa-Michael addition and M is the Michael addition. As the 
monomer is neutral and the species on the energy profile are negatively charged, a balance of 
charge was required. As we are investigating the reaction mechanism for the synthesis of (–)-
angiopterlactone B (2), we utilised HCO3– and CO32– to balance the charge. HCO3– and CO32– 





3.3 Results and Discussion 
 
3.3.1 Investigating the mechanism for the synthesis of angiopterlactone B 
Our investigations began by studying the mechanism for the (bio)synthesis of angiopterlactone 
B (2). During our biosynthetic speculations (Chapter 1, Section 1.1.2), we proposed that the 
formation of dimer 2 could follow a domino oxa-Michael/Michael reaction utilising δ-lactone 
3 and the ring-contracted γ-lactone 4 (Scheme 28). Based on these initial speculations, we set 
out to probe this reaction mechanism.  
 
Scheme 28: Initially proposed starting materials to synthesise (–)-angiopterlactone B (2) 
 
Michael Donor vs Michael Acceptor 
With lactones 3 and 4 each containing a Michael donor and acceptor, there are a variety of 
potential oxa-Michael reactions that could occur. In order to limit these options, we first 
investigated which of the two lactones (3 or 4) would be more likely to act as the nucleophile. 
 
Figure 40: Isolation chemists’2 proposed structure of (–)-angiopterlactone A (1) and in-house 




In all our experiments and those reported by Bhattacharya and co-workers36, no dimers 
resulting from γ-lactone 4 acting as the nucleophile were formed (see Figure 40 for examples). 
This led us to calculate pKa values for the alcohol group in each of the lactones ent-3 and ent-
4 (Table 30). The pKa studies were completed by Dr Fernanda Duarte and a summary of the 
methodology can be found in the Appendix (Section 3.2). Note that this approach tends to 
over-estimates pKa values and that empirical corrections have been suggested based on the 
nature of the chemical groups and the method used.112 As the aim of this work was to compare 
the relative pKa values for the deprotonation of the alcohol in the two species rather than obtain 






OH  O– OH  O– CH  C– 
DCE 
ΔG (kcal/mol) 45.7 50.9 38.5 
pKa 30.5 33.8 25.9 
DMSO 
ΔG (kcal/mol) 34.1 38.9 26.3 
pKa 23.1 26.2 18.2 
Table 30: Free energy (ΔG) and pKa values for lactones ent-3 and ent-4 in DCE and DMSO at 343 K 
The results in Table 30 show that the pKa for the alcohol moiety of δ-lactone ent-3 is three 
orders of magnitude lower than that of γ-lactone ent-4 in both DCE and DMSO. This suggests 
that at the reaction temperature, higher concentrations of the alkoxide of δ-lactone ent-3 will 
be present than of γ-lactone ent-4. It is interesting to note that the acidity of the CH proton in 
γ-lactone ent-4 (included for general interest and labelled in blue in Table 30) resulted in a 
pKa value of approximately 8 orders of magnitudes less than that of the OH proton. This could 
provide an explanation for the experimentally observed epimerisation at this position 
(discussed in Chapter 1, Section 1.2.2). These pKa studies and our previous observations led 
us to only investigate possible mechanistic pathways in which δ-lactone 3 acts as the 






Potential Mechanistic Pathways  
 
Based on the assumption that δ-lactone ent-3 acts as the nucleophile, a number of pathways 
remain which need to be considered for the synthesis of (+)-angiopterlactone B (2). The three 
mechanistic pathways we considered as the most plausible are summarised in Figure 41 and 
are outlined in the sections to follow. The pathways have been colour-coded for ease of reading 
and these colours remain throughout the chapter. Structures following the general connectivity 
within angiopterlactone A (1) will henceforth be referred to as γ,δ-dimers (see Figure 41). 
Pathway 1 (P1, red) is initiated by ring contraction of δ-lactone ent-3 to the corresponding γ-
lactone ent-4. An intermolecular oxa-Michael addition could then give access to a γ,δ-dimer 
(X, Figure 41). A final intramolecular Michael addition could then provide (+)-
angiopterlactone B (2).  
Pathway 2 (P2, black) involves an oxa-Michael addition between two units of δ-lactone ent-
3 to provide a δ,δ-dimer (Y, Figure 41). Ring contraction could then result in a γ,δ-dimer (X, 
Figure 41). Finally an intramolecular Michael addition could provide (+)-angiopterlactone B 
(2). 
Pathway 3 (P3, blue) commences with dimerisation of two units of δ-lactone ent-3 via an 
oxa-Michael addition to provide a δ,δ-dimer (Y, Figure 41). This could then be followed by a 
Michael addition to provide a δ,δ-tricyclic dimer (Z, Figure 41). A ring contraction could then 
result in (+)-angiopterlactone B (2). It is important to note that this pathway does not proceed 








Possible Outcomes from a Domino Oxa-Michael / Michael Reaction 
 
Now that we had established the three mechanistic pathways we were investigating, there were 
a number of possible orientations in which the oxa-Michael and the subsequent Michael 
additions could occur. The example provided in Scheme 29, follows Pathway 1. 
For the initial intermolecular oxa-Michael addition of δ-lactone ent-3 to γ-lactone ent-4 there 
are two possibilities: it can either occur from the Re face or from the Si face (Scheme 29). The 
next step is the intramolecular Michael addition, which can proceed through four different 
transition states (products differ in the relative orientation of the hydrogen atoms around the 
central THF ring being formed; see Scheme 29). Thus, the domino oxa-Michael/Michael 
reaction between lactones ent-3 and ent-4 has eight possible outcomes. In principle, these 
alternatives are available for each of our three proposed mechanistic pathways (Figure 41). 
While these different alternatives were explored, we limit our discussion herein to just two 
possible outcomes for the domino oxa-Michael/Michael addition. Throughout all our 
mechanistic studies, the Re pathway always results in the cis-anti-cis product and the Si 
pathway in the cis-syn-cis product (preferred pathway is substantially lower in energy) 
(Scheme 29). This can be readily understood, as it has previously been reported that due to 
steric strain and geometric requirements, five-five and five-six bicyclic systems are 
energetically favoured when they are cis-fused.113 To demonstrate how these cis- and trans-
fused rings compare, we calculated their relative energies (Table 31).  









Table 31: Investigating cis- and trans-fused ring systems. Negative values indicate that the cis- is 




Scheme 29: Domino oxa-Michael/Michael process, resulting in eight possible products (labelling of 
products results from relative relationship of hydrogen atoms around the central THF ring) 
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Pathway 1 (P1) 
 
 
The mechanistic investigations began by considering δ-lactone ent-3 and pathway 1 (P1) 
(Figure 42). The first step involves the ring contraction (RC) from δ-lactone ent-3 to the 
corresponding γ-lactone ent-4. Our calculations revealed that this ring contraction proceeded 
as a two-step process, in which the first step corresponds to a 5-exo-trig cyclisation (RC1) and 
the second to a retro-5-exo-trig ring opening (RC2). Upon considering the methyl group in 
either the pseudo-axial or the pseudo-equatorial orientation, we found that the lowest energy 
conformer resulted from the methyl group being placed in the pseudo-equatorial position (as 
for the protonated species in Chapter 2) (see Appendix, Table 68). The activation energy 
required to achieve the ring contraction of δ-lactone ent-3, was 19.3 kcal/mol at the 
ωB97XD/6-311++g(d,p) level of theory (TSRC1, Figure 42). Similar results were obtained 
employing the M06-2X functional and the same basis set (study initiated by Dr Fernanda 






Figure 42: Pathway 1 energy profile for the homo-coupling of δ-lactone ent-3 
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It is interesting to note that INTRC2 is 5.5 kcal/mol more stable than the starting δ-lactone ent-
3 (at 0.0 kcal/mol). This result made us curious as to why a 5-membered lactone ring should 
be lower in energy than its 6-membered analogue. Upon searching the literature, we found that 
Stedjan and Augspurger completed a study of ring strain energy within lactones.114 This 
resulted in the observation that ring strain energies for δ-lactones were typically 1-2 kcal/mol 
higher than those of γ-lactones. As this does not account for the large difference of 5.5 kcal/mol 
that we observed, we investigated the relative energies of a number of 5- and 6-membered 
rings, which were based on the initial δ-lactone 3 and γ-lactone 4 (Table 32). The results 
showed that for each of the lactones investigated (options A-D, Table 32), the γ-lactone was 
around 5-6 kcal/mol lower in energy than the δ-lactone equivalent. As soon as the lactone 
moiety is removed, however, the 6-membered ring becomes more favourable (options E-G, 
Table 32). Upon further examination, we noted that whereas the 6-membered rings in options 
E-G were in a chair conformation, the lactones in options A-D were in a boat conformation 
(some structures are summarised in Figure 43, indicating key bond angles). This is a result of 
the planarity of the lactone moiety (see Chapter 1, Section 1.2.3). Upon calculating the 6-
membered ring in option G in the twist-boat conformation (Table 32), a decrease in ΔG from 
+2.1 to –2.8 kcal/mol was observed. This is equivalent to an energy difference between the 

















































Table 32: Investigating and comparing energies of 6- and 5-membered rings. Negative values indicate 








Figure 43: Conformations of 6-membered rings in options D-G, highlighting key bond angles 
The next step in P1 is the oxa-Michael addition of δ-lactone ent-3 to γ-lactone ent-4 (oM, 
Figure 42). The transition state calculations for this step were initially carried out by Dr 
Fernanda Duarte and the analysis was completed by myself. Upon computing the energies for 
the various orientations for both the Re and the Si face oxa-Michael additions, we noted that 
Si face addition was favoured by 3.2 kcal/mol (TSoM). Examination of the two transition states 
showed that in both the Re- and Si-TSoM, the δ-lactone configurations were identical, with the 
methyl groups in the pseudo-equatorial (pseudo-eq) position (Figure 44). The preference for 
the Si-TSoM species arises from the favourable hydrogen bond interaction between the 
nucleophilic alkoxide and the hydroxyl of the γ-lactone, which is only observed in this 





















Figure 44: Transition state for the Re and the Si face oxa-Michael (oM) addition 
The final step in P1 is the intramolecular Michael addition (M, Figure 42), for which the 
required activation energies for the Re and the Si pathways are very similar. The most notable 
difference is the stability of the product, with the Re product being 3.3 kcal/mol more stable 
than the Si product. It is interesting to note that the former resulted in an open chain-like 
structure, whereas the latter was arranged in a more sterically congested bowl-like shape 
(Figure 45). We speculated that the stability of the product is therefore related to sterics. 
  
Re cis-anti-cis product Si cis-syn-cis product 
Figure 45: Final product for the Re- and Si-pathways 
To confirm this hypothesis, we conducted several tests (Table 33). First, we investigated if the 
flexible side chain attached to the γ-lactone has an effect on the relative energy of the products. 
Removal of this side chain resulted in a ΔG of 3.7 kcal/mol in favour of the Re product, thus 
demonstrating that the side chain arrangement was not responsible for the difference in energy 





difference of only 1.5 kcal/mol in favour of the Re product (option C), indicating that the 
energy difference between the Re and Si product is indeed due to sterics.  












Table 33: Stability tests of angiopterlactone B (2) (option A) derivatives (positive values indicate that 
Re is favoured)  
In conclusion, examination of the overall energy profiles for pathway 1 indicated that the rate-
limiting step is the initial ring contraction (TSRC). Similar energetics were obtained for both 
the Re- and Si-pathways, with the main differences being the transition state of the oxa-
Michael addition (TSoM) and the product stability. The thermodynamic product of this reaction 
profile would be the Re product, which is not the product we observed experimentally. Given 
the large initial activation barrier of 19.3 kcal/mol for the ring contraction (TSRC), we moved 










Pathway 2 (P2) 
 
 
The energy profiles for pathway 2 (P2) are shown in Figure 47. P2 is initiated by an oxa-
Michael addition (oM) between two units of δ-lactone ent-3, which can occur from the Re or 
the Si face.  
As seen in Figure 47, the activation energy for the Re and Si face oxa-Michael addition is 
nearly identical (TSoM). However, the resulting Si-INToM species is 2.3 kcal/mol more stable 
than Re-INToM. Upon inspection of the structures, we noted that whereas in the Si species both 
methyl groups were in the pseudo-equatorial, the Re species had one methyl group in the 
pseudo-axial (pseudo-ax) position (Figure 46). This conformation allows a hydrogen bond 
interaction between the OH group of the lactone and the ether linkage between the rings. To 
draw a better comparison to the energetically favourable Si species, we computed the energy 
of the Re species with both methyl groups in the pseudo-equatorial position and found that this 
resulted in the loss of the stabilising hydrogen bond interaction and increased the energy by a 
further 2.0 kcal/mol.  
 
 
Re INToM species Si INToM species 
Figure 46: Re and Si INToM species 






Figure 47: Energy profile for pathway 2 of the homo-coupling of δ-lactone ent-3 
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The next step in P2 is the ring contraction, for which the highest Re- and Si-pathway transition 
states (TSRC) are almost equal in energy. The final step is the Michael addition (M), which is 
identical to the one reported for pathway 1. 
Overall, as a result of the similarities in the overall activation energies for the Re and Si 
pathways, we did not draw a conclusion with respect to which pathway would be kinetically 
favoured. However, if the reaction is under thermodynamic control, the product resulting from 
the Re pathway would be preferred, which is not the product we observed experimentally.  
 
Pathway 3 (P3) 
 
Similarly to pathway 2, pathway 3 (P3) began with the oxa-Michael addition (oM) between 
two units of δ-lactone ent-3 (Figure 49). The next step in P3 is the intramolecular Michael 
addition (M). The activation barriers for the Michael addition in the Re and Si pathways are 
similar to one another (TSM), with the Si pathway being slightly preferred by 2.1 kcal/mol. 
The final step in P3 is the ring contraction, for which we noted that the Si pathway is higher 
in energy than the Re pathway (TSRC, ΔΔG
‡ = 6.6 kcal/mol). Similarly to our observations for 
P1, we noted that whereas the Re-TSRC was arranged in a flat and more open structure, the Si-
TSRC was arranged in a bowl-like and more sterically congested structure (Figure 48). 
  
Re TSRC1 species Si TSRC1 species 
Figure 48: TSRC1 for the Re- and the Si-pathway 
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In order to investigate the effect of these different arrangements on the activation energy, we 
examined simplified structures for TSRC. For the first system we studied, the nucleophilic δ-
lactone from the initial oxa-Michael addition was removed, which barely affected the energy 
difference between Re- and Si-TSRC (ΔΔG
‡ = 6.1 kcal/mol in favour of the Re-TSRC) (option 
B, Table 34). Inspection of the transition state species showed that as observed previously, the 
Si species represented a more closed bowl-like structure, whereas the Re species was flatter 
and less sterically congested. Upon further simplification of the molecule (option C, Table 34), 
ΔΔG‡ between the Re and the Si species was reduced to 2.1 kcal/mol. This suggests that the 
high ΔG‡ observed for the ring contraction in the Si pathway, is linked to the overall sterics of 
the molecule. 





















Table 34: Differences in activation energy for the ring contraction in simplified compounds (positive 
values indicate that Re is favoured 
In summary, the Si-TSM has a lower ΔG
‡ than the Re-TSM. As this step is likely to be 
irreversible under the experimental conditions, P3 would preferentially proceed to form the Si 
product. It is interesting to note that this is the experimentally observed product and thus if P3 
represents the correct pathway for the synthesis of angiopterlactone B (2), it suggests that the 
reaction is under kinetic control. The next step in our investigation was to directly compare 
the lowest energy profiles for pathways 1, 2 and 3 to examine which pathway was most likely 








Comparison of Pathways 1-3 
 
In order to investigate which pathway was most likely for the synthesis of (+)-angiopterlactone 
B (2), we summarise their energy profiles in Figure 51. As the rate limiting step for P1 is the 
initial ring contraction (TSRC), which is identical for the Re and Si pathway, we have only 
shown the Si pathway as a representative example. The Re and Si pathways in P2 had nearly 
identical activation energy barriers (TSRC) and thus we have only included the Re pathway as 
a representative example. We previously concluded for P3, that the reaction preferentially 
proceeds via the Si pathway and thus only this pathway is included on the energy profile.  
It is interesting to note that the activation energy for the ring contraction varies substantially 
between P1 and P2/3. In P1, ΔG‡ is more than 7 kcal/mol higher than in either P2 or P3 (Figure 
50). One of the main differences between the ring contractions is that in P1, the δ-lactone 
contains an alkene, which is not present in either P2 or P3. To determine the effect the alkene 
may have on the activation energy of the ring contraction (TSRC), we carried out an analogous 
study in which we removed the alkene functionality in the δ-lactone. This resulted in an 
activation energy of 7.7 kcal/mol, which is 11.6 kcal/mol lower than that observed in P1. 
 
Figure 50: Summarised activation barriers for the ring contractions in pathways 1, 2 and 3, as well as 
the hydrogenated alternative 
We previously noted that the rate-limiting step for P1 corresponds to the ring contraction (ΔG‡ 
= 19.3 kcal/mol), which is much higher in energy than that of P3 (ΔG‡ = 12.7 kcal/mol; ΔΔG‡ 
= 6.6 kcal/mol). Based on this large energy difference, P1 was excluded from further analysis. 
It is interesting to note that P1 most closely resembled our initial biosynthetic speculations 







Figure 51: Energy profile featuring examples from pathways 1, 2 and 3 
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The highest energy barrier in P3 is 3.6 kcal/mol lower than that in P2 and therefore we 
disregard P2 and propose P3 to be the most energetically favourable reaction pathway. This 
pathway results in the Si-cis-syn-cis-product, which agrees with our experimentally observed 
outcome. 
In summary we propose that P3 represents the most likely pathway for the synthesis of 
angiopterlactone B (2). It is interesting to note that the Si-product is not thermodynamically 
favoured and that P3 does not proceed via a γ,δ-dimer. This could offer an explanation as to 
why angiopterlactone A (1) was not observed during our synthetic investigations.  
 
 
3.3.2 Investigating the mechanism for the synthesis of dia-angiopterlactone B 
 
Our mechanistic investigations of δ-lactone ent-3 to form (+)-angiopterlactone B (2) resulted 
in proposing P3 as the most likely mechanism leading to its formation. Next we examined the 
mechanism for the homo-coupling of δ-lactone 5 to form dia-angiopterlactone B (2.VI) (the 
synthesis of dimer 2.VI was completed by Dr Katherine Law (Lawrence group) (Scheme 30)). 
As the product observed corresponds to the opposite facial addition to that of the oxa-Michael 
addition to form (–)-angiopterlactone B (2), we were intrigued to investigate the mechanism 
for this reaction.  
 









Pathway 1 (P1) 
 
 
We began by investigating the ring contraction from δ-lactone 5 to the corresponding γ-lactone 
6. Similarly to our previous studies, the ring contraction involves a high energy transition state 
(ΔG‡ of 18.6 kcal/mol). Due to this large activation energy barrier, we investigated P2 and P3 
and then draw comparisons between the three pathways at the end of this section.  
 
Pathway 2 (P2) 
 
 
The energy profile for P2 is presented in Figure 53. The first step is the oxa-Michael addition 
between two units of δ-lactone 5, for which we found that addition from the Re face is favoured 
by 5.1 kcal/mol over addition from the Si face (TSoM). Upon examination of the TSoM species 
(Figure 52), it became evident that for the Re species each of the δ-lactones was arranged with 
the methyl groups in the pseudo-equatorial position and the hydroxyl group provided a 
stabilising hydrogen bond interaction. The Si species on the other hand lacked this stabilising 
hydrogen bond interaction and favoured one methyl group in the pseudo-axial position. This 
trend is repeated in the resulting INToM species (the δ,δ-dimer) and explains the differences in 







Re TSoM species Si TSoM species 
Figure 52: Re and Si transition state species for the oxa-Michael addition 
The activation energy for the second step in P2, the ring contraction (RC), is similar between 
the Re and Si pathways. Finally, the Michael addition step (M) favours the Re pathway by 4.0 
kcal/mol. Upon inspection of the optimised TSM species, we observed (as we had previously) 
that the Si species was more sterically congested than the Re species. 
The similarities in the overall energy values prevented us from concluding which pathway 
would be kinetically favoured, however the Re product is thermodynamically favoured. We 









Figure 53: Pathway 2 energy profile for the homo-coupling of δ-lactone 5 
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Pathway 3 (P3) 
 
 
The first step of P3 is equivalent to that of P2 and involves the oxa-Michael addition between 
two units of δ-lactone 5. The results showed that the addition from the Re face (TSoM) was 
favoured by 5.1 kcal/mol (Figure 54). This trend is upheld throughout the Michael addition 
(M) and subsequent ring contraction (RC). Upon inspection of the intermediate and transition 
state species, we generally noted (as observed previously) that the Re species tended to be 
arranged in a flatter, open-chain like structure, with both methyl groups in the pseudo-
equatorial positions. The Si species on the other hand were bowl-like, more sterically 
congested and were thus more stable when one methyl group was placed in the pseudo-axial 
position. This could explain why the Si species are typically higher in energy.  
Overall P3 favours the Re product both kinetically and thermodynamically. It is interesting to 
note that this is the product which was observed experimentally by Dr Katherine Law. Next 
we compared P1, P2 and P3, in order to determine which one is most likely for the reaction 





Figure 54: Energy profile for pathway 3 for the homo-coupling of δ-lactone 5 
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Comparison of Pathways 1-3 
 
A summary of the energy profiles for P2 and the lowest energy profile for P3 is shown in 
Figure 55. For P1 the rate-limiting step is the ring contraction, which requires an activation 
energy of 18.6 kcal/mol. The highest energy barrier to overcome in P3, is 11.3 kcal/mol (TSM) 
(ΔΔG‡ = 7.1) and thus we disregarded P1. 
The highest energy transition state for both the Re and Si pathways in P2 is that of the ring 
contraction (TSRC). There was a substantial difference in energy to overcome these transition 
states when compared to TSM in P3 (ΔΔG
‡ = 8.0 and 9.5 kcal/mol respectively) and thus P2 
could also be disregarded. We therefore propose that the dimerisation of δ-lactone 5 to dia-








Figure 55: Energy profile summarising pathways 2 and 3 for the homo-coupling of δ-lactone 5  
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3.3.3 Cross Dimerisations 
 
Subsequent to our mechanistic investigations into the homo-coupling reactions of δ-lactone 
ent-3 and δ-lactone 5, we turned our attention to investigating their cross-coupling reactions. 
While no experimental data is available for these reactions, this study will serve as a guide to 
further synthetic efforts in the Lawrence group. Our interest in exploring their mechanism 
stems from our proposed structure for (–)-angiopterlactone A (1.II). The formation of this 
compound presumably results from a cross dimerisation of δ-lactone ent-3 and an (R,S)-δ- or 
γ-lactone, where the former acts as the nucleophile and the latter as the electrophile (Scheme 
27, Page 117). Thus we began our investigations by examining the three pathways for such a 
cross-coupling. 
 
Pathway 1 (P1) 
 
As discussed in Section 3.3.2, the ring contraction of P1 has a high initial activation energy 
barrier (ΔG‡ = 18.6 kcal/mol). This will be compared to pathways 2 and 3 at the end of this 
section. 
 
Pathway 2 (P2) 
 
The energy profile for P2 is summarised in Figure 58. The first step is the oxa-Michael addition 
of δ-lactone ent-3 to δ-lactone 5. It is interesting to note that similarly to the oxa-Michael 
addition between two units of δ-lactone 5, the Re addition is preferred (ΔΔG‡ = 6.0 kcal/mol). 
Upon inspection of the oxa-Michael transition state species (TSoM) we noted that the Re species 
had a favourable hydrogen bond interaction between the nucleophile and the hydroxyl group 
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of the electrophile (Figure 56). The Si transition state species on the other hand lacked such a 
H-bonding interaction and furthermore the methyl group of the electrophile was in the pseudo-
axial position. Attempts to place both methyl groups in the pseudo-equatorial position, 




Re TSoM species Si TSoM species 
Figure 56: Re and Si transition state species for the oxa-Michael addition 
The ring contraction (RC) and the final Michael addition (M) in P2 have similar activation 
barriers for both the Re and Si pathways. Inspection of the transition state species (TSM) 
showed that similarly to our previous investigations, the Re species had an open-chained and 
uncongested structure (Figure 57). Although the Si-TSM is stabilised by a H-bond, it is 
destabilised by its sterically congested bowl-like structure. In the product species, this 
stabilising hydrogen bond is weaker than in Si-TSM and thus the Re product is more stable.  
 
 
Re TSM species Si TSM species 










Figure 58: Energy profile for pathway 2 for the cross coupling of lactones ent-3 and 5 
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Pathway 3 (P3) 
 
 
The first step of P3 is identical to the one discussed in P2 (see Figure 60 for full energy profile 
of P3). The subsequent INToM Re and Si species show a clear energy difference between them. 
Inspection of the structures reflected that the Re intermediate has both methyl groups in the 
pseudo-equatorial position and a stabilising H-bond interaction. The Si species on the other 
hand lacks this hydrogen bond interaction and one of its methyl groups is in the pseudo-axial 
position. Attempts to re-create the lower energy structure of Re-INToM in Si-INToM, resulted 
in an energy increase of 1.4 kcal/mol (Figure 59).  
  
Low energy Si INToM species 
ΔG = 0.0 
High energy Si INToM species 
ΔG = +1.4 










Figure 60: Energy profile for Pathway 3 for the cross-coupling of lactones ent-3 and 5 
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The final step in P3 is the ring contraction (RC), in which the Re- is preferred over the Si-
pathway. Similarly to previous observations, we noted that whereas the Re INTM and TSRC 
species were arranged in a flat, open structure, the Si INTM and TSRC are arranged in a bowl-
like and more sterically congested structure. 
Overall, the Re product is both kinetically and thermodynamically favoured. The final step of 
our mechanistic investigations of this cross-coupling, was to consider which of pathways 1, 2 
or 3 was most likely.  
 
 
Pathway 1 vs 2 vs 3 
 
The energy profiles for pathways 2 and 3 are summarised in Figure 61. The rate-limiting step 
of P1 is the ring contraction (ΔG‡ = 18.6 kcal/mol), which has a much larger activation energy 
barrier than that in Re-P3 (TSM, ΔG
‡ = 13.9 kcal/mol). Therefore, as we have done previously, 
P1 was disregarded from further analysis. Comparison of the highest energy transition state 
species for Re-P2 (TSRC1) and Re-P3 (TSM) shows that P3 was favoured by 5.2 kcal/mol. 
In summary, P3 provides the lowest energy pathway for the cross-coupling of δ-lactone ent-3 
with δ-lactone 5. It is interesting to note that this pathway does not proceed via a γ,δ-dimer. 
Given the results of this mechanistic investigations, we have re-directed our synthetic efforts 
in the laboratory, to utilise an alternative method to synthesise our proposed structure for (–)-





Figure 61: Energy profile for pathways 2 and 3 for the cross-coupling of lactones ent-3 and 5 
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Alternative cross coupling: δ-lactone 5 as the nucleophile 
 
 
The results of both homo-couplings as well as the cross-coupling of δ-lactone ent-3 with δ-
lactone 5, indicated that the lowest energy pathway does not proceed via a γ,δ-dimer 
intermediate. This was an interesting outcome, particularly in relation to our initial 
biosynthetic proposal (Chapter 1, Section 1.1.2). We were thus eager to explore whether the 
cross-coupling of δ-lactone 5 with δ-lactone ent-3 would proceed via a γ,δ-dimer. 
Pathways 1, 2 and 3 were studied and similarly to our previous investigations, comparison of 
the highest activation barriers of each pathway led to the exclusion of P1. The energy profiles 
for pathways 2 and 3 are summarised in Figure 63. 
The first step of P2 and P3 is the oxa-Michael addition of δ-lactone 5 to δ-lactone ent-3, for 
which the Re-TSoM was preferred over the Si-TSoM species by 4.1 kcal/mol. Upon inspection 
of the transition state structures, we noted that the main difference between them was that the 
Re species had a stabilising hydrogen bond interaction (Figure 62).  
  
Re TSoM species Si TSoM species 






Figure 63: Pathway 2 and 3 for the alternative cross coupling of δ-lactone 5 with ent-3 
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Throughout the energy profile there is a consistent trend that the activation barriers for the Re 
pathway are lower than those of the Si pathway. We therefore proceeded to exclude the Si 
pathways from further analysis and instead drew comparisons between the Re pathways of P2 
and P3. Whereas the initial oxa-Michael addition is identical in required energy (TSoM), the 
subsequent Michael addition favours P3 by 1.5 kcal/mol (TSM). As this is a small difference 
in energy, it is possible that pathways 2 and 3 are competing with one another.  
Our main interest in computing the pathways for this cross-dimerisation of lactone 5 with ent-
3, was to investigate whether or not it would allow us to access a γ,δ-dimer (i.e., a 
diastereoisomer of angiopterlactone A (1)). If the reaction proceeds solely via P3, then this is 
not possible, as angiopterlactone A (1) is not an intermediate of this pathway. However, even 
if the reaction were to partially proceed via P2, in which a γ,δ-dimer is an intermediate 
(intermediate prior to TSM), it is unlikely that this reaction would result in the isolation of this 
compound. This is due to the low energy barrier of 5.8 kcal/mol for TSM, with a subsequent 
gain in energy of 14.6 kcal/mol to proceed to the final product. Given the high energy barrier 
this pathway has to overcome in the first (TSoM) and second step (TSRC), it is likely that the 
γ,δ-dimer would funnel straight through to the final product, angiopterlactone B (2). Overall 
the cross-coupling of lactone 5 with ent-3 is unlikely to allow us to gain access to a γ,δ-dimer 






In this Chapter we have investigated the underlying mechanism leading to the formation of 
angiopterlactone B (2). The reaction mechanism is suggested to consist of an intermolecular 
oxa-Michael addition between two units of δ-lactone 3, followed by an intramolecular Michael 
addition to form δ,δ-tricyclic dimer 26, before a final ring contraction provides (–)-
angiopterlactone B (2) (Scheme 31).    
 
Scheme 31: Proposed mechanism for our synthesis of (–)-angiopterlactone B (2) 
We have also investigated the underlying reaction mechanism for the formation of dia-
angiopterlactone B (2.VI) (synthesis completed by Dr Katherine Law (Lawrence Group), 
Scheme 32). We suggest that this reaction proceeds via the same elementary steps as in the 
formation of angiopterlactone B (2). Interestingly, however, the oxa-Michael addition now 
proceeds from the opposite face, which is a result of a favourable hydrogen-bond interaction. 
 
Scheme 32: Synthesis of dia-angiopterlactone B (2.VI) (Dr Katherine Law, unpublished work) 
Finally, a mechanistic investigation of the possible cross-coupling reactions of lactones ent-3 
and 5 was carried out, to reveal whether any of them would give rise to a γ,δ-dimer 
(connectivity of angiopterlactone A (1)). As none of the mechanistic pathways are likely to 
allow us to gain access to such structures, synthetic efforts must be re-directed in order to 
access our proposed structure of (–)-angiopterlactone A (1.II) (see Chapter 4, Future Work).  
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Chapter 4: Final Remarks 
 
4.1 Biosynthetic Speculations 
Upon isolation of angiopterlactones A and B (1, 2), Zou and co-workers hypothesised that 
these two natural products are biosynthetically related (Scheme 33).2 Our initial biosynthetic 
speculations resulted in proposing that (–)-angiopterlactone A (1) is formed via an oxa-
Michael addition between δ-lactone 3 and the corresponding ring contracted γ-lactone 4 
(Scheme 33). We further speculated that the precursor to lactone 3 could be lactone 7, which 
bears resemblance to the known natural products osmundalin (8) and angiopteroside (9). The 
results obtained both experimentally and computationally, suggest that these initial 
biosynthetic speculations may be (partially) incorrect and therefore need to be revised.  
 
Scheme 33: Our initial biosynthetic speculations (final Michael addition proposed by Zou and co-
workers)2  
During our dimerisation studies on δ-lactone 3 to synthesise (–)-angiopterlactone B (2) 
(Chapter 1), we never observed the proposed precursor (–)-angiopterlactone A (1). This 
observation combined with our examination of available NMR data, led us to hypothesise that 
the structural assignment of (–)-angiopterlactone A (1) may be incorrect. The results of our 
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computational NMR prediction studies (detailed in Chapter 2) suggest that (–)-
angiopterlactone A (1) may be a diastereoisomer of the structure depicted in Scheme 33. 
Computational mechanistic investigations (outlined in Chapter 3) indicated that the formation 
of (–)-angiopterlactone A (1) is unlikely to be a result of spontaneous reactivity between any 
combination of δ-lactones 3 and ent-5. This led us to re-examine our biosynthetic speculations 
and propose alternative pathways, which are outlined in Scheme 34.  
 
Scheme 34: Further biosynthetic speculations for angiopterlactone A (1) and possible biosynthetic 
precursors 
One possibility is that the biosynthesis of angiopterlactone A (1) involves a sugar derivative, 
which lacks the α,β-unsaturated moiety (examples of such sugar derivatives are depicted in 
the lower half of Scheme 34). An oxa-Michael addition with a γ-lactone (option A) could then 
form angiopterlactone A (1). Alternatively, an oxa-Michael addition with a δ-lactone, followed 
by a ring contraction, could form angiopterlactone A (1) (option B). It is also possible, 
however, that the biosynthesis of angiopterlactone A (1) is governed entirely by enzymes, 
allowing direct and selective access to the natural product via alternative routes. 
In summary, even if there is no conclusive answer with respect to the biosynthetic origins of 
angiopterlactone A (1), our experimental and computational studies suggest that the structure 
originally proposed is incorrect and that it is unlikely that we can synthetically access this 




The total synthesis of (–)-angiopterlactone B (2) was successfully achieved in four steps 
(Scheme 35). The highlight of the synthesis is the final dimerisation reaction, in which three 
new bonds, three new rings and three new stereogenic centres are formed in a single step, with 
complete control of the relative stereochemistry. With (–)-angiopterlactone B (2) in hand, we 
proposed that the stereochemistry of the natural material needed revising. Throughout our 
screening of dimerisation conditions, we never observed the related natural product (–)-
angiopterlactone A (1) (Scheme 35). This led us to investigate the structure originally 
suggested by Zou and co-workers.2  
 
Scheme 35: Structures of (−)-angiopterlactone A (1) (proposed by Zou and co-workers2 and by us) 
and (−)-angiopterlactone B (2) 
Upon analysis of the available NMR data for (–)-angiopterlactone A (1), we proposed that the 
natural material may be a diastereoisomer of the originally reported structure. By utilising 
biosynthetic speculations, we reduced the number of possible structures from sixteen to eight. 
We investigated these eight diastereoisomers by conducting computational NMR prediction 
studies, which led us to propose a revised structure for (–)-angiopterlactone A (1) (Scheme 
35). 
The remarkable selectivity we observed in the dimerisation reaction towards (–)-
angiopterlactone B (2), inspired us to complete computational mechanistic investigations with 
which we could probe its (bio)synthesis. This led us to the conclusion that (–)-angiopterlactone 
B (2) is formed via a domino oxa-Michael/Michael/ring contraction process (Scheme 36). We 
then studied the synthesis of the related compound dia-angiopterlactone B (2.VI) from δ-
lactone 5 and concluded that it is formed following the same synthetic route. It is interesting 
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to note that these syntheses do not proceed via the corresponding diastereoisomers of 
angiopterlactone A (1). 
 
Scheme 36: Proposed mechanism for the formation of (–)-angiopterlactone B (2) and dia-
angiopterlactone B (2.VI) 
In an effort to further probe why we had not observed the related natural product (–)-
angiopterlactone A (1), we completed computational mechanistic studies for the possible 
cross-couplings between lactones ent-3 and 5. Similarly to the homo-dimerisations of lactones 
ent-3 and 5, these showed that it is unlikely that (–)-angiopterlactone A (1) can be accessed 
via this route. As a result of these studies, synthetic efforts in the Lawrence group have been 
re-directed. 
                     
Figure 64: Combining synthetic efforts, biosynthetic speculations and computational studies to work 
towards answering complex questions 
162 
 
In conclusion, the interplay between synthetic efforts, biosynthetic speculations and 
computational studies, allowed us to propose a revised structure for the natural product (–)-
angiopterlactone A (1.II). Furthermore this multi-disciplinary approach assisted us in our 
understanding of the underlying reaction mechanism in the (bio)synthesis of (–)-
angiopterlactone B (2). The combination of these techniques has facilitated working towards 
answering some of the more complex, underlying questions surrounding the (bio)synthesis of 




4.3 Future Work 
 
Following our successful synthesis of (–)-angiopterlactone B (2) and our computational NMR 
and mechanistic studies, there are various aspects of the (bio)syntheses of the 
angiopterlactones (1, 2) which could still be explored. 
In order to further examine the (bio)synthesis of (–)-angiopterlactone B (2) and rule out a 
dimerisation between δ-lactone 3 and γ-lactone 4, isotopic labelling studies could be 
completed. These could involve synthesising a 13C-labelled derivative of the γ-lactone 4 and 
reacting it with unlabelled δ-lactone 3 (Scheme 37). The absence of isotopic labelling in the 
product would suggest that (–)-angiopterlactone B (2) is formed by reacting two units of δ-
lactone 3, as proposed during our computational mechanistic investigations (Chapter 3). 
 
Scheme 37: Isotopic labelling studies of the (bio)synthesis of (–)-angiopterlactone B (2) 
Following our computational mechanistic investigations of cross-couplings between δ-
lactones ent-3 and 5, we concluded that these would be unlikely to proceed via 
angiopterlactone A (1.II). In order to validate this computational result, synthetic test reactions 
could be performed and closely monitored by NMR spectroscopy (Scheme 38). Dr Katherine 
Law (Lawrence group) is currently investigating such cross-dimerisations.  
 
Scheme 38: Cross-coupling of lactones 5 and ent-3 to investigate whether this would result in 
angiopterlactone A (1.II) (currently being studied by Dr Katherine Law, Lawrence group) 
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If the results from these synthetic studies indicate that angiopterlactone A (1.II) cannot be 
targeted by such a cross-coupling, alternative strategies to access this natural product could be 
investigated. These could include masking the alkene in the nucleophilic δ-lactone in the oxa-
Michael addition (as suggested in our biosynthetic speculations above), to prevent the 
subsequent Michael addition from occurring (Scheme 39). Upon completing the oxa-Michael 
addition, the alkene could be revealed and provide our proposed structure of (–)-
angiopterlactone A (1.II). 
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Appendices for Chapter 1 
 
1.1 NMR Spectra for Chapter 1  






















































































































































































































































































































































































































































































































































































1.1.22 1H NMR Spectrum of Compound 4 in CD3OD 
 






































































































































































































1.2 HPLC Data for Chapter 1 
 


























Appendices for Chapter 2 
 





        Method                  Solvent 




     Method                  Solvent 





































Table 35: Summary of conditions used for each of the approaches 
An overview of the slope and intercept factors for each of the methodologies (M1-M3), as well 
as their performance, is listed in Table 36.  
 
Method Solvent 
1H Scaling Factors and Performance 13C Scaling Factors and Performance 
Slope Intercept R2 Slope Intercept R2 
M1 CHCl3 -1.0767 31.9477 - -1.0522 181.2412 - 
M2A CHCl3 -1.0938 31.8723 0.9975 -1.0446 186.7246 0.9989 
M2B CHCl3 -1.0951 31.9773 0.9975 -1.0379 187.2065 0.9990 
M3 CHCl3 -1.0719 31.8733 0.9983 -1.0420 186.3567 0.9990 
M3 DMSO -1.0580 31.7217 0.9985 -1.0496 186.2534 0.9989 











Solvent Shielding tensor values 
1H                               13C 
M1 
Solvent CHCl3 31.8717 183.6718 
Gas CHCl3 31.8780 183.7506 
M2A 
Solvent CHCl3 31.6968 187.936 
Gas CHCl3 31.7280 188.1028 
M3 Gas DMSO 31.6974 187.1118 
M4 Solvent DMSO 31.9121 189.4251 
Sarotti Method Gas CHCl3 31.5506 196.4797 




2.3 Energies for all Conformers for each Section 
 
Energies for all the compounds computed utilising methods M1-M4, are listed in the relevant 
sections below. All energies are provided in Hartrees (a.u.). Input and output files for each 
section have been archived with the University of Edinburgh. 
 









1 -459.1479 -459.1562 
2 -459.1428 -459.1536 
3 -459.1444 -459.1538 
TINKER 
1 -459.1479 -459.1562 
2 -459.1451 -459.1537 
3 -459.1463 -459.1555 
4 -459.1479 -459.1562 
5 -459.1432 -459.1535 
6 -459.1434 -459.1531 
7 -459.1407 -459.1526 
8 -459.1428 -459.1536 
DMSO 
Manual 
1 -459.1479 -459.1598 
2 -459.1428 -459.1584 
3 -459.1444 -459.1577 
TINKER 
1 -459.1479 -459.1598 
2 -459.1451 -459.1573 
3 -459.1463 -459.1593 
4 -459.1479 -459.1598 
5 -459.1432 -459.1580 
6 -459.1434 -459.1571 
7 -459.1407 -459.1578 




1 -459.1383 -459.1473 
2 -459.1371 -459.1454 
TINKER 
1 -459.1383 -459.1473 
2 -459.1383 -459.1469 
3 -459.1414 -459.1491 
DMSO 
Manual 
1 -459.1383 -459.1520 
2 -459.1371 -459.1494 
TINKER 
1 -459.1383 -459.1520 
2 -459.1383 -459.1514 
3 -459.1414 -459.1528 










Structure Conformer # Elow Glow Ehigh Ghigh 
γ-lactone 4 
1 -458.9511 -458.8466 -459.1629 -459.0584 
2 -458.9492 -458.8451 -459.1605 -459.0563 
3 -458.9502 -458.8457 -459.1625 -459.0579 
4 -458.9511 -458.8466 -459.1629 -459.0584 
5 -458.9470 -458.8434 -459.1603 -459.0567 
6 -458.9474 -458.8437 -459.1600 -459.0563 
7 -458.9437 -458.8399 -459.1597 -459.0559 
8 -458.9467 -458.8425 -459.1605 -459.0563 
γ-lactone 6 
1 -458.9497 -458.8458 -459.1615 -459.0576 
2 -458.9458 -458.8418 -459.1598 -459.0557 
3 -458.9507 -458.8460 -459.1625 -459.0578 
4 -458.9488 -458.8450 -459.1615 -459.0578 
5 -458.9502 -458.8455 -459.1617 -459.0570 
δ-lactone 3 
1 -458.9418 -458.8366 -459.1542 -459.0490 
2 -458.9418 -458.8373 -459.1535 -459.0490 
3 -458.9451 -458.8398 -459.1559 -459.0505 
δ-lactone 5 
1 -458.9436 -458.8392 -459.1545 -459.0501 
2 -458.9441 -458.8392 -459.1552 -459.0503 
3 -458.9440 -458.8394 -459.1551 -459.0505 
4 -458.9403 -458.8358 -459.1526 -459.0480 
5 -458.9436 -458.8383 -459.1544 -459.0490 
6 -458.9399 -458.8350 -459.1525 -459.0475 




Structure Conformer # Elow Glow Ehigh Ghigh 
γ-lactone 4 
1 -459.0797 -458.9754 -459.1630 -459.0587 
2 -459.0780 -458.9740 -459.1606 -459.0567 
3 -459.0791 -458.9748 -459.1626 -459.0583 
4 -459.0797 -458.9754 -459.1630 -459.0587 
5 -459.0791 -458.9748 -459.1626 -459.0583 
6 -459.0765 -458.9727 -459.1602 -459.0564 
7 -459.0731 -458.9694 -459.1598 -459.0561 
8 -459.0759 -458.9719 -459.1605 -459.0565 
γ-lactone 6 
1 -459.0784 -458.9746 -459.1616 -459.0578 
2 -459.0750 -458.9712 -459.1599 -459.0560 
3 -459.0794 -458.9749 -459.1626 -459.0582 
4 -459.0778 -458.9741 -459.1616 -459.0580 
5 -459.0790 -458.9746 -459.1618 -459.0574 
δ-lactone 3 
1 -459.0705 -458.9654 -459.1543 -459.0492 
2 -459.0738 -458.9686 -459.1560 -459.0509 
3 -459.0738 -458.9686 -459.1560 -459.0509 
δ-lactone 5 
1 -459.0719 -458.9678 -459.1546 -459.0505 
2 -459.0727 -458.9680 -459.1553 -459.0506 
3 -459.0725 -458.9680 -459.1552 -459.0507 
4 -459.0690 -458.9647 -459.1526 -459.0483 
5 -459.0723 -458.9671 -459.1546 -459.0494 
6 -459.0686 -458.9637 -459.1526 -459.0478 
Table 40: Method M2B, chloroform  
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2.3.3 Solvent Effects on Geometry Optimisation 
 
Method M2A: 
See Table 39 for geometry optimisations in the gas phase for γ-lactone 4 and δ-lactone 3.  
Structure Conformer # Elow Glow Ehigh Ghigh 
γ-lactone 4 
1 -458.9669 -458.8630 -459.1632 -459.0593 
2 -458.9654 -458.8614 -459.1608 -459.0569 
3 -458.9669 -458.8625 -459.1628 -459.0584 
4 -458.9635 -458.8600 -459.1600 -459.0565 
5 -458.9649 -458.8614 -459.1607 -459.0572 
6 -458.9645 -458.8605 -459.1604 -459.0564 
7 -458.9631 -458.8592 -459.1600 -459.0561 
8 -458.9648 -458.8607 -459.1608 -459.0567 
δ-lactone 3 
1 -458.9599 -458.8547 -459.1545 -459.0493 
2 -458.9594 -458.8548 -459.1540 -459.0493 
3 -458.9614 -458.8561 -459.1562 -459.0509 




Structure Conformer # Elow Glow Ehigh Ghigh 
γ-lactone 4 
1 -458.9606 -458.8563 -459.2808 -459.1765 
2 -458.9589 -458.8550 -459.2780 -459.1740 
3 -458.9602 -458.8558 -459.2800 -459.1755 
4 -458.9569 -458.8532 -459.2777 -459.1740 
5 -458.9582 -458.8545 -459.2779 -459.1742 
6 -458.9578 -458.8537 -459.2777 -459.1736 
7 -458.9564 -458.8527 -459.2777 -459.1740 
8 -458.9582 -458.8541 -459.2779 -459.1738 
δ-lactone 3 
1 -458.9533 -458.8479 -459.2729 -459.1675 
2 -458.9530 -458.8483 -459.2723 -459.1676 
3 -458.9548 -458.8496 -459.2746 -459.1694 
γ-lactone 4 
(gas) 
1 -458.9511 -458.8466 -459.2804 -459.1759 
2 -458.9492 -458.8451 -459.2776 -459.1734 
3 -458.9502 -458.8457 -459.2796 -459.1750 
4 -458.9511 -458.8466 -459.2804 -459.1759 
5 -458.9470 -458.8434 -459.2774 -459.1738 
6 -458.9474 -458.8437 -459.2772 -459.1735 
7 -458.9437 -458.8399 -459.2773 -459.1736 
8 -458.9467 -458.8425 -459.2775 -459.1733 
δ-lactone 3 
(gas) 
1 -458.9418 -458.8366 -459.2724 -459.1672 
2 -458.9418 -458.8373 -459.2717 -459.1672 
3 -458.9451 -458.8398 -459.2740 -459.1686 










See Table 39 for the γ-lactone 4 and δ-lactone 3, as well as their respective diastereoisomers 
6 and 5. 




1 -917.9485 -917.7061 -918.3517 -918.1093 
2 -917.9406 -917.6999 -918.3456 -918.1048 
3 -917.9492 -917.7074 -918.3560 -918.1142 
4 -917.9474 -917.7062 -918.3515 -918.1103 
5 -917.9485 -917.7068 -918.3477 -918.1061 
6 -917.9436 -917.7027 -918.3500 -918.1091 
7 -917.9514 -917.7105 -918.3580 -918.1172 
8 -917.9453 -917.7039 -918.3487 -918.1072 
9 -917.9441 -917.7039 -918.3552 -918.1149 
10 -917.9406 -917.7006 -918.3460 -918.1059 
11 -917.9403 -917.7009 -918.3501 -918.1108 
12 -917.9466 -917.7064 -918.3530 -918.1128 
13 -917.9458 -917.7054 -918.3496 -918.1092 
14 -917.9500 -917.7079 -918.3526 -918.1105 
15 -917.9502 -917.7087 -918.3536 -918.1122 
16 -917.9444 -917.7035 -918.3508 -918.1098 





Method M3: Chloroform 
 
Structure Conformer # Elow Glow Ehigh Ghigh 
γ-lactone 4 
1 -459.1479 -459.0452 -459.1562 -459.0536 
2 -459.1451 -459.0430 -459.1537 -459.0516 
3 -459.1463 -459.0438 -459.1555 -459.0530 
4 -459.1479 -459.0452 -459.1562 -459.0536 
5 -459.1432 -459.0415 -459.1535 -459.0517 
6 -459.1434 -459.0414 -459.1531 -459.0511 
7 -459.1407 -459.0389 -459.1526 -459.0508 
8 -459.1428 -459.0407 -459.1536 -459.0516 
δ-lactone 3 
1 -459.1383 -459.0352 -459.1473 -459.0442 
2 -459.1383 -459.0358 -459.1469 -459.0444 




1 -918.3151 -918.0772 -918.3412 -918.1033 
2 -918.3075 -918.0712 -918.3347 -918.0985 
3 -918.3168 -918.0797 -918.3458 -918.1086 
4 -918.3146 -918.0778 -918.3415 -918.1046 
5 -918.3120 -918.0751 -918.3374 -918.1005 
6 -918.3119 -918.0751 -918.3384 -918.1016 
7 -918.3196 -918.0831 -918.3469 -918.1104 
8 -918.3118 -918.0751 -918.3378 -918.1011 
9 -918.3128 -918.0767 -918.3435 -918.1075 
10 -918.3086 -918.0729 -918.3350 -918.0993 
11 -918.3092 -918.0739 -918.3383 -918.1030 
12 -918.3153 -918.0794 -918.3414 -918.1054 
13 -918.3130 -918.0767 -918.3404 -918.1041 
14 -918.3157 -918.0781 -918.3426 -918.1050 
15 -918.3172 -918.0804 -918.3424 -918.1056 
16 -918.3114 -918.0751 -918.3396 -918.1034 




Method M3: DMSO 
 
Structure Conformer # Elow Glow Ehigh Ghigh 
γ-lactone 4 
1 -459.1479 -459.0452 -459.1598 -459.0572 
2 -459.1451 -459.0430 -459.1573 -459.0552 
3 -459.1463 -459.0438 -459.1593 -459.0568 
4 -459.1479 -459.0452 -459.1598 -459.0572 
5 -459.1432 -459.0415 -459.1580 -459.0562 
6 -459.1434 -459.0414 -459.1571 -459.0551 
7 -459.1407 -459.0389 -459.1578 -459.0559 
8 -459.1428 -459.0407 -459.1584 -459.0563 
δ-lactone 3 
1 -459.1383 -459.0352 -459.1520 -459.0489 
2 -459.1383 -459.0358 -459.1514 -459.0489 




1 -918.3151 -918.0772 -918.3481 -918.1102 
2 -918.3075 -918.0712 -918.3418 -918.1056 
3 -918.3168 -918.0797 -918.3548 -918.1177 
4 -918.3146 -918.0778 -918.3489 -918.1121 
5 -918.3120 -918.0751 -918.3443 -918.1074 
6 -918.3119 -918.0751 -918.3454 -918.1086 
7 -918.3196 -918.0831 -918.3545 -918.1181 
8 -918.3118 -918.0751 -918.3444 -918.1077 
9 -918.3128 -918.0767 -918.3529 -918.1169 
10 -918.3086 -918.0729 -918.3419 -918.1062 
11 -918.3092 -918.0739 -918.3464 -918.1111 
12 -918.3153 -918.0794 -918.3481 -918.1122 
13 -918.3130 -918.0767 -918.3482 -918.1119 
14 -918.3157 -918.0781 -918.3500 -918.1124 
15 -918.3172 -918.0804 -918.3486 -918.1117 
16 -918.3114 -918.0751 -918.3471 -918.1109 







2.3.5 Method M3 (DMSO) – Investigation Into Energies 
 
See Table 45 for γ-lactone 4, δ-lactone 3 and (+)-angiopterlactone B (2) (Compound I). 
Structure Conformer # Elow Glow Ehigh Ghigh 
γ-lactone 6 
1 -459.1464 -459.0444 -459.1581 -459.0561 
2 -459.1421 -459.0401 -459.1574 -459.0555 
3 -459.1468 -459.0442 -459.1595 -459.0569 
4 -459.1457 -459.0437 -459.1584 -459.0564 
5 -459.1459 -459.0434 -459.1587 -459.0562 
δ-lactone 5 
1 -459.1399 -459.0375 -459.1518 -459.0494 
2 -459.1406 -459.0377 -459.1522 -459.0493 
3 -459.1404 -459.0377 -459.1520 -459.0494 
4 -459.1368 -459.0341 -459.1504 -459.0476 
5 -459.1398 -459.0364 -459.1513 -459.0479 




1 -918.3140 -918.0775 -918.3468 -918.1104 
2 -918.3151 -918.0790 -918.3467 -918.1106 
3 -918.3173 -918.0800 -918.3482 -918.1109 
4 -918.3116 -918.0761 -918.3460 -918.1106 
5 -918.3122 -918.0752 -918.3444 -918.1074 
6 -918.3156 -918.0783 -918.3543 -918.1170 
7 -918.3140 -918.0761 -918.3476 -918.1097 
8 -918.3166 -918.0802 -918.3490 -918.1126 
9 -918.3172 -918.0815 -918.3524 -918.1167 
10 -918.3140 -918.0761 -918.3476 -918.1097 
11 -918.3135 -918.0767 -918.3483 -918.1115 
12 -918.3201 -918.0832 -918.3544 -918.1174 
13 -918.3105 -918.0742 -918.3444 -918.1081 
14 -918.3105 -918.0742 -918.3444 -918.1081 




1 -918.3203 -918.0844 -918.3532 -918.1172 
2 -918.3214 -918.0858 -918.3530 -918.1174 
3 -918.3236 -918.0871 -918.3546 -918.1180 
4 -918.3174 -918.0817 -918.3506 -918.1149 




1 -918.3213 -918.0846 -918.3549 -918.1182 
2 -918.3182 -918.0812 -918.3487 -918.1117 
3 -918.3187 -918.0819 -918.3500 -918.1132 
4 -918.3104 -918.0735 -918.3430 -918.1060 
5 -918.3235 -918.0871 -918.3549 -918.1185 
6 -918.3171 -918.0814 -918.3486 -918.1128 
7 -918.3141 -918.0769 -918.3518 -918.1146 
8 -918.3100 -918.0740 -918.3498 -918.1137 
9 -918.3131 -918.0754 -918.3470 -918.1093 
10 -918.3177 -918.0818 -918.3534 -918.1176 
11 -918.3168 -918.0800 -918.3515 -918.1147 
12 -918.3103 -918.0740 -918.3452 -918.1088 




1 -918.3262 -918.0904 -918.3580 -918.1222 
2 -918.3262 -918.0904 -918.3580 -918.1221 
3 -918.3258 -918.0903 -918.3578 -918.1223 
4 -918.3258 -918.0903 -918.3578 -918.1223 
5 -918.3245 -918.0887 -918.3573 -918.1215 
6 -918.3227 -918.0871 -918.3548 -918.1192 
7 -918.3223 -918.0858 -918.3537 -918.1172 
8 -918.3226 -918.0875 -918.3543 -918.1192 
9 -918.3245 -918.0887 -918.3573 -918.1215 
10 -918.3162 -918.0811 -918.3514 -918.1163 
11 -918.3223 -918.0858 -918.3537 -918.1172 
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12 -918.3161 -918.0809 -918.3511 -918.1158 
13 -918.3161 -918.0809 -918.3511 -918.1158 




1 -918.3239 -918.0884 -918.3567 -918.1213 
2 -918.3240 -918.0886 -918.3563 -918.1210 
3 -918.3240 -918.0886 -918.3563 -918.1210 
4 -918.3194 -918.0843 -918.3521 -918.1170 
5 -918.3208 -918.0850 -918.3527 -918.1168 




1 -918.3172 -918.0811 -918.3499 -918.1138 
2 -918.3128 -918.0773 -918.3451 -918.1096 
3 -918.3172 -918.0812 -918.3494 -918.1134 
4 -918.3172 -918.0812 -918.3494 -918.1134 
5 -918.3247 -918.0892 -918.3568 -918.1212 
6 -918.3244 -918.0887 -918.3571 -918.1215 
7 -918.3247 -918.0892 -918.3568 -918.1212 
8 -918.3244 -918.0887 -918.3571 -918.1215 




1 -918.3195 -918.0829 -918.3512 -918.1146 
2 -918.3169 -918.0810 -918.3480 -918.1121 
3 -918.3191 -918.0829 -918.3510 -918.1148 
4 -918.3191 -918.0829 -918.3510 -918.1148 
5 -918.3266 -918.0907 -918.3583 -918.1224 
6 -918.3266 -918.0907 -918.3583 -918.1224 
7 -918.3267 -918.0906 -918.3583 -918.1222 
8 -918.3267 -918.0906 -918.3583 -918.1222 
9 -918.3262 -918.0901 -918.3578 -918.1216 
10 -918.3231 -918.0874 -918.3558 -918.1201 
11 -918.3201 -918.0849 -918.3552 -918.1201 
12 -918.3161 -918.0800 -918.3480 -918.1119 
13 -918.3201 -918.0849 -918.3552 -918.1201 
14 -918.3202 -918.0848 -918.3555 -918.1201 
15 -918.3106 -918.0753 -918.3461 -918.1108 
16 -918.3175 -918.0826 -918.3538 -918.1189 






2.3.6 An alternative approach: method M4 
 
Note that when utilising method M4 for the eight viable (–)-angiopterlactone A (1) structures, 
conformers within the 10 kcal/mol energy window set by TINKER were pre-optimised 
utilising SMD (DCE), wB97XD/6-311+G(d,p)//wB97XD/6-31G(d). For structures I-IV, the 
Ghigh energy value was then utilised to exclude any conformers outwith 5 kcal/mol (21 kJ/mol) 
of the lowest energy conformer. All conformers within 5 kcal/mol of the lowest energy 





Elow Glow Ehigh Ghigh 
γ-lactone 4 
1 -459.1348 -459.0313 -459.1348 -459.0313 
2 -459.1340 -459.0307 -459.1340 -459.0307 
3 -459.1362 -459.0326 -459.1362 -459.0326 
4 -459.1359 -459.0322 -459.1359 -459.0322 
5 -459.1344 -459.0311 -459.1344 -459.0311 
6 -459.1333 -459.0302 -459.1333 -459.0302 
7 -459.1338 -459.0303 -459.1338 -459.0303 
8 -459.1337 -459.0303 -459.1337 -459.0303 
γ-lactone 6 
1 -459.1348 -459.0317 -459.1348 -459.0317 
2 -459.1338 -459.0303 -459.1338 -459.0303 
3 -459.1356 -459.0318 -459.1356 -459.0318 
4 -459.1354 -459.0317 -459.1354 -459.0317 
5 -459.1355 -459.0318 -459.1355 -459.0318 
δ-lactone 3 
1 -459.1283 -459.0238 -459.1283 -459.0238 
2 -459.1279 -459.0238 -459.1279 -459.0238 
3 -459.1296 -459.0250 -459.1296 -459.0250 
4 -459.1259 -459.0218 -459.1259 -459.0218 
5 -459.1263 -459.0218 -459.1263 -459.0218 
6 -459.1266 -459.0222 -459.1266 -459.0222 
δ-lactone 5 
1 -459.1284 -459.0248 -459.1284 -459.0248 
2 -459.1292 -459.0249 -459.1292 -459.0249 
3 -459.1286 -459.0248 -459.1286 -459.0248 
4 -459.1265 -459.0223 -459.1265 -459.0223 
5 -459.1277 -459.0231 -459.1277 -459.0231 




1 -918.3082 -918.0673 -918.3082 -918.0673 
2 -918.3005 -918.0615 -918.3005 -918.0615 
3 -918.3141 -918.0738 -918.3141 -918.0738 
4 -918.3085 -918.0689 -918.3085 -918.0689 
5 -918.3141 -918.0738 -918.3141 -918.0738 
6 -918.3044 -918.0653 -918.3044 -918.0653 
7 -918.3127 -918.0734 -918.3127 -918.0734 
8 -918.3031 -918.0633 -918.3031 -918.0633 
9 -918.3107 -918.0713 -918.3107 -918.0713 
10 -918.2994 -918.0612 -918.2994 -918.0612 
11 -918.3033 -918.0651 -918.3033 -918.0651 
12 -918.3053 -918.0672 -918.3053 -918.0672 
13 -918.3067 -918.0680 -918.3067 -918.0680 
14 -918.3100 -918.0695 -918.3100 -918.0695 
15 -918.3068 -918.0674 -918.3068 -918.0674 
16 -918.3050 -918.0657 -918.3050 -918.0657 
Angiopterlactone B 
2 
1 -918.3055 -918.0662 -918.3055 -918.0662 
2 -918.3050 -918.0663 -918.3050 -918.0663 
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(Compound II) 3 -918.3070 -918.0674 -918.3070 -918.0674 
4 -918.3035 -918.0653 -918.3035 -918.0653 
5 -918.3040 -918.0641 -918.3040 -918.0641 
6 -918.3136 -918.0734 -918.3136 -918.0734 
7 -918.3078 -918.0670 -918.3078 -918.0670 
8 -918.3069 -918.0681 -918.3069 -918.0681 
9 -918.3107 -918.0719 -918.3107 -918.0719 
10 -918.3078 -918.0670 -918.3078 -918.0670 
11 -918.3081 -918.0684 -918.3081 -918.0684 
12 -918.3135 -918.0736 -918.3135 -918.0736 
13 -918.3029 -918.0640 -918.3029 -918.0640 
14 -918.3029 -918.0640 -918.3029 -918.0640 




1 -918.3111 -918.0722 -918.3111 -918.0722 
2 -918.3106 -918.0723 -918.3106 -918.0723 
3 -918.3127 -918.0739 -918.3127 -918.0739 
4 -918.3081 -918.0697 -918.3081 -918.0697 




1 -918.3129 -918.0735 -918.3129 -918.0735 
2 -918.3053 -918.0672 -918.3053 -918.0672 
3 -918.3088 -918.0693 -918.3088 -918.0693 
4 -918.3027 -918.0645 -918.3027 -918.0645 
5 -918.3123 -918.0736 -918.3123 -918.0736 
6 -918.3066 -918.0682 -918.3066 -918.0682 
7 -918.3105 -918.0707 -918.3105 -918.0707 
8 -918.3076 -918.0683 -918.3076 -918.0683 
9 -918.3069 -918.0666 -918.3069 -918.0666 
10 -918.3106 -918.0720 -918.3106 -918.0720 
11 -918.3095 -918.0704 -918.3095 -918.0704 
12 -918.3039 -918.0649 -918.3039 -918.0649 




1 -918.3163 -918.0778 -918.3163 -918.0778 
2 -918.3163 -918.0778 -918.3163 -918.0778 
3 -918.3162 -918.0782 -918.3162 -918.0782 
4 -918.3162 -918.0782 -918.3162 -918.0782 
5 -918.3145 -918.0762 -918.3145 -918.0762 
6 -918.3135 -918.0752 -918.3135 -918.0752 
7 -918.3113 -918.0731 -918.3113 -918.0731 
8 -918.3134 -918.0756 -918.3134 -918.0756 
9 -918.3115 -918.0737 -918.3115 -918.0737 
10 -918.3085 -918.0707 -918.3085 -918.0707 
11 -918.3117 -918.0739 -918.3117 -918.0739 
12 -918.3092 -918.0712 -918.3092 -918.0712 
13 -918.3088 -918.0704 -918.3088 -918.0704 




1 -918.3147 -918.0765 -918.3147 -918.0765 
2 -918.3142 -918.0763 -918.3142 -918.0763 
3 -918.3142 -918.0763 -918.3142 -918.0763 
4 -918.3130 -918.0757 -918.3130 -918.0757 
5 -918.3113 -918.0740 -918.3113 -918.0740 




1 -918.3081 -918.0692 -918.3081 -918.0692 
2 -918.3032 -918.0652 -918.3032 -918.0652 
3 -918.3076 -918.0691 -918.3076 -918.0691 
4 -918.3076 -918.0691 -918.3076 -918.0691 
5 -918.3152 -918.0769 -918.3152 -918.0769 
6 -918.3157 -918.0773 -918.3157 -918.0773 
7 -918.3152 -918.0769 -918.3152 -918.0769 
8 -918.3157 -918.0773 -918.3157 -918.0773 




1 -918.3097 -918.0707 -918.3097 -918.0707 
2 -918.3064 -918.0682 -918.3064 -918.0682 
3 -918.3096 -918.0713 -918.3096 -918.0713 
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4 -918.3096 -918.0713 -918.3096 -918.0713 
5 -918.3172 -918.0788 -918.3172 -918.0788 
6 -918.3172 -918.0788 -918.3172 -918.0788 
7 -918.3173 -918.0785 -918.3173 -918.0785 
8 -918.3173 -918.0785 -918.3173 -918.0785 
9 -918.3156 -918.0772 -918.3156 -918.0772 
10 -918.3129 -918.0747 -918.3129 -918.0747 
11 -918.3132 -918.0744 -918.3132 -918.0744 
12 -918.3056 -918.0672 -918.3056 -918.0672 
13 -918.3106 -918.0724 -918.3106 -918.0724 
14 -918.3129 -918.0746 -918.3129 -918.0746 
15 -918.3032 -918.0649 -918.3032 -918.0649 




1 -918.2738 -918.0398 -918.2738 -918.0398 
2 -918.2706 -918.0362 -918.2706 -918.0362 
3 -918.2761 -918.0414 -918.2761 -918.0414 
4 -918.2753 -918.0407 -918.2753 -918.0407 
5 -918.2762 -918.0425 -918.2762 -918.0425 
6 -918.2795 -918.0450 -918.2795 -918.0450 
7 -918.2808 -918.0456 -918.2808 -918.0456 
8 -918.2776 -918.0432 -918.2776 -918.0432 
9 -918.2756 -918.0412 -918.2756 -918.0412 
10 -918.2758 -918.0417 -918.2758 -918.0417 
11 -918.2788 -918.0447 -918.2788 -918.0447 
12 -918.2741 -918.0400 -918.2741 -918.0400 
13 -918.2783 -918.0436 -918.2783 -918.0436 
14 -918.2765 -918.0422 -918.2765 -918.0422 
15 -918.2755 -918.0408 -918.2755 -918.0408 
16 -918.2812 -918.0459 -918.2812 -918.0459 
17 -918.2787 -918.0442 -918.2787 -918.0442 
18 -918.2761 -918.0414 -918.2761 -918.0414 
19 -918.2730 -918.0381 -918.2730 -918.0381 
20 -918.2784 -918.0436 -918.2784 -918.0436 
21 -918.2765 -918.0422 -918.2765 -918.0422 
22 -918.2763 -918.0418 -918.2763 -918.0418 
23 -918.2737 -918.0377 -918.2737 -918.0377 
24 -918.2728 -918.0380 -918.2728 -918.0380 
25 -918.2737 -918.0392 -918.2737 -918.0392 
26 -918.2736 -918.0393 -918.2736 -918.0393 
27 -918.2781 -918.0424 -918.2781 -918.0424 
28 -918.2747 -918.0394 -918.2747 -918.0394 
29 -918.2775 -918.0433 -918.2775 -918.0433 
30 -918.2770 -918.0411 -918.2770 -918.0411 
31 -918.2767 -918.0423 -918.2767 -918.0423 
32 -918.2734 -918.0392 -918.2734 -918.0392 
33 -918.2716 -918.0366 -918.2716 -918.0366 
34 -918.2732 -918.0384 -918.2732 -918.0384 




1 -918.2726 -918.0392 -918.2726 -918.0392 
2 -918.2751 -918.0410 -918.2751 -918.0410 
3 -918.2718 -918.0371 -918.2718 -918.0371 
4 -918.2740 -918.0397 -918.2740 -918.0397 
5 -918.2731 -918.0397 -918.2731 -918.0397 
6 -918.2788 -918.0434 -918.2788 -918.0434 
7 -918.2750 -918.0404 -918.2750 -918.0404 
8 -918.2729 -918.0395 -918.2729 -918.0395 
9 -918.2722 -918.0384 -918.2722 -918.0384 
10 -918.2778 -918.0435 -918.2778 -918.0435 
11 -918.2763 -918.0412 -918.2763 -918.0412 
12 -918.2779 -918.0438 -918.2779 -918.0438 
13 -918.2763 -918.0410 -918.2763 -918.0410 
14 -918.2742 -918.0402 -918.2742 -918.0402 
15 -918.2745 -918.0403 -918.2745 -918.0403 
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16 -918.2738 -918.0395 -918.2738 -918.0395 
17 -918.2725 -918.0393 -918.2725 -918.0393 
18 -918.2781 -918.0437 -918.2781 -918.0437 
19 -918.2740 -918.0401 -918.2740 -918.0401 
20 -918.2751 -918.0411 -918.2751 -918.0411 
21 -918.2747 -918.0405 -918.2747 -918.0405 
22 -918.2734 -918.0390 -918.2734 -918.0390 
23 -918.2776 -918.0431 -918.2776 -918.0431 
24 -918.2754 -918.0400 -918.2754 -918.0400 
25 -918.2722 -918.0383 -918.2722 -918.0383 
26 -918.2757 -918.0413 -918.2757 -918.0413 
27 -918.2729 -918.0381 -918.2729 -918.0381 
28 -918.2756 -918.0407 -918.2756 -918.0407 
29 -918.2718 -918.0378 -918.2718 -918.0378 
30 -918.2805 -918.0451 -918.2805 -918.0451 
31 -918.2721 -918.0380 -918.2721 -918.0380 
32 -918.2745 -918.0400 -918.2745 -918.0400 
33 -918.2772 -918.0420 -918.2772 -918.0420 
34 -918.2796 -918.0451 -918.2796 -918.0451 
35 -918.2791 -918.0452 -918.2791 -918.0452 
36 -918.2789 -918.0440 -918.2789 -918.0440 
37 -918.2806 -918.0451 -918.2806 -918.0451 
38 -918.2740 -918.0385 -918.2740 -918.0385 
39 -918.2754 -918.0409 -918.2754 -918.0409 
40 -918.2723 -918.0379 -918.2723 -918.0379 
41 -918.2758 -918.0411 -918.2758 -918.0411 
42 -918.2756 -918.0409 -918.2756 -918.0409 
43 -918.2745 -918.0407 -918.2745 -918.0407 
44 -918.2741 -918.0400 -918.2741 -918.0400 
45 -918.2763 -918.0417 -918.2763 -918.0417 
46 -918.2765 -918.0410 -918.2765 -918.0410 
47 -918.2766 -918.0422 -918.2766 -918.0422 
48 -918.2765 -918.0410 -918.2765 -918.0410 




1 -918.2748 -918.0416 -918.2748 -918.0416 
2 -918.2748 -918.0409 -918.2748 -918.0409 
3 -918.2761 -918.0417 -918.2761 -918.0417 
4 -918.2753 -918.0408 -918.2753 -918.0408 
5 -918.2755 -918.0409 -918.2755 -918.0409 
6 -918.2742 -918.0405 -918.2742 -918.0405 
7 -918.2741 -918.0398 -918.2741 -918.0398 
8 -918.2723 -918.0382 -918.2723 -918.0382 
9 -918.2765 -918.0425 -918.2765 -918.0425 
10 -918.2740 -918.0394 -918.2740 -918.0394 
11 -918.2743 -918.0404 -918.2743 -918.0404 
12 -918.2760 -918.0423 -918.2760 -918.0423 
13 -918.2784 -918.0436 -918.2784 -918.0436 
14 -918.2766 -918.0424 -918.2766 -918.0424 
15 -918.2732 -918.0393 -918.2732 -918.0393 
16 -918.2761 -918.0419 -918.2761 -918.0419 
17 -918.2747 -918.0407 -918.2747 -918.0407 
18 -918.2792 -918.0444 -918.2792 -918.0444 
19 -918.2783 -918.0448 -918.2783 -918.0448 
20 -918.2814 -918.0467 -918.2814 -918.0467 
21 -918.2733 -918.0394 -918.2733 -918.0394 
22 -918.2752 -918.0409 -918.2752 -918.0409 
23 -918.2751 -918.0407 -918.2751 -918.0407 
24 -918.2738 -918.0401 -918.2738 -918.0401 
25 -918.2752 -918.0405 -918.2752 -918.0405 
26 -918.2804 -918.0450 -918.2804 -918.0450 
27 -918.2795 -918.0450 -918.2795 -918.0450 
28 -918.2746 -918.0405 -918.2746 -918.0405 
29 -918.2798 -918.0461 -918.2798 -918.0461 
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30 -918.2737 -918.0399 -918.2737 -918.0399 
31 -918.2724 -918.0387 -918.2724 -918.0387 
32 -918.2775 -918.0421 -918.2775 -918.0421 
33 -918.2775 -918.0421 -918.2775 -918.0421 
34 -918.2753 -918.0404 -918.2753 -918.0404 
35 -918.2786 -918.0434 -918.2786 -918.0434 
36 -918.2743 -918.0407 -918.2743 -918.0407 
37 -918.2777 -918.0429 -918.2777 -918.0429 
38 -918.2749 -918.0412 -918.2749 -918.0412 
39 -918.2784 -918.0437 -918.2784 -918.0437 
40 -918.2728 -918.0378 -918.2728 -918.0378 
41 -918.2743 -918.0407 -918.2743 -918.0407 
42 -918.2734 -918.0390 -918.2734 -918.0390 
43 -918.2729 -918.0388 -918.2729 -918.0388 




1 -918.2759 -918.0421 -918.2759 -918.0421 
2 -918.2715 -918.0368 -918.2715 -918.0368 
3 -918.2787 -918.0450 -918.2787 -918.0450 
4 -918.2749 -918.0410 -918.2749 -918.0410 
5 -918.2727 -918.0382 -918.2727 -918.0382 
6 -918.2809 -918.0459 -918.2809 -918.0459 
7 -918.2714 -918.0370 -918.2714 -918.0370 
8 -918.2799 -918.0453 -918.2799 -918.0453 
9 -918.2755 -918.0414 -918.2755 -918.0414 
10 -918.2768 -918.0416 -918.2768 -918.0416 
11 -918.2714 -918.0370 -918.2714 -918.0370 
12 -918.2759 -918.0405 -918.2759 -918.0405 
13 -918.2804 -918.0457 -918.2804 -918.0457 
14 -918.2771 -918.0418 -918.2771 -918.0418 
15 -918.2796 -918.0446 -918.2796 -918.0446 
16 -918.2800 -918.0450 -918.2800 -918.0450 
17 -918.2747 -918.0403 -918.2747 -918.0403 
18 -918.2768 -918.0416 -918.2768 -918.0416 
19 -918.2779 -918.0431 -918.2779 -918.0431 
20 -918.2738 -918.0390 -918.2738 -918.0390 
21 -918.2775 -918.0425 -918.2775 -918.0425 
22 -918.2751 -918.0393 -918.2751 -918.0393 
23 -918.2777 -918.0436 -918.2777 -918.0436 
24 -918.2808 -918.0461 -918.2808 -918.0461 
25 -918.2758 -918.0419 -918.2758 -918.0419 
26 -918.2763 -918.0410 -918.2763 -918.0410 
27 -918.2781 -918.0446 -918.2781 -918.0446 
28 -918.2763 -918.0418 -918.2763 -918.0418 
29 -918.2761 -918.0415 -918.2761 -918.0415 
30 -918.2771 -918.0434 -918.2771 -918.0434 
31 -918.2759 -918.0421 -918.2759 -918.0421 
32 -918.2771 -918.0434 -918.2771 -918.0434 
33 -918.2782 -918.0441 -918.2782 -918.0441 
34 -918.2756 -918.0411 -918.2756 -918.0411 
35 -918.2762 -918.0416 -918.2762 -918.0416 
36 -918.2784 -918.0429 -918.2784 -918.0429 
37 -918.2738 -918.0390 -918.2738 -918.0390 
38 -918.2797 -918.0446 -918.2797 -918.0446 
39 -918.2763 -918.0410 -918.2763 -918.0410 
40 -918.2785 -918.0435 -918.2785 -918.0435 
41 -918.2786 -918.0443 -918.2786 -918.0443 
42 -918.2775 -918.0425 -918.2775 -918.0425 
43 -918.2744 -918.0392 -918.2744 -918.0392 
44 -918.2765 -918.0421 -918.2765 -918.0421 
45 -918.2774 -918.0430 -918.2774 -918.0430 
46 -918.2785 -918.0434 -918.2785 -918.0434 
47 -918.2797 -918.0449 -918.2797 -918.0449 
48 -918.2784 -918.0429 -918.2784 -918.0429 
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49 -918.2752 -918.0405 -918.2752 -918.0405 
50 -918.2759 -918.0419 -918.2759 -918.0419 
51 -918.2773 -918.0431 -918.2773 -918.0431 
52 -918.2761 -918.0415 -918.2761 -918.0415 
53 -918.2754 -918.0414 -918.2754 -918.0414 
54 -918.2773 -918.0417 -918.2773 -918.0417 




1 -918.2795 -918.0459 -918.2795 -918.0459 
2 -918.2805 -918.0466 -918.2805 -918.0466 
3 -918.2743 -918.0403 -918.2743 -918.0403 
4 -918.2785 -918.0448 -918.2785 -918.0448 
5 -918.2736 -918.0393 -918.2736 -918.0393 
6 -918.2790 -918.0449 -918.2790 -918.0449 
7 -918.2773 -918.0432 -918.2773 -918.0432 




1 -918.2797 -918.0461 -918.2797 -918.0461 
2 -918.2749 -918.0404 -918.2749 -918.0404 
3 -918.2752 -918.0412 -918.2752 -918.0412 
4 -918.2810 -918.0475 -918.2810 -918.0475 
5 -918.2775 -918.0436 -918.2775 -918.0436 
6 -918.2791 -918.0455 -918.2791 -918.0455 
7 -918.2745 -918.0402 -918.2745 -918.0402 
8 -918.2741 -918.0399 -918.2741 -918.0399 




1 -918.2782 -918.0446 -918.2782 -918.0446 
2 -918.2787 -918.0452 -918.2787 -918.0452 
3 -918.2735 -918.0395 -918.2735 -918.0395 
4 -918.2796 -918.0458 -918.2796 -918.0458 
5 -918.2790 -918.0450 -918.2790 -918.0450 
6 -918.2760 -918.0415 -918.2760 -918.0415 
7 -918.2807 -918.0466 -918.2807 -918.0466 
8 -918.2738 -918.0400 -918.2738 -918.0400 
9 -918.2756 -918.0411 -918.2756 -918.0411 
10 -918.2776 -918.0436 -918.2776 -918.0436 




1 -918.2794 -918.0450 -918.2794 -918.0450 
2 -918.2800 -918.0460 -918.2800 -918.0460 
3 -918.2787 -918.0446 -918.2787 -918.0446 
4 -918.2725 -918.0381 -918.2725 -918.0381 
5 -918.2751 -918.0408 -918.2751 -918.0408 
6 -918.2779 -918.0438 -918.2779 -918.0438 
7 -918.2782 -918.0442 -918.2782 -918.0442 
8 -918.2723 -918.0381 -918.2723 -918.0381 
9 -918.2729 -918.0393 -918.2729 -918.0393 











 I II III IV V VI VII VIII 
1H MAE 0.18 0.17 0.22 0.24 0.24 0.25 0.27 0.23 
Difference 
wrt I 
0.00 -0.01 0.04 0.07 0.07 0.07 0.09 0.05 
13C MAE 1.1 1.1 1.0 1.1 1.6 1.3 1.4 1.8 
Difference 
wrt I 
0.0 0.0 -0.1 0.1 0.5 0.3 0.3 0.8 
JH-H MAE 1.4 0.8 1.4 1.8 4.0 3.2 2.2 3.0 
Difference 
wrt I 
0.0 -0.6 0.0 0.4 2.6 1.8 0.7 1.5 
Table 48: Method M4; DMSO; angiopterlactone B (2); MAE values including all data points (wrt = with 
respect to) 
 
 I II III IV V VI VII VIII 
1H MAE 0.08 0.09 0.11 0.12 0.22 0.22 0.22 0.22 
Difference 
wrt I 
0.00 0.00 0.03 0.04 0.14 0.13 0.14 0.14 
13C MAE 1.1 0.8 1.1 1.4 2.6 2.4 3.1 3.2 
Difference 
wrt I 
0.0 -0.3 0.0 0.3 1.4 1.2 1.9 2.1 
JH-H MAE 0.6 0.6 1.5 1.4 3.6 3.7 2.4 2.3 
Difference 
wrt I 
0.0 -0.1 0.8 0.8 2.9 3.0 1.8 1.7 
Table 49: Method M4; DMSO; angiopterlactone B (2); MAE values excluding certain data points, as 
discussed in main text (wrt = with respect to) 
 
 
2.3.7 Final method choice: Method M3 (DMSO) 
 
See Table 45 for γ-lactone 4, δ-lactone 3 and (+)-angiopterlactone B (2) (compound I). For all 
relevant diastereoisomers of these compounds, see Table 46.  




1 -918.2915 -918.0598 -918.3163 -918.0846 
2 -918.2860 -918.0536 -918.3104 -918.0780 
3 -918.2885 -918.0563 -918.3129 -918.0807 
4 -918.2902 -918.0590 -918.3150 -918.0838 
5 -918.2869 -918.0552 -918.3116 -918.0800 
6 -918.2839 -918.0515 -918.3091 -918.0767 
7 -918.2825 -918.0508 -918.3113 -918.0797 
8 -918.2871 -918.0550 -918.3106 -918.0785 
9 -918.2833 -918.0520 -918.3112 -918.0798 
10 -918.2881 -918.0553 -918.3142 -918.0814 
11 -918.2898 -918.0580 -918.3136 -918.0817 
12 -918.2927 -918.0607 -918.3180 -918.0860 
13 -918.2913 -918.0587 -918.3165 -918.0840 
14 -918.2845 -918.0523 -918.3077 -918.0756 
15 -918.2939 -918.0625 -918.3193 -918.0879 
16 -918.2882 -918.0568 -918.3153 -918.0840 
17 -918.2871 -918.0550 -918.3106 -918.0785 
18 -918.2934 -918.0612 -918.3215 -918.0893 
19 -918.2959 -918.0634 -918.3228 -918.0902 
20 -918.2926 -918.0602 -918.3193 -918.0869 
221 
 
21 -918.2924 -918.0602 -918.3170 -918.0849 
22 -918.2870 -918.0547 -918.3124 -918.0801 
23 -918.2915 -918.0604 -918.3176 -918.0865 
24 -918.2903 -918.0583 -918.3141 -918.0821 
25 -918.2954 -918.0633 -918.3226 -918.0906 
26 -918.2874 -918.0567 -918.3176 -918.0869 
27 -918.2933 -918.0612 -918.3198 -918.0877 
28 -918.2923 -918.0613 -918.3175 -918.0865 
29 -918.2919 -918.0597 -918.3172 -918.0850 
30 -918.2941 -918.0620 -918.3239 -918.0918 
31 -918.2949 -918.0630 -918.3209 -918.0890 
32 -918.2927 -918.0607 -918.3180 -918.0860 
33 -918.2876 -918.0557 -918.3131 -918.0812 
34 -918.2910 -918.0585 -918.3162 -918.0837 
35 -918.2956 -918.0634 -918.3219 -918.0897 
36 -918.2937 -918.0619 -918.3182 -918.0865 
37 -918.2934 -918.0613 -918.3190 -918.0869 
38 -918.2897 -918.0573 -918.3148 -918.0824 
39 -918.2901 -918.0571 -918.3153 -918.0823 
40 -918.2907 -918.0586 -918.3147 -918.0826 
41 -918.2918 -918.0594 -918.3159 -918.0835 
42 -918.2832 -918.0515 -918.3100 -918.0783 
43 -918.2907 -918.0587 -918.3148 -918.0829 
44 -918.2932 -918.0602 -918.3189 -918.0860 
45 -918.2908 -918.0589 -918.3145 -918.0826 
46 -918.2900 -918.0574 -918.3167 -918.0842 
47 -918.2953 -918.0635 -918.3206 -918.0888 
48 -918.2877 -918.0554 -918.3116 -918.0793 
49 -918.2924 -918.0595 -918.3177 -918.0848 
50 -918.2876 -918.0555 -918.3144 -918.0823 
51 -918.2885 -918.0571 -918.3208 -918.0894 
52 -918.2890 -918.0574 -918.3146 -918.0830 
53 -918.2934 -918.0613 -918.3190 -918.0869 
54 -918.2865 -918.0543 -918.3146 -918.0825 
55 -918.2914 -918.0588 -918.3159 -918.0833 




1 -918.2900 -918.0587 -918.3147 -918.0835 
2 -918.2914 -918.0593 -918.3173 -918.0852 
3 -918.2860 -918.0535 -918.3108 -918.0783 
4 -918.2890 -918.0566 -918.3132 -918.0808 
5 -918.2913 -918.0595 -918.3165 -918.0847 
6 -918.2897 -918.0587 -918.3148 -918.0839 
7 -918.2860 -918.0545 -918.3109 -918.0794 
8 -918.2918 -918.0591 -918.3218 -918.0891 
9 -918.2919 -918.0602 -918.3159 -918.0842 
10 -918.2897 -918.0584 -918.3158 -918.0844 
11 -918.2876 -918.0565 -918.3153 -918.0842 
12 -918.2942 -918.0625 -918.3193 -918.0876 
13 -918.2891 -918.0572 -918.3125 -918.0806 
14 -918.2855 -918.0539 -918.3110 -918.0794 
15 -918.2868 -918.0544 -918.3104 -918.0780 
16 -918.2910 -918.0588 -918.3175 -918.0853 
17 -918.2957 -918.0643 -918.3195 -918.0882 
18 -918.2929 -918.0606 -918.3177 -918.0854 
19 -918.2899 -918.0586 -918.3170 -918.0858 
20 -918.2920 -918.0604 -918.3156 -918.0840 
21 -918.2907 -918.0588 -918.3154 -918.0836 
22 -918.2882 -918.0572 -918.3155 -918.0845 
23 -918.2868 -918.0545 -918.3104 -918.0780 
24 -918.2882 -918.0555 -918.3122 -918.0795 
25 -918.2866 -918.0548 -918.3099 -918.0782 
26 -918.2955 -918.0637 -918.3196 -918.0878 
27 -918.2906 -918.0589 -918.3161 -918.0844 
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28 -918.2952 -918.0635 -918.3198 -918.0881 
29 -918.2897 -918.0584 -918.3186 -918.0873 
30 -918.2916 -918.0600 -918.3174 -918.0857 
31 -918.2908 -918.0585 -918.3162 -918.0839 
32 -918.2946 -918.0626 -918.3197 -918.0877 
33 -918.2885 -918.0569 -918.3137 -918.0821 
34 -918.2859 -918.0546 -918.3099 -918.0786 
35 -918.2907 -918.0582 -918.3166 -918.0841 
36 -918.2894 -918.0578 -918.3143 -918.0827 
37 -918.2916 -918.0598 -918.3189 -918.0871 
38 -918.2881 -918.0566 -918.3166 -918.0851 
39 -918.2909 -918.0588 -918.3182 -918.0862 
40 -918.2872 -918.0557 -918.3150 -918.0835 
41 -918.2960 -918.0638 -918.3218 -918.0896 
42 -918.2894 -918.0578 -918.3143 -918.0827 
43 -918.2919 -918.0598 -918.3180 -918.0859 
44 -918.2936 -918.0609 -918.3203 -918.0877 
45 -918.2967 -918.0645 -918.3220 -918.0898 
46 -918.2962 -918.0646 -918.3210 -918.0894 
47 -918.2934 -918.0616 -918.3202 -918.0883 
48 -918.2970 -918.0644 -918.3222 -918.0896 
49 -918.2922 -918.0595 -918.3160 -918.0833 
50 -918.2929 -918.0612 -918.3169 -918.0852 
51 -918.2886 -918.0560 -918.3145 -918.0819 
52 -918.2934 -918.0610 -918.3179 -918.0854 
53 -918.2926 -918.0609 -918.3169 -918.0852 
54 -918.2900 -918.0585 -918.3182 -918.0867 
55 -918.2895 -918.0571 -918.3141 -918.0816 
56 -918.2886 -918.0560 -918.3145 -918.0819 
57 -918.2895 -918.0585 -918.3159 -918.0849 
58 -918.2935 -918.0623 -918.3195 -918.0882 
59 -918.2912 -918.0585 -918.3171 -918.0843 
60 -918.2889 -918.0571 -918.3144 -918.0826 
61 -918.2928 -918.0609 -918.3198 -918.0879 
62 -918.2912 -918.0585 -918.3171 -918.0843 




1 -918.2930 -918.0621 -918.3171 -918.0862 
2 -918.2923 -918.0609 -918.3181 -918.0867 
3 -918.2943 -918.0626 -918.3190 -918.0873 
4 -918.2928 -918.0618 -918.3175 -918.0865 
5 -918.2922 -918.0600 -918.3188 -918.0867 
6 -918.2912 -918.0593 -918.3170 -918.0850 
7 -918.2914 -918.0590 -918.3162 -918.0838 
8 -918.2874 -918.0562 -918.3162 -918.0850 
9 -918.2945 -918.0632 -918.3196 -918.0883 
10 -918.2912 -918.0593 -918.3175 -918.0856 
11 -918.2906 -918.0596 -918.3177 -918.0867 
12 -918.2929 -918.0620 -918.3193 -918.0884 
13 -918.2943 -918.0621 -918.3199 -918.0877 
14 -918.2929 -918.0611 -918.3200 -918.0882 
15 -918.2886 -918.0570 -918.3164 -918.0847 
16 -918.2916 -918.0601 -918.3198 -918.0883 
17 -918.2906 -918.0588 -918.3135 -918.0816 
18 -918.2883 -918.0554 -918.3117 -918.0789 
19 -918.2911 -918.0596 -918.3174 -918.0859 
20 -918.2899 -918.0575 -918.3142 -918.0818 
21 -918.2951 -918.0631 -918.3217 -918.0897 
22 -918.2952 -918.0643 -918.3204 -918.0895 
23 -918.2880 -918.0558 -918.3145 -918.0823 
24 -918.2984 -918.0661 -918.3224 -918.0901 
25 -918.2887 -918.0579 -918.3170 -918.0861 
26 -918.2909 -918.0596 -918.3183 -918.0870 
27 -918.2925 -918.0611 -918.3170 -918.0856 
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28 -918.2905 -918.0595 -918.3174 -918.0864 
29 -918.2924 -918.0601 -918.3183 -918.0860 
30 -918.2929 -918.0606 -918.3231 -918.0907 
31 -918.2969 -918.0651 -918.3216 -918.0897 
32 -918.2891 -918.0585 -918.3180 -918.0875 
33 -918.2983 -918.0669 -918.3219 -918.0905 
34 -918.2888 -918.0575 -918.3177 -918.0864 
35 -918.2904 -918.0586 -918.3190 -918.0872 
36 -918.2947 -918.0616 -918.3191 -918.0861 
37 -918.2947 -918.0616 -918.3191 -918.0860 
38 -918.2947 -918.0628 -918.3205 -918.0887 
39 -918.2883 -918.0566 -918.3125 -918.0808 
40 -918.2899 -918.0575 -918.3142 -918.0818 
41 -918.2932 -918.0610 -918.3201 -918.0878 
42 -918.2890 -918.0576 -918.3156 -918.0842 
43 -918.2921 -918.0608 -918.3177 -918.0863 
44 -918.2908 -918.0579 -918.3146 -918.0817 
45 -918.2925 -918.0600 -918.3192 -918.0867 
46 -918.2924 -918.0607 -918.3173 -918.0856 
47 -918.2947 -918.0628 -918.3205 -918.0887 
48 -918.2902 -918.0587 -918.3165 -918.0850 
49 -918.2908 -918.0584 -918.3153 -918.0829 
50 -918.2874 -918.0563 -918.3122 -918.0811 
51 -918.2921 -918.0608 -918.3177 -918.0863 
52 -918.2911 -918.0594 -918.3159 -918.0842 
53 -918.2891 -918.0580 -918.3166 -918.0855 
54 -918.2902 -918.0587 -918.3165 -918.0850 




1 -918.2944 -918.0630 -918.3188 -918.0873 
2 -918.2911 -918.0593 -918.3144 -918.0827 
3 -918.2899 -918.0573 -918.3145 -918.0819 
4 -918.2861 -918.0542 -918.3129 -918.0810 
5 -918.2979 -918.0665 -918.3222 -918.0908 
6 -918.2922 -918.0606 -918.3178 -918.0862 
7 -918.2905 -918.0581 -918.3149 -918.0826 
8 -918.2943 -918.0620 -918.3241 -918.0918 
9 -918.2851 -918.0537 -918.3131 -918.0817 
10 -918.2897 -918.0577 -918.3147 -918.0827 
11 -918.2968 -918.0648 -918.3234 -918.0914 
12 -918.2926 -918.0608 -918.3187 -918.0869 
13 -918.2914 -918.0585 -918.3163 -918.0834 
14 -918.2850 -918.0529 -918.3132 -918.0811 
15 -918.2897 -918.0577 -918.3147 -918.0827 
16 -918.2920 -918.0593 -918.3181 -918.0854 
17 -918.2905 -918.0581 -918.3149 -918.0826 
18 -918.2966 -918.0646 -918.3222 -918.0902 
19 -918.2939 -918.0616 -918.3188 -918.0865 
20 -918.2921 -918.0604 -918.3222 -918.0904 
21 -918.2952 -918.0629 -918.3222 -918.0899 
22 -918.2844 -918.0529 -918.3134 -918.0818 
23 -918.2935 -918.0611 -918.3177 -918.0853 
24 -918.2922 -918.0595 -918.3192 -918.0865 
25 -918.2905 -918.0591 -918.3217 -918.0903 
26 -918.2921 -918.0595 -918.3159 -918.0833 
27 -918.2851 -918.0538 -918.3131 -918.0817 
28 -918.2934 -918.0609 -918.3183 -918.0858 
29 -918.2917 -918.0585 -918.3165 -918.0832 
30 -918.2947 -918.0628 -918.3204 -918.0885 
31 -918.2961 -918.0643 -918.3237 -918.0919 
32 -918.2927 -918.0617 -918.3190 -918.0880 
33 -918.2934 -918.0612 -918.3177 -918.0855 
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34 -918.2954 -918.0645 -918.3203 -918.0894 
35 -918.2918 -918.0598 -918.3187 -918.0868 
36 -918.2926 -918.0610 -918.3180 -918.0864 
37 -918.2935 -918.0624 -918.3200 -918.0888 
38 -918.2924 -918.0612 -918.3179 -918.0866 
39 -918.2926 -918.0612 -918.3190 -918.0876 
40 -918.2946 -918.0629 -918.3220 -918.0903 
41 -918.2918 -918.0601 -918.3172 -918.0855 
42 -918.2935 -918.0611 -918.3177 -918.0853 
43 -918.2940 -918.0609 -918.3195 -918.0865 
44 -918.2921 -918.0595 -918.3159 -918.0833 
45 -918.2961 -918.0643 -918.3237 -918.0919 
46 -918.2934 -918.0612 -918.3177 -918.0855 
47 -918.2928 -918.0606 -918.3208 -918.0886 
48 -918.2966 -918.0649 -918.3208 -918.0891 
49 -918.2920 -918.0605 -918.3165 -918.0849 
50 -918.2894 -918.0574 -918.3165 -918.0846 
51 -918.2892 -918.0575 -918.3165 -918.0848 
52 -918.2937 -918.0618 -918.3182 -918.0863 
53 -918.2949 -918.0631 -918.3197 -918.0880 
54 -918.2942 -918.0619 -918.3199 -918.0877 
55 -918.2947 -918.0626 -918.3216 -918.0894 
56 -918.2940 -918.0609 -918.3196 -918.0865 
57 -918.2935 -918.0611 -918.3177 -918.0853 
58 -918.2904 -918.0595 -918.3187 -918.0878 
59 -918.2949 -918.0631 -918.3198 -918.0880 
60 -918.2869 -918.0550 -918.3116 -918.0797 
61 -918.2926 -918.0610 -918.3180 -918.0864 
62 -918.2935 -918.0619 -918.3172 -918.0856 
63 -918.2935 -918.0618 -918.3197 -918.0879 




1 -918.2985 -918.0672 -918.3233 -918.0920 
2 -918.2992 -918.0679 -918.3245 -918.0931 
3 -918.2933 -918.0614 -918.3175 -918.0856 
4 -918.2964 -918.0646 -918.3228 -918.0910 
5 -918.2923 -918.0601 -918.3170 -918.0848 
6 -918.2963 -918.0645 -918.3235 -918.0916 
7 -918.2943 -918.0625 -918.3214 -918.0896 




1 -918.2989 -918.0674 -918.3231 -918.0916 
2 -918.2940 -918.0621 -918.3178 -918.0860 
3 -918.2935 -918.0620 -918.3177 -918.0862 
4 -918.3004 -918.0693 -918.3246 -918.0935 
5 -918.2948 -918.0630 -918.3211 -918.0893 
6 -918.2979 -918.0666 -918.3231 -918.0917 
7 -918.2921 -918.0604 -918.3170 -918.0853 
8 -918.2925 -918.0605 -918.3170 -918.0851 




1 -918.2966 -918.0651 -918.3214 -918.0898 
2 -918.2974 -918.0660 -918.3220 -918.0906 
3 -918.2920 -918.0605 -918.3164 -918.0848 
4 -918.2966 -918.0650 -918.3233 -918.0918 
5 -918.2962 -918.0650 -918.3224 -918.0912 
6 -918.2935 -918.0617 -918.3182 -918.0864 
7 -918.2992 -918.0677 -918.3242 -918.0927 
8 -918.2913 -918.0597 -918.3160 -918.0845 
9 -918.2939 -918.0619 -918.3183 -918.0862 
10 -918.2963 -918.0642 -918.3202 -918.0881 
11 -918.2957 -918.0640 -918.3203 -918.0887 
Angiopterlactone A 
1 
1 -918.2965 -918.0646 -918.3235 -918.0916 
2 -918.2976 -918.0663 -918.3240 -918.0927 
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(Compound VIII) 3 -918.2956 -918.0640 -918.3226 -918.0910 
4 -918.2872 -918.0559 -918.3155 -918.0841 
5 -918.2937 -918.0613 -918.3182 -918.0858 
6 -918.2960 -918.0641 -918.3215 -918.0897 
7 -918.2963 -918.0647 -918.3219 -918.0903 
8 -918.2911 -918.0595 -918.3161 -918.0845 
9 -918.2911 -918.0595 -918.3161 -918.0845 
Table 50: Method M3; DMSO 
 
 I II III IV V VI VII VIII 
1H MAE 0.12 0.12 0.18 0.18 0.18 0.26 0.23 0.15 
Difference 
wrt I 
0.00 0.00 0.06 0.05 0.05 0.13 0.11 0.02 
13C MAE 1.3 1.4 2.2 2.2 3.1 2.7 3.1 3.4 
Difference 
wrt I 
0.0 0.1 0.9 0.9 1.8 1.3 1.8 2.1 
JH-H MAE 0.9 0.8 2.4 2.5 4.1 3.6 1.8 2.3 
Difference 
wrt I 
0.0 -0.1 1.5 1.7 3.2 2.7 1.0 1.4 
Table 51: Method M3; DMSO; angiopterlactone B (2); MAE values including all data points (wrt = with 
respect to) 
 
 I II III IV V VI VII VIII 
1H MAE 0.09 0.10 0.19 0.18 0.17 0.27 0.24 0.13 
Difference 
wrt I 
0.00 0.00 0.10 0.09 0.07 0.17 0.14 0.03 
13C MAE 0.9 1.0 2.0 2.1 2.7 2.3 2.7 2.9 
Difference 
wrt I 
0.0 0.1 1.1 1.1 1.8 1.4 1.8 2.0 
JH-H MAE 0.5 0.6 1.7 1.7 3.5 3.6 2.5 2.4 
Difference 
wrt I 
0.0 0.1 1.2 1.2 3.0 3.1 2.0 1.9 
Table 52: Method M3; DMSO; angiopterlactone B (2); MAE values excluding certain data points, as 






2.4 Slope and Intercept Values for Linear Regression Analyses 
 
Slope and intercept values for the TMS referenced 1H and 13C chemical shifts, for methods 
M3 and M4. 
Compound 
1H chemical shift data 13C chemical shift data 
Slope Intercept Slope Intercept 
γ-lactone 
4 1.0110 0.0696 1.0467 1.7479 
6 1.0303 0.0513 1.0543 0.7937 
δ-lactone 
3 1.0660 -0.0379 1.0512 1.3651 
5 1.0233 0.1107 1.0339 4.9700 
Angiopterlactone B (2) 
I 1.0423 0.0199 1.0455 2.1237 
II 1.0441 0.0337 1.0423 2.4012 
III 1.0117 0.0505 1.0454 3.0563 
IV 1.0234 0.0014 1.0497 2.7318 
V 1.0271 -0.0164 1.0439 4.4608 
VI 1.0137 -0.0155 1.0394 4.3894 
VII 1.0094 0.0258 1.0459 4.2049 
VIII 1.0273 0.0218 1.0486 4.3878 
Angiopterlactone A (1) 
I 1.0148 0.1220 1.0508 1.1814 
II 1.0116 0.1488 1.0519 0.8284 
III 1.0084 0.1358 1.0444 1.6129 
IV 1.0031 0.1495 1.0458 1.9378 
V 1.0156 -0.0252 1.0585 0.6747 
VI 1.0229 0.0583 1.0598 0.5046 
VII 1.0563 -0.0555 1.0689 -0.7388 
VIII 1.0565 -0.1640 1.0680 -0.8138 
Table 53: Method M3, using all chemical shifts that could be confidently assigned 
 
Compound 
1H chemical shift data 13C chemical shift data 
Slope Intercept Slope Intercept 
γ-lactone 
4 0.9933 0.0999 - - 
6 1.0204 -0.0020 - - 
δ-lactone 
3 0.9967 0.1097 - - 
5 0.9554 0.2318 - - 
Angiopterlactone B (2) 
I 0.9364 0.2063 0.9625 4.3242 
II 0.9220 0.2526 0.9675 3.9466 
III 0.8540 0.3152 0.9537 5.6315 
IV 0.8757 0.2390 0.9556 5.7555 
V 0.9014 0.1987 0.9332 10.4099 
VI 0.8656 0.2427 0.9435 9.2430 
VII 0.8949 0.2405 0.9374 10.1175 
VIII 0.9335 0.1840 0.9281 11.1060 
Angiopterlactone A (1) 
I 0.9747 0.1399 - - 
II 0.9538 0.2096 - - 
III 0.9749 0.1201 - - 
IV 0.9758 0.1255 - - 
V 0.9556 0.1246 - - 
VI 0.9577 0.1552 - - 
VII 0.9899 0.0696 - - 
VIII 0.9902 0.0195 - - 
Table 54: Method M4, excluding largely deviating chemical shifts 
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Appendices for Chapter 3 
 
All input and output files have been archived with the University of Edinburgh. 
 
3.1 Energy values 
 
All energies (E) and Gibbs Free energies (G) are provided in Hartrees (a.u.) at 343 K. Only 
the energies of the lowest energy conformer are provided. The energies and imaginary 
frequencies for all transition states (TS) are listed below (cm–1). Transition states are labelled 
as follows: RC1/2 are the first and second step of the ring contraction, oM is the oxa-Michael 
addition and M is the Michael addition. Furthermore, energy values for all ground state (GS) 
species are provided.  These dimeric species are defined by the nomenclature used within 
Chapter 3 (Figure 65). 
 











 Species E G 
Imaginary 
Frequency 
CO32- GS -264.004662 -264.020189  
HCO31- GS -264.547187 -264.551086  
Table 55: Energies of CO32- and HCO31- 
 
Homo-coupling of ent-3 
 
Pathway 1 - Re Species E G 
Imaginary 
Frequency 
Lactone ent-3 GS -458.598816 -458.514077  
RC1 TS -458.568036 -458.483337 -285.77 
RC intermediate GS -458.577393 -458.492242  
RC2 TS -458.577016 -458.491844 -194.19 
Encounter complex GS -917.748085 -917.539703  
oM TS -917.728998 -917.518948 -172.81 
γ,δ-dimer GS -917.741526   -917.529806  
M TS -917.729734 -917.517116 -299.86 
γ,δ-tricyclic dimer GS -917.769585 -917.552848  
Table 56: Energies for the Re-pathway (P1) of the homo-coupling of ent-3 
Pathway 1 - Si Species E G 
Imaginary 
Frequency 
oM TS -917.734906 -917.524120 -297.53 
γ,δ-dimer GS -917.740281 -917.528517  
M TS -917.729953    -917.515762 -344.44 
γ,δ-tricyclic dimer GS -917.765910 -917.547584  
Table 57: Energies for the Si-pathway (P1) of the homo-coupling of ent-3 
Ring Contraction M06-2X Species E G 
Imaginary 
Frequency 
Reactant State GS -458.565317 -458.480739  
RC1 TS -458.537719 -458.452897 -272.82 
RC intermediate GS -458.548675 -458.462852  
RC2 TS -458.547511 -458.462167 -198.34 
Product State GS -458.564284 -458.480633  




Ring-fused Cis/trans E G 
Option A 
cis -313.289084 -313.119484 
trans -313.274656 -313.106684 
Option B 
cis -352.607254 -352.410104 
trans -352.597905 -352.402148 
Table 59: Testing the stability of cis- and trans- fused ring systems 
 





5 -459.121758 -459.024656 
6 -459.115478 -459.016887 
Option B 
5 -460.357227 -460.236739 
6 -460.350223   -460.228657 
Option C 
5 -344.583766 -344.516128 
6   -344.576253 -344.506593 
Option D 
5 -345.817870 -345.726615 
6 -345.808432 -345.715610 
Option E 
5 -271.768991 -271.658496 
6 -271.770294 -271.657421 
Option F 
5 -309.890650 -309.777669 
6 -309.894459 -309.779103 
Option G 
5 -235.869315 -235.736216 
6 -235.877548 -235.739484 
Option G (Twist-boat) 6 -235.867635 -235.731828 
Table 60: Testing the stability of various 5- and 6-membered rings 
 
Product Stability Tests Re / Si E G 
Option B 
Re -803.230063   -803.044497 
Si -803.225201 -803.038497 
Option C 
Re -615.864411 -615.670438 
Si -615.861770 -615.668076 







RC - hydrogenated Species E G 
Imaginary 
Frequency 
Reactant State GS -459.828288 -459.721221  
RC1 TS -459.817601 -459.708976 -251.30 
RC intermediate GS -459.825648 -459.715980  
RC2 TS -459.820105 -459.711363 -216.71 
Product State GS -459.829814 -459.723127  
Table 62: Computing the ring contraction for the hydrogenated δ-lactone 
 





Re   -612.456055 -612.310949  
Si -612.460504 -612.315261  
RC1 
Re -612.451098 -612.305156 -251.48 
Si -612.450251 -612.304003 -228.44 
RC intermediate 
Re -612.460235 -612.313022  
Si -612.455434 -612.308134  
RC2 
Re -612.454031 -612.308221 -222.58 
Si -612.445654 -612.299714 -221.87 
Product State 
Re -612.461371 -612.316873  
Si -612.450407 -612.305565  
Option C 
Reactant State 
Re -574.348898 -574.211768  
Si -574.351588 -574.215597  
RC1 
Re   -574.335710 -574.198715 -250.79 
Si -574.338407 -574.201080 -234.63 
RC intermediate 
Re -574.344557 -574.206771  
Si -574.344469 -574.206494  
RC2 
Re -574.339437 -574.202328 -210.70 
Si -574.336505 -574.199279 -230.55 
Product State 
Re -574.349257 -574.213762  
Si -574.342112 -574.205647  








Pathway 2 - Re Species E G 
Imaginary 
Frequency 
Encounter complex GS -917.741601 -917.533829  
oM TS -917.725746 -917.513668 -256.14 
δ,δ-dimer GS   -917.737223   -917.523941  
RC1 TS -917.721602 -917.507927 -240.24 
RC intermediate GS -917.730433 -917.516291  
RC2 TS -917.724985 -917.511605 -220.34 
Table 64: Energies for the Re-pathway (P2) of the homo-coupling of ent-3 
 
Pathway 2 - Si Species E G 
Imaginary 
Frequency 
oM TS -917.723006 -917.513813 -129.59 
δ,δ-dimer GS -917.739312 -917.527540  
RC1 TS -917.724537 -917.510795 -233.90 
RC intermediate GS -917.730279 -917.516084  
RC2 TS -917.721756 -917.508212 -225.24 
Table 65: Energies for the Si pathway (P2) of the homo-coupling of ent-3 
 
Pathway 3 - Re Species E G 
Imaginary 
Frequency 
M TS -917.725518 -917.510300 -278.31 
δ,δ-tricyclic dimer GS -917.768868 -917.551132  
RC1 TS -917.762430 -917.543938 -236.38 
RC intermediate GS -917.770943 -917.551934  
RC2 TS -917.760045 -917.542328 -207.25 
Table 66: Energies for the Re pathway (P3) of the homo-coupling of ent-3 
Pathway 3 - Si Species E G 
Imaginary 
Frequency 
M TS -917.727386 -917.513629 -266.37 
δ,δ-tricyclic dimer GS -917.766782 -917.548574  
RC1 TS -917.756509 -917.536673 -195.65 
RC intermediate GS -917.761788 -917.541839  
RC2 TS -917.746473 -917.528370 -214.49 





Testing axial vs equatorial Ax/eq E G 
Lactone ent-3 
Protonated ax -459.111861 -459.013868 
Protonated eq -459.115478 -459.016887 
Deprotonated ax -458.596662 -458.512225 
Deprotonated eq -458.598816 -458.514077 
Lactone 5 
Protonated ax -459.11287 -459.014848 
Protonated eq -459.113881 -459.016554 
Deprotonated ax -458.597313 -458.512619 
Deprotonated eq -458.599114 -458.515214 
Table 68: Testing the energies of protonated/deprotonated ent-3 and 5 with the methyl group in the 
axial or equatorial position 
 
Homo-coupling of 5 
 
Pathway 1 Species E G 
Imaginary 
Frequency 
Lactone 5 GS -458.599114 -458.515214  
RC1 TS -458.567587 -458.482903 -283.75 
RC intermediate GS -458.577156 -458.491902  
RC2 TS -458.576915 -458.491656 -196.01 
Table 69: Energies for P1 in the homo-coupling of 5 
 
Pathway 2 - Re Species E G 
Imaginary 
Frequency 
Encounter complex GS -917.745789 -917.538372  
oM TS -917.732040 -917.520631 -303.80 
δ,δ-dimer GS -917.740022 -917.528372  
RC1 TS -917.721397 -917.507263 -241.86 
RC intermediate GS -917.727898 -917.513002  
RC2 TS   -917.722053 -917.507601 -202.84 
γ,δ-dimer GS -917.740106 -917.529513  
M TS -917.733027 -917.520069 -304.49 
γ,δ-tricyclic dimer GS -917.769906 -917.553732  






Pathway 2 - Si Species E G 
Imaginary 
Frequency 
oM TS -917.721587 -917.512555 -142.74 
δ,δ-dimer GS -917.735821 -917.523927  
RC1 TS -917.720776 -917.507853 -210.40 
RC intermediate GS -917.726127 -917.512832  
RC2 TS -917.718662 -917.504814 -212.59 
γ,δ-dimer GS -917.740014 -917.527041  
M TS -917.725465 -917.511163 -290.71 
γ,δ-tricyclic dimer GS -917.765473 -917.548180  
Table 71: Energies for the Si pathway (P2) in the homo-coupling of 5 
 
 
Pathway 3 - Re Species E G 
Imaginary 
Frequency 
M TS -917.733879 -917.519941 -328.61 
δ,δ-tricyclic dimer GS -917.765241 -917.549035  
RC1 TS -917.759599 -917.540655 -227.66 
RC intermediate GS -917.768061 -917.548758  
RC2 TS -917.760914 -917.542627 -188.10 
Table 72: Energies for the Re pathway (P3) in the homo-coupling of 5 
 
Pathway 3 - Si Species E G 
Imaginary 
Frequency 
M TS -917.725456 -917.511320 -284.98 
δ,δ-tricyclic dimer GS -917.761893 -917.545613  
RC1 TS -917.751238 -917.531757 -222.23 
RC intermediate GS -917.756242 -917.536705  
RC2 TS -917.752242 -917.532318 -166.23 









Cross-coupling of ent-3 with 5 
 
Pathway 2 - Re Species E G 
Imaginary 
Frequency 
Encounter complex GS -917.743763 -917.536877  
oM TS -917.731761 -917.520207 -280.31 
δ,δ-dimer GS -917.740279 -917.527757  
RC1 TS -917.720121 -917.506340 -244.83 
RC intermediate GS -917.728910 -917.514761  
RC2 TS -917.724018 -917.510118 -180.55 
γ,δ-dimer GS -917.740749 -917.529529  
M TS -917.728483   -917.515857 -365.49 
γ,δ-tricyclic dimer GS -917.768915 -917.553426  
Table 74: Energies for the Re pathway (P2) in the cross-coupling of ent-3 with 5 
 
Pathway 2 - Si Species E G 
Imaginary 
Frequency 
oM TS -917.721348 -917.510645 -155.44 
δ,δ-dimer GS -917.736088 -917.524079  
RC1 TS -917.720743 -917.507033 -234.51 
RC intermediate GS   -917.726150 -917.511556  
RC2 TS -917.718353 -917.504433 -208.70 
γ,δ-dimer GS -917.740596 -917.528836  
M TS -917.730207 -917.515181 -339.93 
γ,δ-tricyclic dimer GS -917.767620 -917.549538  
Table 75: Energies for the Si pathway (P2) in the cross-coupling of ent-3 with 5 
 
Pathway 3 - Re Species E G 
Imaginary 
Frequency 
M TS -917.729664   -917.514756 -310.15 
δ,δ-tricyclic dimer GS -917.767356 -917.549257  
RC1 TS -917.760876 -917.542532 -224.78 
RC intermediate GS -917.769436 -917.550011  
RC2 TS -917.758983 -917.541002 -183.11 





Pathway 3 - Si Species E G 
Imaginary 
Frequency 
M TS -917.727406 -917.512813 -276.98 
δ,δ-tricyclic dimer GS -917.763515 -917.546772  
RC1 TS -917.750580 -917.531245 -224.02 
RC intermediate GS -917.755492 -917.534986  
RC2 TS -917.742791 -917.524394 -205.00 




Cross-coupling of 5 with ent-3 
 
Pathway 2 - Re Species E G 
Imaginary 
Frequency 
Encounter complex GS -917.743617 -917.536883  
oM TS -917.727872 -917.515318 -294.42 
δ,δ-dimer GS -917.736956 -917.524714  
RC1 TS -917.724463 -917.510783 -220.86 
RC intermediate GS   -917.731599 -917.517398  
RC2 TS -917.726186 -917.512539 -211.73 
γ,δ-dimer GS   -917.741849 -917.530758  
M TS -917.734230 -917.521594 -347.62 
γ,δ-tricyclic dimer GS -917.769832 -917.554046  
Table 78: Energies for the Re pathway (P2) in the cross-coupling of 5 with ent-3 
 
Pathway 2 - Si Species E G 
Imaginary 
Frequency 
oM TS -917.717402 -917.508812 -204.82 
δ,δ-dimer GS   -917.737402 -917.526605  
RC1 TS -917.725816 -917.512489 -223.22 
RC intermediate GS -917.730796 -917.516567  
RC2 TS -917.722949 -917.508944 -219.11 
γ,δ-dimer GS -917.740086 -917.528417  
M TS -917.731038 -917.517013 -304.21 
γ,δ-tricyclic dimer GS -917.764150 -917.547492  




Pathway 3 - Re Species E G 
Imaginary 
Frequency 
M TS -917.727221 -917.513104 -285.21 
δ,δ-tricyclic dimer GS -917.766919   -917.549850  
RC1 TS -917.760903    -917.542742 -224.28 
RC intermediate GS -917.769656 -917.550815  
RC2 TS -917.762091 -917.544425 -202.18 
Table 80: Energies for the Re pathway (P3) in the cross-coupling of 5 with ent-3 
 
 
Pathway 3 - Si Species E G 
Imaginary 
Frequency 
M TS -917.726055 -917.512638 -292.24 
δ,δ-tricyclic dimer GS -917.766863 -917.548797  
RC1 TS -917.757389 -917.538412 -248.14 
RC intermediate GS   -917.764707 -917.544133  
RC2 TS -917.758521 -917.539282 -202.09 
Table 81: Energies for the Si pathway (P3) in the cross-coupling of 5 with ent-3 
 
3.2 pKa Studies 
 
The pKa studies were completed by following the approach reported by Ho116, in which 
solution phase dissociation free energies are calculated following: ΔG* = G(A–) – G(HA) + 
G*(H+). In this equation, G(A–) and G(HA) are computed directly within the SMD solvation 
model on the solution-phase optimised geometry and the value for the proton free energy 
(G*(H+)) is used from the literature and corrected at a standard state of 1 mol/L. Values have 
been reported for various solvents, such as water, dimethylsulfoxide (DMSO) and methanol. 
As a result of the lack in literature data in dichloroethane (DCE), the reported value for 
methanol (-263.5 kcal/mol) was utilised.117 As the aim was to compare the relative pKa values 
of the different species rather than obtain an absolute pKa, we considered that this 
approximation should not affect our conclusions. Nonetheless, pKa calculations were also 






3.3 NBO Analysis 
 
This section contains the second-order perturbation analysis from which the relevant 
hydrogen-bond contributions (in kcal/mol) are obtained. LP refers to the lone pair, σ* to the 
antibonding orbital. 
Coupling Pathway TS/INT Step Donor Acceptor 
H-bond contribution 
(kcal/mol) 
Homo (ent-3) 1 TS-Si oM 
LP(1)O3 σ*(1)O6-H33 6.3 
LP(2)O3 σ*(1)O6-H33 25.3 
Homo (ent-3) 2 INT-Re δ,δ-dimer LP(1)O7 σ*(1)O21-H31 3.0 
Homo (5) 2 TS-Re oM 
LP(1)O7 σ*(1)O21-H31 4.2 
LP(2)O7 σ*(1)O21-H31 13.9 
Cross (ent-3 
with 5) 
2 TS-Re oM 
LP(1)O7 σ*(1)O21-H31 5.1 
LP(2)O7 σ*(1)O21-H31 11.4 
Cross (ent-3 
with 5) 
2 TS-Si M 
LP(1)O7 σ*(1)O22-H33 2.7 
LP(2)O7 σ*(1)O22-H33 5.3 
Cross (ent-3 
with 5) 
2 Si Product LP(1)O5 σ*(1)O8-H33 4.1 
Cross (ent-3 
with 5) 
3 INT-Re δ,δ-dimer LP(1)O7 σ*(1)O21-H31 3.2 (nbodel: 3.1) 
Cross (5 with 
ent-3) 
2 TS-Re oM 
LP(1)O7 σ*(1)O21-H31 4.5 
LP(2)O7 σ*(1)O21-H31 25.0 















Useful Figures for Chapter 2 
Figure A: Our eight investigated structures of (+)-angiopterlactone A (1). Structure originally proposed 
by isolation chemists is compound I. Si face oxa-Michael addition denoted by blue, Re by red 
 
Figure B: Our eight investigated structures of (+)-angiopterlactone B (2). Si face oxa-Michael addition 
denoted by blue, Re by red) 
 
